Details of Disease

General Information of Disease (ID: DIS86UK6)

Disease Name	Metastatic malignant neoplasm
Synonyms	malignant metastatic neoplasm; metastatic neoplasm, malignant; metastatic malignant neoplasm; metastatic cancer
Disease Class	2D50-2E09: Metastatic malignant neoplasm
Definition	A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.\|Note that we currently treat secondary neoplasms as being neoplastic diseases that are derived from neoplasm; classes such as 'neoplasm', 'carcinoma' are implicitly primary. This may change in future.
Disease Hierarchy	DISIV4KF: Secondary malignant neoplasm DISFAXQ5: Metastatic neoplasm DIS86UK6: Metastatic malignant neoplasm
ICD Code	ICD-11 ICD-11: 2D50-2E09
Disease Identifiers	MONDO ID MONDO_0024880 UMLS CUI C2939419 MedGen ID 422475 SNOMED CT ID 128462008

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Irsogladine	DM0TGTY	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BGB-324	DMDI43Y	Phase 2	siRNA drug	[2]
INCAGN01949	DMK7OHI	Phase 2	Antibody	[3]
H-103	DMRCHOU	Phase 1	NA	[4]
HER2-CAR T Cells	DMZXDBN	Phase 1	CAR T Cell Therapy	[5]
ICasp9M28z T cell	DMY6V5T	Phase 1	CAR T Cell Therapy	[6]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 4 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DCC-2909	DMC38WO	Investigative	NA	[7]
Integrin alpha 5/beta 1	DMF5IVB	Investigative	NA	[7]
Recombinant uteroglobin	DMTICZA	Investigative	NA	[7]
ZP-103	DMTW3VE	Investigative	NA	[7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 595 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCG1	TTMWDGU	Limited	Biomarker	[8]
ADAM10	TTVXEGU	Limited	Altered Expression	[9]
ADAMTS5	TTXSU2Y	Limited	Altered Expression	[10]
ALPI	TTHYMUV	Limited	Biomarker	[11]
ASRGL1	TT4WT91	Limited	Altered Expression	[12]
AZGP1	TTUPYLV	Limited	Biomarker	[13]
BRS3	TTKYEPM	Limited	Biomarker	[14]
CAMKK2	TTV298Y	Limited	Biomarker	[15]
CCNE1	TTCEJ4F	Limited	Biomarker	[16]
CCR4	TT7HQD0	Limited	Altered Expression	[17]
CCR5	TTJIH8Q	Limited	Altered Expression	[18]
CD6	TTMF6KC	Limited	Biomarker	[19]
CD96	TT83C4X	Limited	Biomarker	[20]
CDC20	TTBKFDV	Limited	Biomarker	[21]
CDK19	TTNABU9	Limited	Altered Expression	[22]
CPE	TTXPWO6	Limited	Biomarker	[23]
CRLF1	TT6YF5K	Limited	Biomarker	[24]
CRY1	TT5MLZR	Limited	Altered Expression	[25]
CRY2	TTAO58M	Limited	Altered Expression	[25]
CTAG1A	TTE5ITK	Limited	Biomarker	[26]
CTCFL	TTY0RZT	Limited	Biomarker	[27]
CTSK	TTDZN01	Limited	Biomarker	[28]
DEPDC1	TT8S9CM	Limited	Altered Expression	[29]
DICER1	TTTEOPU	Limited	Altered Expression	[30]
DKK2	TTST5KX	Limited	Biomarker	[31]
EEF2K	TT1QFLA	Limited	Biomarker	[32]
F13A1	TTXI2RA	Limited	Altered Expression	[33]
FES	TTLBY21	Limited	Altered Expression	[34]
FGR	TTPOGS1	Limited	Biomarker	[35]
FNDC1	TTQJCV8	Limited	Altered Expression	[36]
FYN	TT2B9KF	Limited	Biomarker	[37]
HAX1	TT21BYA	Limited	Altered Expression	[38]
HNRNPA2B1	TT8UPW6	Limited	Altered Expression	[39]
HTATIP2	TTC6IX5	Limited	Biomarker	[40]
HTR1D	TT6MSOK	Limited	Biomarker	[41]
IAPP	TTHN8EM	Limited	Biomarker	[11]
IFNAR1	TTSYFMA	Limited	Altered Expression	[42]
IL13RA2	TTMPZ7V	Limited	Altered Expression	[43]
IL2RB	TT9721Y	Limited	Biomarker	[44]
IL7R	TTAWI51	Limited	Biomarker	[45]
ITGAL	TT48WR6	Limited	Biomarker	[46]
ITK	TT3C80U	Limited	Biomarker	[47]
LAG3	TTNVXAW	Limited	Biomarker	[48]
LAMP1	TTC214J	Limited	Biomarker	[49]
LAPTM4B	TTEJQT0	Limited	Altered Expression	[50]
LGMN	TTPTWV5	Limited	Biomarker	[51]
LIFR	TTID542	Limited	Altered Expression	[52]
LIN28A	TTO50LN	Limited	Altered Expression	[53]
LPAR2	TTB7Y8I	Limited	Biomarker	[14]
LTB4R2	TTVJX54	Limited	Biomarker	[54]
MAGEA2	TTOZT28	Limited	Genetic Variation	[55]
MALT1	TTCI81G	Limited	Biomarker	[56]
MMP15	TTNSTO3	Limited	Altered Expression	[57]
NAAA	TTMN4HY	Limited	Biomarker	[58]
NCR1	TTQNRJM	Limited	Biomarker	[59]
NUAK1	TT65FL0	Limited	Biomarker	[60]
PARP3	TTD8MEH	Limited	Biomarker	[61]
PBRM1	TTH8ZRL	Limited	Genetic Variation	[62]
PF4	TTSG7Q5	Limited	Biomarker	[63]
PFKFB3	TTTHMQJ	Limited	Biomarker	[64]
PGD	TTZ3IFB	Limited	Biomarker	[65]
PI4KA	TTCUS9F	Limited	Biomarker	[66]
PLD2	TTRLMKF	Limited	Altered Expression	[67]
PPP3CA	TTA4LDE	Limited	Biomarker	[68]
PRKAR2B	TTW4Y2M	Limited	Altered Expression	[69]
PRKDC	TTK3PY9	Limited	Biomarker	[70]
PRMT1	TTVOJAI	Limited	Altered Expression	[71]
PSIP1	TTH9LDP	Limited	Altered Expression	[72]
PSMB8	TTEAD9J	Limited	Altered Expression	[73]
RGS6	TTJ96M8	Limited	Biomarker	[74]
RIPK2	TTCQ2E5	Limited	Biomarker	[75]
ROR2	TTUDPCI	Limited	Altered Expression	[76]
SLC12A5	TTH6UZY	Limited	Biomarker	[77]
SLC22A1	TTM5Q4V	Limited	Altered Expression	[78]
SLC38A3	TTMAVJQ	Limited	Altered Expression	[79]
SRPK2	TTCZEJ9	Limited	Altered Expression	[80]
SSTR2	TTZ6T9E	Limited	Altered Expression	[81]
STC2	TT4EFTR	Limited	Altered Expression	[82]
SULF2	TTLQTHB	Limited	Biomarker	[83]
SYK	TT2HUPM	Limited	Biomarker	[84]
TAAR1	TTIU98M	Limited	Altered Expression	[85]
TDGF1	TTN7HMG	Limited	Altered Expression	[86]
TIGIT	TTWNL74	Limited	Biomarker	[87]
UGT1A1	TT34ZAF	Limited	Biomarker	[88]
WNT7A	TT8NARC	Limited	Altered Expression	[89]
AGR2	TT9K86S	Disputed	Biomarker	[90]
AXL	TTZPY6J	Disputed	Biomarker	[91]
BMP4	TTD3BSX	Disputed	Biomarker	[92]
COL18A1	TT63DI9	Disputed	Altered Expression	[93]
CSF1	TT0IQER	Disputed	Biomarker	[94]
CYP19A1	TTSZLWK	Disputed	Biomarker	[95]
EIF5A2	TTH53G9	Disputed	Biomarker	[96]
EPHA2	TTRJB2G	Disputed	Biomarker	[97]
FLT1	TT1VAUK	Disputed	Altered Expression	[98]
FSHR	TTZFDBT	Disputed	Altered Expression	[99]
HSPA5	TTW26OG	Disputed	Biomarker	[100]
PLG	TTP86E2	Disputed	Altered Expression	[101]
PTK2B	TTTEFBV	Disputed	Altered Expression	[102]
RICTOR	TT143WL	Disputed	Altered Expression	[103]
SERPINF1	TTR59S1	Disputed	Biomarker	[104]
TIAM1	TTNU6I5	Disputed	Biomarker	[105]
TNFRSF25	TTDV6BQ	Disputed	Biomarker	[106]
VDR	TTK59TV	Disputed	Genetic Variation	[107]
ACR	TTAHE2N	moderate	Biomarker	[108]
ACVR2A	TTX2DRI	moderate	Altered Expression	[109]
ADAM9	TTTYQNS	moderate	Biomarker	[110]
AKR1C3	TT5ZWB6	moderate	Altered Expression	[111]
ANO1	TTOJI4S	moderate	Biomarker	[112]
BGN	TT0JPVF	moderate	Biomarker	[113]
CCL21	TTLZK1U	moderate	Altered Expression	[114]
CD163	TTTZ9DE	moderate	Biomarker	[64]
CD19	TTW640A	moderate	Biomarker	[26]
CD248	TTYJWT7	moderate	Biomarker	[115]
CD70	TTNCIE0	moderate	Altered Expression	[116]
CD74	TTCMYP9	moderate	Genetic Variation	[117]
CDK7	TTQYF7G	moderate	Biomarker	[118]
CDK8	TTBJR4L	moderate	Biomarker	[119]
CDKN2C	TTBRUGA	moderate	Genetic Variation	[120]
CHKA	TT10AWB	moderate	Altered Expression	[121]
CLCN3	TT8XNZ7	moderate	Biomarker	[122]
CLDN18	TT6PKBX	moderate	Altered Expression	[123]
CNTN1	TTPR8FK	moderate	Biomarker	[124]
COL1A2	TTUABC1	moderate	Altered Expression	[125]
CSPG4	TT7MYXI	moderate	Altered Expression	[126]
CTSS	TTUMQVO	moderate	Altered Expression	[127]
CX3CL1	TT1OFBQ	moderate	Biomarker	[128]
CXCR1	TTMWT8Z	moderate	Biomarker	[129]
CYP24A1	TT82UI1	moderate	Altered Expression	[130]
E2F3	TTWIJYH	moderate	Biomarker	[131]
EGFL7	TT7WD0H	moderate	Altered Expression	[132]
EML4	TT92GY4	moderate	Genetic Variation	[133]
ENTPD1	TTYM8DJ	moderate	Biomarker	[134]
EREG	TTYSB89	moderate	Altered Expression	[135]
EYA2	TTUY9C6	moderate	Biomarker	[136]
F2RL2	TTVSEBF	moderate	Biomarker	[137]
FOXQ1	TTEJZOL	moderate	Biomarker	[138]
FST	TTDNM9W	moderate	Biomarker	[139]
FUT3	TTUPAD7	moderate	Biomarker	[140]
GDF2	TTAP4T1	moderate	Altered Expression	[141]
GHR	TTHJWYD	moderate	Biomarker	[142]
GJB1	TTSJIRP	moderate	Biomarker	[143]
GLUL	TTURQ2G	moderate	Biomarker	[144]
GNAQ	TTL1SRG	moderate	Altered Expression	[145]
GPNMB	TT7315J	moderate	Altered Expression	[146]
GPR12	TT3IPW2	moderate	Biomarker	[147]
GZMB	TTKEPHX	moderate	Altered Expression	[148]
HDGF	TTKGV26	moderate	Altered Expression	[149]
HSF1	TTN6STZ	moderate	Biomarker	[150]
HSPA9	TTMTPG3	moderate	Biomarker	[151]
IL25	TTVMO5W	moderate	Biomarker	[152]
IMP3	TTEJA2R	moderate	Altered Expression	[153]
ITGA4	TTJMF9P	moderate	Altered Expression	[154]
ITGAE	TTH0Z37	moderate	Altered Expression	[155]
ITGB3	TTJA1ZO	moderate	Altered Expression	[156]
KAT2B	TTVK7SB	moderate	Biomarker	[157]
KCNJ6	TTTIBVP	moderate	Genetic Variation	[158]
KLK6	TTLPF4X	moderate	Altered Expression	[159]
KMT5A	TTGC95K	moderate	Biomarker	[160]
LATS2	TTML7FG	moderate	Biomarker	[161]
LGR5	TTTSGRH	moderate	Altered Expression	[162]
LIMK1	TTWL9TY	moderate	Altered Expression	[163]
LIPA	TTS8T1M	moderate	Biomarker	[164]
LPAR3	TTE2YJR	moderate	Biomarker	[165]
LRP5	TT7VMG4	moderate	Biomarker	[166]
LY6K	TT5GKHN	moderate	Altered Expression	[167]
MAP3K7	TTJQT60	moderate	Biomarker	[168]
MAPK12	TTYT93M	moderate	Biomarker	[169]
MBTPS1	TTNSM2I	moderate	Biomarker	[170]
MELK	TTBZOTY	moderate	Biomarker	[171]
MMP10	TTXLEG7	moderate	Biomarker	[172]
MMP12	TTXZ0KQ	moderate	Altered Expression	[95]
MSI1	TTSM4BA	moderate	Altered Expression	[173]
MTAP	TTDBX7N	moderate	Genetic Variation	[174]
MYLK	TT18ETS	moderate	Biomarker	[175]
NEDD4	TT1QU6G	moderate	Biomarker	[176]
NLRP1	TTQX29T	moderate	Altered Expression	[177]
NOTCH3	TTVX7IA	moderate	Altered Expression	[178]
NRP2	TTRXUVC	moderate	Genetic Variation	[179]
NTSR1	TTTUMEP	moderate	Altered Expression	[180]
ORAI1	TTE76YK	moderate	Altered Expression	[181]
PARG	TT39J16	moderate	Biomarker	[182]
PDE4D	TTSKMI8	moderate	Biomarker	[183]
PDGFD	TTSN0GA	moderate	Biomarker	[184]
PDX1	TT8SGZK	moderate	Biomarker	[185]
PINX1	TT4FJ3A	moderate	Biomarker	[186]
PKN3	TTW3P4R	moderate	Altered Expression	[187]
PLA2G7	TTDNFMT	moderate	Biomarker	[188]
PPM1D	TTENJAB	moderate	Altered Expression	[189]
PPY	TTIB95A	moderate	Biomarker	[190]
PTPN14	TTNIR6C	moderate	Altered Expression	[191]
RACK1	TTJ10AL	moderate	Biomarker	[192]
RASA1	TTPNZ1F	moderate	Biomarker	[193]
RHD	TTLCKI8	moderate	Biomarker	[194]
ROBO1	TTND1YP	moderate	Biomarker	[195]
ROCK1	TTZN7RP	moderate	Biomarker	[196]
RPS6KA3	TTUM2ZR	moderate	Biomarker	[197]
SEMA4D	TT5UT28	moderate	Biomarker	[198]
SENP1	TTW9HY5	moderate	Genetic Variation	[199]
SHH	TTIENCJ	moderate	Genetic Variation	[200]
SIRT2	TTLKF5M	moderate	Biomarker	[201]
SLC22A3	TTG2UMS	moderate	Biomarker	[47]
SLC7A5	TTPH2JB	moderate	Altered Expression	[202]
SLIT2	TTDWK85	moderate	Altered Expression	[195]
SMPD1	TTJTM88	moderate	Biomarker	[203]
SOX5	TTXHSZK	moderate	Biomarker	[204]
TAGLN	TTDRZ9H	moderate	Altered Expression	[205]
TBX21	TTNF9PH	moderate	Biomarker	[206]
TDO2	TTXNCBV	moderate	Biomarker	[207]
TERF1	TT1Y6J2	moderate	Altered Expression	[208]
TERF2	TT5XSLT	moderate	Altered Expression	[209]
TKTL1	TTNQ1J3	moderate	Altered Expression	[210]
TLR7	TTRJ1K4	moderate	Biomarker	[211]
TNFRSF10A	TT5WLRX	moderate	Altered Expression	[212]
TNFRSF12A	TTKPS7V	moderate	Biomarker	[213]
TRPC5	TT32NQ1	moderate	Biomarker	[214]
TSPAN7	TTMT6VE	moderate	Biomarker	[215]
ACKR3	TTRQJTC	Strong	Biomarker	[216]
ADAM8	TTQWYMD	Strong	Biomarker	[217]
ADORA1	TTK25J1	Strong	Altered Expression	[218]
AFP	TTCFEA1	Strong	Altered Expression	[219]
AIF1	TT12MEP	Strong	Biomarker	[220]
ALCAM	TT2AFT6	Strong	Biomarker	[221]
ALOX15	TTN9T81	Strong	Altered Expression	[222]
AMACR	TTLN1AP	Strong	Altered Expression	[223]
ANG	TTURHFP	Strong	Biomarker	[224]
ANGPT1	TTWNQ1T	Strong	Biomarker	[225]
ANGPTL4	TTWALY5	Strong	Biomarker	[226]
ANXA2	TT4YANI	Strong	Altered Expression	[227]
ARRB1	TTMVD4A	Strong	Biomarker	[228]
ASPA	TT6TLZP	Strong	Genetic Variation	[229]
ATAD2	TT9A0HI	Strong	Biomarker	[230]
ATAT1	TTWUHQ1	Strong	Altered Expression	[231]
AURKA	TTPS3C0	Strong	Biomarker	[232]
B2M	TTY7FKA	Strong	Biomarker	[233]
BACH1	TT2ME4S	Strong	Altered Expression	[234]
BAK1	TTFM7V0	Strong	Genetic Variation	[235]
BCAT1	TTES57P	Strong	Altered Expression	[236]
BIRC7	TTHZ8TA	Strong	Biomarker	[237]
BMP6	TT07RIB	Strong	Altered Expression	[238]
BSG	TT5UJWD	Strong	Posttranslational Modification	[239]
BST2	TT90BJT	Strong	Altered Expression	[240]
BTG1	TTL7N2W	Strong	Altered Expression	[241]
BUB1	TT78309	Strong	Altered Expression	[242]
C5AR1	TTHXFA1	Strong	Altered Expression	[243]
CA12	TTSYM0R	Strong	Biomarker	[244]
CALCR	TTLWS2O	Strong	Biomarker	[245]
CCL20	TT2XAZY	Strong	Altered Expression	[246]
CCR1	TTC24WT	Strong	Altered Expression	[247]
CCR6	TTFDB30	Strong	Altered Expression	[246]
CCR7	TT2GIDQ	Strong	Altered Expression	[248]
CCR9	TTIPS8B	Strong	Altered Expression	[249]
CD1A	TTBGTFN	Strong	Biomarker	[250]
CD200	TT0BE68	Strong	Altered Expression	[251]
CD22	TTM6QSK	Strong	Biomarker	[252]
CD24	TTCTYNP	Strong	Altered Expression	[253]
CD276	TT6CQUM	Strong	Biomarker	[254]
CD300A	TTI2YFK	Strong	Altered Expression	[255]
CD58	TT5KSBY	Strong	Biomarker	[256]
CD83	TTT9MRQ	Strong	Biomarker	[257]
CD9	TTZEIBV	Strong	Altered Expression	[258]
CDH2	TT1WS0T	Strong	Biomarker	[259]
CDH6	TT9QHUK	Strong	Altered Expression	[260]
CDKN1C	TTBSUAR	Strong	Altered Expression	[261]
CEACAM1	TTA9CK4	Strong	Biomarker	[262]
CEACAM6	TTIGH2W	Strong	Biomarker	[263]
CEBPB	TTUI35N	Strong	Altered Expression	[264]
CMA1	TT8VUE0	Strong	Altered Expression	[265]
CTSC	TT4H0V2	Strong	Biomarker	[266]
CXCR2	TT30C9G	Strong	Biomarker	[267]
CXCR3	TT1UCIJ	Strong	Biomarker	[268]
CXCR4	TTBID49	Strong	Biomarker	[269]
CXCR6	TT2BVUA	Strong	Biomarker	[270]
CYP3A5	TTHS0OK	Strong	Biomarker	[88]
DAG1	TT4X7PG	Strong	Biomarker	[271]
DCN	TTB3XAN	Strong	Biomarker	[272]
DHCR24	TTTK0NH	Strong	Biomarker	[273]
DHFR	TTYZVDJ	Strong	Altered Expression	[274]
DLK1	TTF4AVB	Strong	Biomarker	[275]
DLL4	TTV23LH	Strong	Altered Expression	[276]
DPYD	TTZPS91	Strong	Altered Expression	[277]
EGF	TTED8JB	Strong	Altered Expression	[278]
EIF2AK3	TT79U1M	Strong	Biomarker	[279]
EIF4E	TTZGCP6	Strong	Posttranslational Modification	[280]
ENPP2	TTSCIM2	Strong	Altered Expression	[281]
EPHA3	TTHS2LR	Strong	Biomarker	[282]
EPHA8	TTHZ2LW	Strong	Biomarker	[283]
EPHB3	TT5LM7U	Strong	Altered Expression	[284]
EPHB4	TTI4ZX2	Strong	Altered Expression	[285]
ESRRA	TTPNQAC	Strong	Biomarker	[286]
ETS1	TTTGPSD	Strong	Biomarker	[10]
ETS2	TT9AH0M	Strong	Altered Expression	[287]
F2R	TTL935N	Strong	Biomarker	[56]
F2RL3	TTD0652	Strong	Biomarker	[288]
F7	TTF0EGX	Strong	Biomarker	[289]
FER	TTRA9G0	Strong	Altered Expression	[290]
FFAR1	TTB8FUC	Strong	Altered Expression	[291]
FGF4	TTCEKVZ	Strong	Biomarker	[292]
FGFR4	TT1KX2S	Strong	Biomarker	[283]
FKBP5	TT0J5KQ	Strong	Biomarker	[293]
FOSL1	TTY8LZG	Strong	Biomarker	[294]
FOXC1	TTNT3YA	Strong	Altered Expression	[295]
FOXC2	TTLBAP1	Strong	Biomarker	[296]
FOXJ2	TTV1FDA	Strong	Altered Expression	[297]
FPR2	TTOJ1NF	Strong	Biomarker	[298]
FURIN	TTH9WF6	Strong	Altered Expression	[299]
FUT4	TTNV1KZ	Strong	Altered Expression	[300]
FZD7	TTUQMO5	Strong	Biomarker	[301]
GATA3	TT45KOB	Strong	Biomarker	[302]
GCK	TTDLNGZ	Strong	Biomarker	[303]
GMNN	TT390KA	Strong	Altered Expression	[304]
GNA11	TTSRXJW	Strong	Genetic Variation	[305]
GNRH1	TT0ID4A	Strong	Altered Expression	[306]
GPER1	TTDSB34	Strong	Altered Expression	[307]
GPI	TT19JIZ	Strong	Biomarker	[308]
GPR119	TT7QNVC	Strong	Biomarker	[309]
GPR18	TTSLJAR	Strong	Biomarker	[309]
GPR183	TTME5YJ	Strong	Biomarker	[309]
GPR34	TTVXSTQ	Strong	Biomarker	[309]
GRHL2	TTUGH4C	Strong	Altered Expression	[310]
GRM1	TTVBPDM	Strong	Biomarker	[311]
GUCY2C	TTLDPRG	Strong	Biomarker	[312]
GUSB	TTHS7CM	Strong	Biomarker	[313]
HCAR2	TTWNV8U	Strong	Altered Expression	[314]
HCN1	TTNB6UQ	Strong	Biomarker	[88]
HCRTR1	TT60Q8D	Strong	Altered Expression	[315]
HHAT	TT1VNCG	Strong	Biomarker	[316]
HLA-G	TTLKFB3	Strong	Biomarker	[317]
HMGA1	TTBA219	Strong	Biomarker	[318]
HNF4A	TT2F3CD	Strong	Biomarker	[319]
HOXA5	TTXSVQP	Strong	Biomarker	[320]
HOXB13	TTZ6I58	Strong	Biomarker	[321]
HPN	TT25MVL	Strong	Biomarker	[322]
HRC	TTR4FKD	Strong	Biomarker	[323]
HSP90AA1	TT78R5H	Strong	Biomarker	[324]
HSPA8	TTMQL3K	Strong	Biomarker	[325]
HTRA1	TT8POQR	Strong	Biomarker	[326]
HTT	TTIWZ0O	Strong	Genetic Variation	[327]
ID1	TTBXVDE	Strong	Biomarker	[328]
IGFBP2	TTU4QSN	Strong	Biomarker	[329]
IGFBP5	TTDWEA8	Strong	Altered Expression	[330]
IL23A	TTC1GLB	Strong	Biomarker	[331]
IL24	TT1EPXZ	Strong	Altered Expression	[332]
ILK	TT7ALZG	Strong	Biomarker	[333]
IMPDH2	TTTB4UP	Strong	Altered Expression	[334]
ISG15	TTVOH3T	Strong	Biomarker	[335]
ITGA2	TTSJ542	Strong	Altered Expression	[336]
ITGA5	TTHIZP9	Strong	Altered Expression	[337]
ITGA6	TT165T3	Strong	Biomarker	[338]
ITGAM	TTB69FJ	Strong	Biomarker	[339]
ITGAV	TTT1R2L	Strong	Biomarker	[340]
ITGB1	TTBVIQC	Strong	Altered Expression	[341]
ITGB6	TTKQSXZ	Strong	Biomarker	[342]
ITGB8	TTIF29E	Strong	Biomarker	[343]
KDM3A	TTKXS4A	Strong	Biomarker	[344]
KDM5B	TTCLI75	Strong	Altered Expression	[345]
KIF26B	TTQWICZ	Strong	Altered Expression	[346]
KISS1R	TT3KBZY	Strong	Altered Expression	[347]
KIT	TTX41N9	Strong	Altered Expression	[348]
KLF4	TTTI53X	Strong	Altered Expression	[349]
KLK2	TTJLNAW	Strong	Biomarker	[350]
KLK4	TT4319X	Strong	Biomarker	[351]
KLK5	TTULSEW	Strong	Altered Expression	[352]
KLK7	TTE6GTB	Strong	Altered Expression	[352]
KLRK1	TTLRN4A	Strong	Biomarker	[353]
KRT6A	TT2FX8W	Strong	Biomarker	[354]
L1CAM	TTC9D3K	Strong	Biomarker	[355]
LGALS1	TTO3NYT	Strong	Biomarker	[356]
LGR4	TTY6C71	Strong	Altered Expression	[357]
LOXL2	TTFSUHX	Strong	Biomarker	[358]
LPAR1	TTQ6S1K	Strong	Biomarker	[359]
MAGEA1	TT63M7Q	Strong	Biomarker	[360]
MAGEA3	TTWSKHD	Strong	Biomarker	[361]
MAGEA4	TT9EQUY	Strong	Biomarker	[361]
MAP3K1	TTW8TJI	Strong	Biomarker	[362]
MAP3K8	TTGECUM	Strong	Altered Expression	[363]
MAP4K3	TTI0AHJ	Strong	Biomarker	[303]
MAP4K4	TT6NI13	Strong	Biomarker	[364]
MCAM	TTHRE05	Strong	Altered Expression	[365]
MDK	TTV8UE7	Strong	Biomarker	[366]
MERTK	TTO7LKR	Strong	Altered Expression	[367]
MLANA	TT362RB	Strong	Biomarker	[368]
MLH1	TTISG27	Strong	Biomarker	[369]
MME	TT5TKPM	Strong	Biomarker	[370]
MMP1	TTMX39J	Strong	Altered Expression	[371]
MMP14	TTJ4QE7	Strong	Biomarker	[372]
MMP16	TTNP4CU	Strong	Biomarker	[373]
MMP8	TTGA1IV	Strong	Altered Expression	[374]
MSLN	TT4RXME	Strong	Biomarker	[375]
MST1R	TTBQ3OC	Strong	Biomarker	[376]
MTDH	TTH6SA5	Strong	Altered Expression	[377]
MUC16	TTC1PS3	Strong	Altered Expression	[378]
NCOA3	TT124R0	Strong	Altered Expression	[379]
NDUFA13	TTRU1NG	Strong	Biomarker	[380]
NECTIN4	TTPO9EG	Strong	Altered Expression	[381]
NEDD9	TT1UREA	Strong	Altered Expression	[382]
NES	TTHZ752	Strong	Altered Expression	[302]
NISCH	TT789FN	Strong	Biomarker	[383]
NOTCH4	TTXDIK2	Strong	Altered Expression	[276]
NPTX2	TTNJ5A6	Strong	Altered Expression	[384]
NR1I3	TTRANFM	Strong	Biomarker	[385]
NR4A3	TTJQB49	Strong	Biomarker	[386]
NRP1	TTIPJCB	Strong	Altered Expression	[387]
NT5E	TTK0O6Y	Strong	Altered Expression	[388]
OLFM4	TTK1CX7	Strong	Altered Expression	[389]
OSM	TTIVXSE	Strong	Biomarker	[390]
P2RX7	TT473XN	Strong	Biomarker	[391]
P2RY10	TTMFOU6	Strong	Biomarker	[309]
PADI4	TTQHAXM	Strong	Altered Expression	[392]
PAWR	TT3I4WV	Strong	Biomarker	[288]
PCSK1	TTED9LZ	Strong	Biomarker	[354]
PCSK9	TTNIZ2B	Strong	Biomarker	[393]
PDCD1LG2	TTW14O3	Strong	Altered Expression	[394]
PDGFRB	TTI7421	Strong	Altered Expression	[395]
PIKFYVE	TTA4M1N	Strong	Biomarker	[396]
PIM3	TTCGOIN	Strong	Biomarker	[397]
PIN1	TTJNTSI	Strong	Altered Expression	[398]
PKN1	TTSL41O	Strong	Biomarker	[399]
PLAUR	TTNOSTX	Strong	Genetic Variation	[400]
PLCG1	TT6T4JI	Strong	Biomarker	[401]
PLEKHA5	TTCDZMO	Strong	Biomarker	[402]
PLK1	TTH4IP0	Strong	Biomarker	[403]
PLOD1	TTEKJP3	Strong	Altered Expression	[404]
PPM1A	TTLA7IX	Strong	Altered Expression	[405]
PRAME	TTPH7T0	Strong	Biomarker	[406]
PRSS8	TTT4N0Q	Strong	Biomarker	[407]
PSCA	TT9T4AV	Strong	Altered Expression	[408]
PSMB10	TTPNACM	Strong	Biomarker	[409]
PTGER3	TTPNGDE	Strong	Biomarker	[410]
PTK2	TTON5IT	Strong	Biomarker	[411]
PTK6	TT6TH8V	Strong	Altered Expression	[412]
PTP4A1	TTA8GFO	Strong	Altered Expression	[413]
PTP4A2	TT1MHKD	Strong	Altered Expression	[414]
PTPRB	TT64I9Q	Strong	Biomarker	[415]
PYGM	TTZHY6R	Strong	Genetic Variation	[416]
RAD51	TTC0G1L	Strong	Altered Expression	[417]
RALBP1	TTVSRUA	Strong	Altered Expression	[418]
RECK	TTRZBW7	Strong	Posttranslational Modification	[419]
RENBP	TTZCG0Q	Strong	Biomarker	[420]
RHO	TTH0KSX	Strong	Biomarker	[421]
RIPK1	TTVJHX8	Strong	Altered Expression	[418]
ROCK2	TTGWKQJ	Strong	Genetic Variation	[422]
ROR1	TTDEJAU	Strong	Biomarker	[423]
RORB	TTGB2LZ	Strong	Altered Expression	[424]
ROS1	TTSZ6Y3	Strong	Biomarker	[425]
RPE65	TTBOH16	Strong	Biomarker	[426]
RPS6KA1	TTIXKA4	Strong	Biomarker	[427]
RRM2	TT1S4LJ	Strong	Biomarker	[428]
RSF1	TTMP86V	Strong	Altered Expression	[429]
RUNX2	TTD6SZ8	Strong	Biomarker	[430]
RUNX3	TTKCVO7	Strong	Biomarker	[431]
S100B	TTQ0V86	Strong	Altered Expression	[432]
SCGB2A2	TT1W3RE	Strong	Altered Expression	[433]
SDHD	TTVH9W8	Strong	Genetic Variation	[434]
SELPLG	TTS5K8U	Strong	Altered Expression	[435]
SETD2	TTPC3H4	Strong	Genetic Variation	[436]
SFTPD	TTGLMU7	Strong	Genetic Variation	[437]
SGCB	TTEDCQ0	Strong	Biomarker	[438]
SGCG	TTSMT9W	Strong	Altered Expression	[439]
SH3GL1	TTTYNAM	Strong	Biomarker	[440]
SIK3	TTW6L4V	Strong	Altered Expression	[441]
SKP2	TT5B2EO	Strong	Altered Expression	[442]
SLC16A1	TTN1J82	Strong	Altered Expression	[265]
SLC16A3	TTG6VD5	Strong	Altered Expression	[265]
SLC19A1	TT09I7D	Strong	Altered Expression	[274]
SLC1A5	TTF7WRM	Strong	Altered Expression	[443]
SLC22A2	TT0XOJN	Strong	Biomarker	[444]
SLC26A4	TT7X02I	Strong	Altered Expression	[445]
SLC39A6	TTZN1CF	Strong	Altered Expression	[446]
SLC6A12	TTQBMPI	Strong	Posttranslational Modification	[447]
SLC9A1	TTGSEFH	Strong	Genetic Variation	[448]
SLCO1B3	TTU86P0	Strong	Genetic Variation	[449]
SLCO2B1	TTDL3UZ	Strong	Genetic Variation	[449]
SMYD3	TTKLJYX	Strong	Biomarker	[450]
SNCG	TT5TQNZ	Strong	Altered Expression	[451]
SOST	TTYRO4F	Strong	Biomarker	[452]
SPDEF	TT2ZUPY	Strong	Biomarker	[453]
SRC	TT6PKBN	Strong	Altered Expression	[454]
SRD5A2	TTT02K8	Strong	Genetic Variation	[455]
SRGN	TTCHB06	Strong	Biomarker	[456]
SSTR1	TTIND6G	Strong	Biomarker	[457]
SSTR4	TTAE1BR	Strong	Biomarker	[14]
SSTR5	TT2BC4G	Strong	Biomarker	[457]
ST14	TTPRO7W	Strong	Biomarker	[458]
STC1	TTDLUER	Strong	Biomarker	[459]
STK33	TTP34DQ	Strong	Posttranslational Modification	[460]
STMN1	TT7W5OT	Strong	Altered Expression	[461]
STYK1	TTRMCYJ	Strong	Biomarker	[462]
SYVN1	TT8XKYM	Strong	Genetic Variation	[463]
TACSTD2	TTP2HE5	Strong	Altered Expression	[464]
TBL1XR1	TTYXT16	Strong	Altered Expression	[465]
TEK	TT9VGXW	Strong	Biomarker	[466]
TFPI	TT068JH	Strong	Biomarker	[467]
TGFBR1	TTP4520	Strong	Biomarker	[468]
TGM2	TT2F4OL	Strong	Biomarker	[469]
TMEM97	TT9NXW4	Strong	Altered Expression	[470]
TMPRSS2	TT1GM2Z	Strong	Genetic Variation	[471]
TNC	TTUCPMY	Strong	Altered Expression	[472]
TNFRSF11A	TT3K9S2	Strong	Altered Expression	[473]
TNFRSF11B	TT2CJ75	Strong	Altered Expression	[473]
TNFSF12	TTBTDM1	Strong	Altered Expression	[474]
TNFSF14	TTKVENM	Strong	Biomarker	[475]
TNFSF4	TTBW580	Strong	Biomarker	[476]
TNNC1	TT8RDXP	Strong	Biomarker	[477]
TOP2A	TTCGY2K	Strong	Altered Expression	[478]
TPO	TT52XDZ	Strong	Altered Expression	[479]
TPT1	TT3PTB6	Strong	Biomarker	[480]
TRIM27	TTTO3QN	Strong	Biomarker	[298]
TRIM28	TTQ2BKV	Strong	Biomarker	[481]
TRIM59	TT613U4	Strong	Biomarker	[482]
TRPM1	TTTDAI9	Strong	Biomarker	[424]
TRPM4	TTJ2HKA	Strong	Altered Expression	[483]
TRPM7	TTFPVZO	Strong	Biomarker	[484]
TRPV2	TTBECWA	Strong	Altered Expression	[485]
TSG101	TTHU7JA	Strong	Biomarker	[486]
TSHR	TT6NYJA	Strong	Altered Expression	[487]
TSPO	TTPTXIN	Strong	Altered Expression	[488]
TYMP	TTO0IB8	Strong	Genetic Variation	[489]
TYMS	TTP1UKZ	Strong	Altered Expression	[490]
TYRO3	TTIEMFN	Strong	Altered Expression	[491]
TYRP1	TTFRV98	Strong	Genetic Variation	[492]
ULK1	TT4D7MJ	Strong	Genetic Variation	[493]
UTS2R	TTW5UDX	Strong	Genetic Variation	[494]
VEGFD	TTOM5H4	Strong	Biomarker	[495]
VWF	TT3SZBT	Strong	Biomarker	[496]
WEE1	TTJFOAL	Strong	Genetic Variation	[497]
ZNF217	TTY3BRA	Strong	Altered Expression	[498]
ABCB1	TT3OT40	Definitive	Biomarker	[499]
ANPEP	TTPHMWB	Definitive	Biomarker	[500]
AR	TTKPW01	Definitive	Genetic Variation	[501]
AREG	TT76B3W	Definitive	Biomarker	[502]
ATF4	TTQCKWT	Definitive	Biomarker	[503]
BMPR2	TTGKF90	Definitive	Altered Expression	[504]
CA9	TT2LVK8	Definitive	Altered Expression	[505]
CALCA	TTVSFJW	Definitive	Biomarker	[506]
CALR	TTUZ7OA	Definitive	Biomarker	[245]
CCN1	TTPK79J	Definitive	Altered Expression	[507]
CD36	TTPJMCU	Definitive	Biomarker	[508]
CDH11	TTRGWZC	Definitive	Altered Expression	[509]
CSNK2A2	TT7GR5W	Definitive	Biomarker	[510]
CTLA4	TTI2S1D	Definitive	Biomarker	[511]
CXCL1	TTLK1RW	Definitive	Biomarker	[512]
CXCL11	TTWG0RE	Definitive	Biomarker	[513]
CXCL12	TT4UGTF	Definitive	Altered Expression	[514]
CXCL2	TTZF0K2	Definitive	Altered Expression	[515]
DDR2	TTU98HG	Definitive	Biomarker	[516]
DKK1	TTE3RAC	Definitive	Altered Expression	[517]
DPP4	TTDIGC1	Definitive	Altered Expression	[518]
EPHB2	TTKPV6O	Definitive	Biomarker	[519]
EZH2	TT9MZCQ	Definitive	Biomarker	[520]
F3	TT38MDJ	Definitive	Altered Expression	[521]
FOXM1	TTD3KOX	Definitive	Altered Expression	[522]
FOXO1	TTLRVIA	Definitive	Biomarker	[523]
FSCN1	TTTRS9B	Definitive	Biomarker	[524]
FZD10	TTP1S2F	Definitive	Biomarker	[525]
GDF15	TT4MXVG	Definitive	Altered Expression	[526]
HMGB1	TTWQYB7	Definitive	Biomarker	[495]
HPSE	TTR7GJO	Definitive	Biomarker	[527]
HSPB3	TTLH8WG	Definitive	Biomarker	[528]
IL2	TTF89GD	Definitive	Biomarker	[529]
IL7	TT8FRMO	Definitive	Biomarker	[45]
IRF1	TT4TU3L	Definitive	Altered Expression	[530]
KDR	TTUTJGQ	Definitive	Posttranslational Modification	[531]
KISS1	TTU2O6T	Definitive	Altered Expression	[532]
LCN2	TTKTLAI	Definitive	Biomarker	[512]
LDHA	TTW76JE	Definitive	Biomarker	[533]
LILRB1	TTC0QRJ	Definitive	Altered Expression	[534]
LYVE1	TTG8DNU	Definitive	Biomarker	[535]
MC1R	TT0MV2T	Definitive	Altered Expression	[536]
MIA	TT5HNVS	Definitive	Biomarker	[537]
MMP13	TTHY57M	Definitive	Altered Expression	[538]
MMP7	TTMTWOS	Definitive	Altered Expression	[539]
MTA1	TTO4HUS	Definitive	Biomarker	[540]
MYCN	TT9JBY5	Definitive	Genetic Variation	[541]
NGFR	TTEDJN4	Definitive	Altered Expression	[542]
NPEPPS	TT371QC	Definitive	Biomarker	[543]
PEBP1	TT1BGU8	Definitive	Biomarker	[544]
PECAM1	TT4EZB2	Definitive	Biomarker	[545]
PGR	TTUV8G9	Definitive	Biomarker	[546]
PIK3CB	TT9H4P3	Definitive	Biomarker	[547]
POSTN	TT8ALTZ	Definitive	Altered Expression	[548]
PTGES	TTYLQ8V	Definitive	Biomarker	[549]
PTP4A3	TT7YM8D	Definitive	Biomarker	[550]
S100A9	TT0TMQG	Definitive	Altered Expression	[551]
SATB1	TTLFRIC	Definitive	Biomarker	[552]
SELE	TT1PL7M	Definitive	Biomarker	[553]
SELP	TTE5VG0	Definitive	Altered Expression	[203]
SF3B1	TTL2WUI	Definitive	Genetic Variation	[554]
SLC5A5	TTW7HI9	Definitive	Altered Expression	[555]
SLC6A8	TTYUHB5	Definitive	Biomarker	[556]
TNFSF11	TT9E8HR	Definitive	Altered Expression	[557]
TNK2	TTIET93	Definitive	Biomarker	[558]
TWIST1	TTX1MY7	Definitive	Biomarker	[559]
TYR	TTULVH8	Definitive	Biomarker	[560]
USP5	TTGYTMA	Definitive	Genetic Variation	[561]
ZEB2	TTT2WK4	Definitive	Altered Expression	[562]
------------------------------------------------------------------------------------


⏷ Show the Full List of 595 DTT(s)

This Disease Is Related to 9 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC2A3	DT9SQ3L	Limited	Biomarker	[563]
SLC39A14	DTZ6IJW	Limited	Altered Expression	[564]
ATP7A	DT0LT17	moderate	Biomarker	[565]
ABCB6	DTF9Y2V	Strong	Altered Expression	[566]
SLC26A2	DTFSLX5	Strong	Altered Expression	[567]
SLC39A4	DTEZCUM	Strong	Biomarker	[568]
SLC4A7	DT03V27	Strong	Altered Expression	[569]
SLC4A9	DTSQY0W	Strong	Biomarker	[570]
SLC52A1	DT7NOKR	Strong	Altered Expression	[571]
------------------------------------------------------------------------------------


⏷ Show the Full List of 9 DTP(s)

This Disease Is Related to 27 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
DHRS3	DEXPVUN	Limited	Altered Expression	[572]
GLDC	DEIN8FB	Limited	Biomarker	[559]
HPRT1	DEVXTP5	Limited	Altered Expression	[573]
HSD3B1	DERDQWN	Limited	Genetic Variation	[574]
LAP3	DENZF0O	Limited	Biomarker	[575]
MT1A	DE5ME8A	Limited	Biomarker	[576]
UGDH	DE48Q2Z	Limited	Biomarker	[577]
UGT2B15	DENZ6B1	Limited	Biomarker	[578]
ACP3	DEDW5H6	moderate	Biomarker	[579]
CHST3	DEQIZP2	moderate	Genetic Variation	[580]
CYP27B1	DE3FYEM	moderate	Altered Expression	[581]
WARS1	DEPVE0M	moderate	Altered Expression	[582]
AKR1C1	DE7P2FB	Strong	Biomarker	[583]
CMPK1	DEMPH4I	Strong	Biomarker	[584]
DIO3	DET89OV	Strong	Biomarker	[275]
HPGD	DEHKSC6	Strong	Biomarker	[585]
HSD17B10	DEGSPC9	Strong	Altered Expression	[586]
NT5C	DE4E31Z	Strong	Biomarker	[587]
PLPP1	DE6WXTH	Strong	Altered Expression	[588]
PTGDS	DER3H9C	Strong	Altered Expression	[445]
SI	DE5EO4Y	Strong	Biomarker	[589]
TPMT	DEFQ8VO	Strong	Biomarker	[590]
UGT1A7	DEZO4N3	Strong	Genetic Variation	[591]
UGT2B17	DEAZDL8	Strong	Biomarker	[592]
UPP2	DEBQ2WU	Strong	Altered Expression	[593]
CYB5R3	DE4A3BL	Definitive	Altered Expression	[594]
PSAT1	DEBS17P	Definitive	Biomarker	[543]
------------------------------------------------------------------------------------


⏷ Show the Full List of 27 DME(s)

This Disease Is Related to 968 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACTR3	OT05LJSH	Limited	Biomarker	[595]
AEBP1	OTBI1RZ6	Limited	Altered Expression	[596]
AGO1	OTD3R434	Limited	Altered Expression	[597]
AHNAK2	OTD2X4BX	Limited	Altered Expression	[598]
ALDH6A1	OT8LCZCT	Limited	Biomarker	[528]
ALPP	OTZU4G9W	Limited	Biomarker	[11]
AMFR	OTQRX7LC	Limited	Biomarker	[308]
ANXA3	OTDD8OI7	Limited	Altered Expression	[599]
APOBEC3A	OTYO6F5P	Limited	Biomarker	[595]
APOBEC3B	OTHLNI51	Limited	Altered Expression	[600]
ARHGEF7	OT9BPJCL	Limited	Biomarker	[601]
ARL2BP	OT7REEDA	Limited	Altered Expression	[602]
ARPC2	OTSOKOMY	Limited	Biomarker	[603]
ASAP1	OT4DLRYY	Limited	Biomarker	[193]
ATP2C2	OTGIHTYQ	Limited	Biomarker	[604]
ATP6V0C	OTKPL09B	Limited	Biomarker	[605]
AXIN1	OTRGZGZ5	Limited	Biomarker	[41]
BAG1	OTRQNIA4	Limited	Altered Expression	[606]
BCORL1	OTPTFQN5	Limited	Biomarker	[607]
CACYBP	OTJMZD2T	Limited	Biomarker	[608]
CADM4	OT0TFMFE	Limited	Altered Expression	[609]
CAP2	OTC1WFNO	Limited	Altered Expression	[610]
CARMIL3	OT4ZN0K3	Limited	Altered Expression	[611]
CBX4	OT4XVRRF	Limited	Altered Expression	[612]
CCN4	OT69BER9	Limited	Biomarker	[613]
CD226	OT4UG0KB	Limited	Biomarker	[20]
CD99	OTPUZ5DE	Limited	Biomarker	[614]
CETN1	OTGQ8JOZ	Limited	Altered Expression	[615]
CHAC1	OTJGE772	Limited	Altered Expression	[616]
CHD1	OT9R9G0H	Limited	Altered Expression	[617]
CLDN1	OT27KV99	Limited	Biomarker	[618]
CLDN2	OTRF3D6Y	Limited	Altered Expression	[619]
CLDN5	OTUX60YO	Limited	Altered Expression	[620]
CLDN7	OTNE0XHQ	Limited	Altered Expression	[621]
CLEC4G	OTUGTR0H	Limited	Biomarker	[622]
CMTM8	OTG28GH2	Limited	Altered Expression	[623]
COPS3	OTZWPJ24	Limited	Altered Expression	[624]
CRABP2	OTY01V9G	Limited	Genetic Variation	[625]
CSH1	OT33HTRR	Limited	Biomarker	[626]
CSH2	OTW8JVAN	Limited	Biomarker	[626]
CST1	OTE4I83Q	Limited	Altered Expression	[627]
CST6	OTZVHJTF	Limited	Altered Expression	[628]
CSTA	OT1K68KE	Limited	Altered Expression	[629]
CTAG1B	OTIQGW6U	Limited	Biomarker	[26]
CXCL14	OTM189TA	Limited	Altered Expression	[630]
CYFIP1	OTOBEH24	Limited	Altered Expression	[631]
CYP4Z1	OTKRGJBG	Limited	Biomarker	[632]
CYREN	OT5ZL00R	Limited	Biomarker	[633]
CYRIB	OTLRN4L1	Limited	Biomarker	[634]
CYTL1	OTLYUPUY	Limited	Biomarker	[635]
DACH1	OTMKNAGG	Limited	Altered Expression	[636]
DCX	OTISR7K3	Limited	Biomarker	[637]
DEF6	OTIRBYVK	Limited	Altered Expression	[488]
DIAPH1	OTZBYPLH	Limited	Biomarker	[638]
DUSP2	OTH54FMR	Limited	Altered Expression	[639]
DVL1	OTD67RF1	Limited	Altered Expression	[640]
DVL3	OTPRROHJ	Limited	Altered Expression	[640]
EIF6	OTEXMUED	Limited	Altered Expression	[641]
EPS8	OTZ6ES6V	Limited	Altered Expression	[642]
ERRFI1	OT7VZ2IZ	Limited	Altered Expression	[643]
EYA1	OTHU807A	Limited	Biomarker	[644]
FAM83A	OTBI16V7	Limited	Altered Expression	[645]
FARP2	OTNRQIMK	Limited	Biomarker	[646]
FASTK	OTTHFZMP	Limited	Biomarker	[647]
FAT4	OT7QONNV	Limited	Altered Expression	[648]
FBLN1	OT5MHHOP	Limited	Biomarker	[649]
FBXW5	OT5TQK3H	Limited	Altered Expression	[650]
FDCSP	OT8KGE9M	Limited	Altered Expression	[651]
FGF13	OTHNNVSG	Limited	Biomarker	[652]
FGF9	OT2SKDGM	Limited	Biomarker	[653]
FLI1	OT0EV3LX	Limited	Biomarker	[654]
FOXL2	OTFRQUYL	Limited	Biomarker	[336]
FSTL1	OT6KEZUD	Limited	Biomarker	[655]
FUT7	OTJF6BSN	Limited	Biomarker	[656]
FUT8	OTJJCVG1	Limited	Biomarker	[657]
FZD6	OTBCPII8	Limited	Altered Expression	[658]
GASK1B	OT2HPHEI	Limited	Biomarker	[659]
GGPS1	OTVEHG28	Limited	Altered Expression	[660]
GLUD1	OTXKOCUH	Limited	Biomarker	[15]
GNLY	OTZJKA8C	Limited	Altered Expression	[73]
GPAA1	OTWVRR35	Limited	Altered Expression	[661]
GPRC5A	OTPOCWR7	Limited	Altered Expression	[662]
H2AZ1	OT3KJJNQ	Limited	Altered Expression	[663]
H3-3B	OT9XHQ3C	Limited	Genetic Variation	[664]
HECTD1	OTJ95JJS	Limited	Altered Expression	[665]
HHIP	OT77RQYS	Limited	Biomarker	[666]
HHLA2	OTYBTVQS	Limited	Altered Expression	[667]
HIPK1	OTSEA8RS	Limited	Biomarker	[668]
HIPK3	OT4WYQM2	Limited	Altered Expression	[669]
HLA-DOA	OTZE5Q7R	Limited	Biomarker	[670]
HNRNPM	OTFU3OEZ	Limited	Biomarker	[671]
HOXB8	OTKHOD17	Limited	Biomarker	[672]
ICAM3	OTTZ5A5D	Limited	Biomarker	[46]
IL10RA	OTOX3D1D	Limited	Altered Expression	[673]
IL20RA	OTSIVBVS	Limited	Altered Expression	[332]
INSRR	OT3F75WA	Limited	Genetic Variation	[674]
IRF7	OTC1A2PQ	Limited	Altered Expression	[675]
ISL1	OTVNVKAX	Limited	Biomarker	[676]
JAG1	OT3LGT6K	Limited	Altered Expression	[677]
KANK2	OT3SZIWM	Limited	Biomarker	[608]
KDM4B	OT5P1UPY	Limited	Altered Expression	[678]
KIF18A	OTSMBJ24	Limited	Biomarker	[679]
KLF10	OT4F4UGS	Limited	Biomarker	[680]
KLF12	OTVH4KD4	Limited	Altered Expression	[681]
KLF8	OTUC5CDB	Limited	Altered Expression	[682]
LAMA4	OTHI7TA0	Limited	Altered Expression	[683]
LDOC1	OTWZH4O9	Limited	Biomarker	[684]
LIN28B	OTVWP0FN	Limited	Biomarker	[685]
LOXL1	OTA0NEJU	Limited	Biomarker	[686]
LOXL3	OTLLY1QI	Limited	Biomarker	[686]
LPXN	OTUNV3CK	Limited	Biomarker	[106]
LRIG1	OTY5HZN5	Limited	Biomarker	[687]
LRRC8A	OT23OE7H	Limited	Altered Expression	[688]
MAGT1	OTQSAV5C	Limited	Biomarker	[11]
MAP1LC3B	OTUYHB84	Limited	Biomarker	[689]
MARCHF1	OTI2EYO6	Limited	Genetic Variation	[690]
MARCHF8	OTH7PNN2	Limited	Biomarker	[691]
MB	OTYWYL2D	Limited	Biomarker	[692]
MED1	OTOO24C4	Limited	Altered Expression	[693]
MFF	OTEVIXOM	Limited	Altered Expression	[694]
MFSD2A	OTVG1VG0	Limited	Altered Expression	[695]
MGAT3	OTXI5X4T	Limited	Biomarker	[696]
MLLT10	OTURMDV7	Limited	Biomarker	[697]
MLXIP	OT30UNI7	Limited	Biomarker	[691]
MLXIPL	OTR9MLLW	Limited	Biomarker	[698]
MMRN1	OT7ZNYHT	Limited	Biomarker	[699]
MOCOS	OT0TL3Q5	Limited	Biomarker	[700]
MPEG1	OT7DAO0F	Limited	Biomarker	[701]
MRI1	OTOP49DM	Limited	Biomarker	[633]
MTA2	OTCCYIQJ	Limited	Altered Expression	[702]
MTMR2	OTNCYGBP	Limited	Altered Expression	[703]
MUC13	OTWKS9MF	Limited	Biomarker	[704]
MYLIP	OTL0PFGV	Limited	Biomarker	[691]
MYOCD	OTSJNHTH	Limited	Altered Expression	[705]
MYOD1	OTV2S79X	Limited	Genetic Variation	[706]
NANS	OTMQ2FUH	Limited	Genetic Variation	[707]
NCR3LG1	OT15YWU7	Limited	Altered Expression	[708]
NCS1	OT6JHAWM	Limited	Biomarker	[709]
NFIB	OTX94PD0	Limited	Biomarker	[710]
NMU	OTW9X7BQ	Limited	Altered Expression	[711]
NPNT	OTFZAO1G	Limited	Biomarker	[712]
NUPR1	OT4FU8C0	Limited	Biomarker	[713]
OCIAD2	OTSWB4SZ	Limited	Biomarker	[714]
PBOV1	OT67PERT	Limited	Altered Expression	[715]
PBXIP1	OTEAAUBY	Limited	Biomarker	[716]
PIP	OTH719AH	Limited	Biomarker	[717]
PIWIL3	OTQ1B8R4	Limited	Altered Expression	[718]
PKD1	OT5ALRZ5	Limited	Altered Expression	[719]
PLOD3	OTT00T7Q	Limited	Biomarker	[720]
PLXND1	OTNK9ALK	Limited	Altered Expression	[721]
POU2F1	OTK7ELJ0	Limited	Altered Expression	[78]
PSMD14	OTJWHMZ5	Limited	Biomarker	[722]
PTCHD3	OTFQ1VGM	Limited	Biomarker	[723]
PTOV1	OT94WT5X	Limited	Biomarker	[724]
PTPRM	OTCEL6PN	Limited	Altered Expression	[725]
PUF60	OTG90DYF	Limited	Biomarker	[646]
RAB27B	OTPF9D0K	Limited	Biomarker	[726]
RAP1GAP	OTC31ONQ	Limited	Biomarker	[727]
RASGRP3	OTEMEV3P	Limited	Altered Expression	[728]
RBBP8	OTRHJ3GI	Limited	Biomarker	[713]
RBM14	OTO9GMBD	Limited	Biomarker	[608]
RHBDD1	OTL5J132	Limited	Biomarker	[729]
RHOC	OTOLE1FT	Limited	Altered Expression	[730]
RPL36A	OT1LYV85	Limited	Altered Expression	[643]
RPLP1	OT7B0SIB	Limited	Biomarker	[731]
SDF4	OTQ7WFYW	Limited	Altered Expression	[615]
SEC23A	OTBRNIJ3	Limited	Biomarker	[732]
SEMA3D	OTD5TJV1	Limited	Biomarker	[733]
SEMA4A	OT8901H3	Limited	Biomarker	[734]
SESN2	OT889IXY	Limited	Biomarker	[735]
SHROOM2	OTZ2FJ7Q	Limited	Biomarker	[736]
SIRT7	OT5M4OT4	Limited	Altered Expression	[737]
SMCP	OTXKY794	Limited	Biomarker	[700]
SND1	OTT734JN	Limited	Altered Expression	[738]
SNPH	OTL6XBFA	Limited	Altered Expression	[739]
SORBS1	OTWH8762	Limited	Biomarker	[740]
SOX17	OT9H4WWE	Limited	Biomarker	[741]
SOX18	OTPUMHWA	Limited	Biomarker	[742]
SPRTN	OT01D5CE	Limited	Genetic Variation	[743]
SRF	OTW18FQN	Limited	Altered Expression	[705]
SRI	OT4R3EAC	Limited	Altered Expression	[744]
STIP1	OT7TXLOX	Limited	Biomarker	[745]
STK3	OTLNSCQD	Limited	Biomarker	[746]
SYNM	OTOI8TRJ	Limited	Biomarker	[37]
TBX2	OTTOT7A9	Limited	Altered Expression	[628]
TCEA1	OTBFO594	Limited	Biomarker	[608]
TENM3	OTWY13GR	Limited	Biomarker	[596]
TFIP11	OT7NVSWU	Limited	Biomarker	[747]
TGIF1	OTN9VHAG	Limited	Biomarker	[748]
TJP1	OTBDCUPK	Limited	Biomarker	[51]
TMED9	OTYGAQS0	Limited	Biomarker	[319]
TMEM41A	OTAAULKY	Limited	Biomarker	[749]
TMSB10	OTLVZ13T	Limited	Altered Expression	[750]
TNFAIP1	OT37EWR0	Limited	Biomarker	[751]
TNFSF9	OTV9L89D	Limited	Biomarker	[752]
TOPORS	OT1ERFFQ	Limited	Biomarker	[753]
TRAF2	OT1MEZZN	Limited	Biomarker	[754]
TRAPPC9	OTF0CVMC	Limited	Altered Expression	[488]
TRIM31	OT7VW6RP	Limited	Biomarker	[755]
TRIM44	OT0B1T2B	Limited	Altered Expression	[756]
TRIM72	OTFAFXPC	Limited	Altered Expression	[757]
TSACC	OT3QW6PH	Limited	Biomarker	[608]
TSPAN31	OT8WQ83R	Limited	Genetic Variation	[707]
TTC4	OTAPMYXU	Limited	Genetic Variation	[758]
ATXN7	OTL3YF1H	Disputed	Biomarker	[759]
AZIN2	OT8OB7CG	Disputed	Biomarker	[760]
C16orf82	OT77Z5Y5	Disputed	Biomarker	[761]
CABIN1	OT4G5CIK	Disputed	Biomarker	[762]
CADM2	OT45PVKC	Disputed	Biomarker	[763]
CASP8AP2	OTTWT68S	Disputed	Biomarker	[764]
CD200R1	OT65Q9M6	Disputed	Altered Expression	[765]
CD2AP	OTC76KQM	Disputed	Biomarker	[766]
CDC45	OT6NNLOD	Disputed	Biomarker	[767]
CDCA5	OTZLCQ5U	Disputed	Biomarker	[767]
CLIP1	OTTGAEJE	Disputed	Altered Expression	[768]
CMTM7	OTI7Q2JW	Disputed	Altered Expression	[769]
COL15A1	OTTFKK18	Disputed	Altered Expression	[768]
COL5A1	OT24078H	Disputed	Altered Expression	[770]
DPT	OTINRFC7	Disputed	Biomarker	[106]
EFNA1	OTU2NUA2	Disputed	Altered Expression	[771]
ETV4	OT8C98UZ	Disputed	Altered Expression	[16]
FBN2	OT3KYJQL	Disputed	Biomarker	[772]
GADL1	OTJM4A0R	Disputed	Biomarker	[760]
GAGE7	OTF8BTR9	Disputed	Biomarker	[773]
HM13	OTGEO1LP	Disputed	Altered Expression	[774]
HUWE1	OTFH6BJS	Disputed	Biomarker	[775]
IFI16	OT4SPU0U	Disputed	Altered Expression	[776]
IMMP1L	OTA6LOLR	Disputed	Altered Expression	[774]
IQGAP2	OTX2UA7P	Disputed	Altered Expression	[777]
MADD	OTUFYVGG	Disputed	Biomarker	[778]
MAGEH1	OTVE05K7	Disputed	Altered Expression	[768]
MAP2K4	OTZPZX11	Disputed	Biomarker	[779]
MEST	OT8Q4U8Y	Disputed	Biomarker	[780]
MUC4	OTLT11V1	Disputed	Biomarker	[781]
OPCML	OT93PQ6Y	Disputed	Altered Expression	[782]
OPN3	OTON6BFU	Disputed	Altered Expression	[783]
PARP10	OTILI1DU	Disputed	Biomarker	[784]
PDCD5	OT6T2DDL	Disputed	Biomarker	[785]
POLE	OTFM3MMU	Disputed	Biomarker	[786]
PPP1CB	OTYFTYFR	Disputed	Biomarker	[775]
PRSS3	OTN3S5YB	Disputed	Altered Expression	[787]
SAG	OTDNS3ZQ	Disputed	Altered Expression	[788]
SBSN	OT89RKJH	Disputed	Altered Expression	[789]
SMR3B	OTL5HNM8	Disputed	Altered Expression	[414]
TFPI2	OTZCRWOR	Disputed	Altered Expression	[790]
TRAM1	OT3I0H8E	Disputed	Biomarker	[106]
AADAC	OT8VACT2	moderate	Altered Expression	[177]
ADAM12	OTZKOTDB	moderate	Altered Expression	[791]
ADGRG1	OTQBB8NT	moderate	Altered Expression	[792]
AGFG1	OTI8ZKC4	moderate	Biomarker	[793]
ALX1	OTZVARA5	moderate	Altered Expression	[794]
ANXA4	OTUCRYXL	moderate	Altered Expression	[795]
AQP5	OT77GBY8	moderate	Altered Expression	[796]
ASPM	OTKXQMNA	moderate	Altered Expression	[797]
ATF2	OTNIZPEA	moderate	Altered Expression	[798]
ATG4A	OTDHXAPG	moderate	Biomarker	[799]
AXIN2	OTRMGQNU	moderate	Altered Expression	[800]
BMS1	OTEGQ8ZO	moderate	Biomarker	[801]
BNIP3	OT4SO7J4	moderate	Altered Expression	[155]
BUD23	OTJS7VU3	moderate	Biomarker	[802]
CALU	OTSYQN71	moderate	Biomarker	[649]
CANX	OTYP1F6J	moderate	Biomarker	[197]
CAPN3	OTCHG3YK	moderate	Altered Expression	[803]
CARD10	OT2RPM4I	moderate	Altered Expression	[804]
CBFA2T3	OTOJ10S1	moderate	Altered Expression	[805]
CBX8	OT4U5V1T	moderate	Biomarker	[806]
CCDC8	OTO295IH	moderate	Biomarker	[197]
CCDC88A	OT3SSYYC	moderate	Altered Expression	[807]
CD81	OTQFXNAZ	moderate	Biomarker	[808]
CDH9	OTV9N5XK	moderate	Biomarker	[809]
CEMIP	OTK80FYN	moderate	Biomarker	[810]
CFL1	OTT6D5MH	moderate	Altered Expression	[811]
CKLF	OTHLPHA0	moderate	Biomarker	[812]
CMTM3	OTS75IGC	moderate	Biomarker	[813]
COL11A1	OTB0DRMS	moderate	Biomarker	[770]
CTBP1	OTVYH2DH	moderate	Biomarker	[814]
CTHRC1	OTV88X2G	moderate	Biomarker	[815]
CTNND1	OTUMPSHR	moderate	Altered Expression	[816]
CUL4A	OTTBV70J	moderate	Altered Expression	[817]
CYC1	OT0962IM	moderate	Altered Expression	[818]
CYLD	OT37FKH0	moderate	Genetic Variation	[819]
DEGS1	OT4WXPKW	moderate	Biomarker	[820]
DERL2	OTI3TUUZ	moderate	Biomarker	[821]
DLC1	OTP8LMCR	moderate	Biomarker	[822]
DLX2	OTKC2DQ0	moderate	Genetic Variation	[179]
DNM3	OTDMUGCR	moderate	Altered Expression	[823]
DUSP4	OT6WAO12	moderate	Altered Expression	[824]
ECD	OT3L3PCU	moderate	Biomarker	[825]
ECM1	OT1K65VW	moderate	Biomarker	[826]
ECRG4	OTHZYUXX	moderate	Biomarker	[827]
ECT2	OTQDUCT6	moderate	Altered Expression	[828]
EMP1	OTSZHUHQ	moderate	Biomarker	[829]
EMP2	OTPS2H0L	moderate	Altered Expression	[830]
ENO2	OTRODL0T	moderate	Biomarker	[831]
ESRP1	OTNCS4SL	moderate	Altered Expression	[832]
ETV1	OT6PMJIK	moderate	Altered Expression	[833]
FAM3C	OTBR6U9G	moderate	Altered Expression	[834]
FANCC	OTTIDM3P	moderate	Genetic Variation	[835]
FBP1	OTQBANEP	moderate	Altered Expression	[836]
FBXO32	OTUE978R	moderate	Biomarker	[837]
FBXO4	OT6VYX67	moderate	Biomarker	[838]
FBXW4	OTEGSZOX	moderate	Altered Expression	[177]
FKBP14	OT55W5WC	moderate	Altered Expression	[839]
FLNB	OTPCOYL6	moderate	Biomarker	[840]
FOXF2	OTV20NGX	moderate	Altered Expression	[841]
FOXK1	OTLZGS7J	moderate	Biomarker	[842]
FOXO4	OT90X9LN	moderate	Biomarker	[843]
FZD1	OTZATHVS	moderate	Biomarker	[844]
FZD2	OT952ML1	moderate	Biomarker	[845]
FZD5	OTXFFY56	moderate	Biomarker	[844]
G3BP2	OTAWW3KI	moderate	Biomarker	[846]
GALNT14	OT9BSDDQ	moderate	Biomarker	[847]
GDF1	OTZ1VRBH	moderate	Biomarker	[848]
GFPT1	OTQBDO45	moderate	Biomarker	[849]
GOLM1	OTOZSV6O	moderate	Biomarker	[850]
GPC2	OT3WSQE1	moderate	Biomarker	[851]
GRB14	OTFET2YM	moderate	Altered Expression	[852]
GSTM3	OTLA2WJT	moderate	Biomarker	[853]
HOXA9	OTKNK5H0	moderate	Biomarker	[854]
ICMT	OT8CNKBO	moderate	Biomarker	[793]
IFIT3	OTPGHZB9	moderate	Altered Expression	[855]
IFITM3	OT2QP8D3	moderate	Altered Expression	[856]
IL17RB	OT0KDNSF	moderate	Altered Expression	[857]
IL1RAPL1	OTW3T4B2	moderate	Biomarker	[858]
ING1	OTEZBRKW	moderate	Genetic Variation	[859]
ING4	OT0VVG4V	moderate	Biomarker	[860]
INPP4B	OTLROA7G	moderate	Altered Expression	[861]
INSM1	OTG8RV8E	moderate	Biomarker	[862]
IQGAP1	OTZRWTGA	moderate	Biomarker	[303]
IRF2	OTAZRUW3	moderate	Biomarker	[863]
KAT2A	OTN0W2SW	moderate	Genetic Variation	[864]
KAT8	OT5LPQTR	moderate	Biomarker	[865]
KLF17	OT5NWVP7	moderate	Biomarker	[866]
KLRD1	OTMYLOV4	moderate	Altered Expression	[867]
KRT14	OTUVZ1DW	moderate	Altered Expression	[868]
KRT7	OTLT3JFN	moderate	Altered Expression	[869]
LAD1	OT6YGTVX	moderate	Biomarker	[870]
LATS1	OTOOCG4R	moderate	Posttranslational Modification	[871]
LEF1	OTWS5I5H	moderate	Altered Expression	[872]
LUM	OTSRC874	moderate	Altered Expression	[643]
MAGEB6	OTOTV1FU	moderate	Genetic Variation	[55]
MAGI1	OTMV4ASV	moderate	Biomarker	[873]
MAPK6	OTDDNF3Q	moderate	Biomarker	[169]
METTL14	OT6TPQMH	moderate	Biomarker	[874]
MIEN1	OTCQ8DAD	moderate	Altered Expression	[875]
MIIP	OT79EXZ7	moderate	Biomarker	[876]
MMUT	OTBBBV70	moderate	Biomarker	[877]
MOK	OTQK7M9V	moderate	Biomarker	[878]
MSC	OTBRPZL5	moderate	Biomarker	[879]
MST1	OTOC4UNG	moderate	Altered Expression	[746]
MVP	OTJGHJRB	moderate	Altered Expression	[880]
MYBBP1A	OTIVEMIU	moderate	Biomarker	[881]
MYOF	OTRFC3IJ	moderate	Biomarker	[882]
NAB2	OTG4BDF3	moderate	Biomarker	[883]
NCOR1	OT04XNOU	moderate	Biomarker	[884]
NID2	OTHC33FF	moderate	Biomarker	[885]
NOB1	OTW0YNSL	moderate	Biomarker	[886]
NR2C2	OTDZWVOJ	moderate	Biomarker	[168]
NXF1	OTEFHXG6	moderate	Biomarker	[840]
OCM	OTQRML29	moderate	Biomarker	[887]
OTUB1	OT8WWM9O	moderate	Altered Expression	[888]
PARD3	OTH5BPLO	moderate	Biomarker	[137]
PDLIM5	OTLQVV22	moderate	Biomarker	[889]
PEAK1	OTVVM637	moderate	Altered Expression	[890]
PFN1	OTHTGA1H	moderate	Biomarker	[891]
PIK3C2B	OTY2PROB	moderate	Altered Expression	[892]
PITPNA	OTTWC00K	moderate	Biomarker	[893]
PLAAT3	OTVXXJ5K	moderate	Biomarker	[894]
PLAGL1	OTZAO900	moderate	Altered Expression	[895]
PLK3	OT19CT2Z	moderate	Altered Expression	[896]
PLXNA1	OTN0BING	moderate	Altered Expression	[897]
PMEPA1	OTY8Z9UF	moderate	Biomarker	[898]
PNPLA2	OTR3ERMR	moderate	Biomarker	[104]
PODXL	OTPNQXF3	moderate	Biomarker	[899]
POLD1	OTWO4UCJ	moderate	Altered Expression	[900]
POLH	OTN07WXU	moderate	Altered Expression	[901]
POLK	OTKZ38JH	moderate	Altered Expression	[901]
POU2F2	OTPV0J0C	moderate	Biomarker	[902]
POU3F3	OT6BBXPD	moderate	Altered Expression	[903]
PPP1R13L	OTNCPLWE	moderate	Biomarker	[848]
PPP2R1A	OTYA3GB4	moderate	Genetic Variation	[904]
PPP4C	OT4B0TNV	moderate	Biomarker	[905]
PPRC1	OT6GB3WR	moderate	Biomarker	[906]
PRDX1	OTZ3BEC4	moderate	Altered Expression	[907]
PRUNE1	OTQ3UHWQ	moderate	Biomarker	[908]
PTPRF	OTH5KF2D	moderate	Genetic Variation	[909]
PXN	OTVMMUOF	moderate	Posttranslational Modification	[910]
RAB27A	OT9SQRWY	moderate	Biomarker	[726]
RAB37	OTRL8IUO	moderate	Biomarker	[911]
RAB3D	OTGKRR3C	moderate	Biomarker	[912]
RANBP9	OTM8COM5	moderate	Altered Expression	[913]
RASSF6	OT25GVWY	moderate	Biomarker	[914]
RBM5	OTCBWHHV	moderate	Biomarker	[915]
RCC2	OTUJVTLS	moderate	Biomarker	[916]
RMC1	OT7K8MTJ	moderate	Altered Expression	[917]
RND3	OTXMXPIH	moderate	Altered Expression	[918]
RNH1	OT6EC79B	moderate	Biomarker	[848]
RPL10	OTBHOZGC	moderate	Altered Expression	[897]
RPS15A	OT0BUA12	moderate	Altered Expression	[919]
RSPO2	OT3HHXU0	moderate	Altered Expression	[920]
S100A10	OTI71243	moderate	Altered Expression	[155]
S100A13	OT582SUS	moderate	Altered Expression	[921]
SALL4	OTC08PR5	moderate	Altered Expression	[922]
SDCBP	OTS3NCC5	moderate	Biomarker	[923]
SDHC	OTC8G2MX	moderate	Biomarker	[924]
SEMA3F	OTQFMS8S	moderate	Biomarker	[925]
SEMA7A	OT0ZJK64	moderate	Genetic Variation	[926]
SH3BGRL	OTUOCTMT	moderate	Biomarker	[927]
SHC3	OT305NPA	moderate	Biomarker	[848]
SIRT4	OT5S0J23	moderate	Altered Expression	[928]
SIX1	OT70YYWM	moderate	Biomarker	[636]
SMC1A	OT9ZMRK9	moderate	Altered Expression	[929]
SMOC2	OTK1EQ49	moderate	Biomarker	[930]
SMS	OT8JYKNH	moderate	Biomarker	[931]
SOCS2	OTBPNKJQ	moderate	Biomarker	[932]
SOHLH2	OTB9EM6C	moderate	Biomarker	[933]
SPANXB1	OTLMGC9T	moderate	Biomarker	[934]
SPRY2	OTH0CRCZ	moderate	Biomarker	[935]
SRGAP2	OTUWFMCQ	moderate	Biomarker	[936]
SS18L1	OT9ZEGV7	moderate	Genetic Variation	[937]
ST6GAL1	OT7US3NO	moderate	Biomarker	[938]
STUB1	OTSUYI9A	moderate	Biomarker	[939]
SUZ12	OT655XF8	moderate	Altered Expression	[940]
TBPL1	OT4I143E	moderate	Altered Expression	[209]
TET1	OTZDHT1D	moderate	Posttranslational Modification	[941]
TGFBI	OTR443C5	moderate	Biomarker	[942]
THBS2	OTXET551	moderate	Biomarker	[943]
TLE5	OTEH0BFG	moderate	Altered Expression	[944]
TMEM52B	OTOC70IF	moderate	Altered Expression	[945]
TNNT1	OT8PBOAR	moderate	Biomarker	[761]
TOMM20	OT76TPR2	moderate	Biomarker	[946]
TOPBP1	OT6UPZPD	moderate	Genetic Variation	[947]
TPD52	OTPKSK43	moderate	Biomarker	[948]
TPM1	OTD73X6R	moderate	Altered Expression	[949]
TRIM16	OTLRXYOZ	moderate	Altered Expression	[950]
TRIM25	OT35SG1R	moderate	Biomarker	[951]
TRIM3	OT704FQ0	moderate	Biomarker	[952]
TRIM62	OT15YO6N	moderate	Biomarker	[953]
TSPAN2	OTTDPQF1	moderate	Biomarker	[954]
TSPAN9	OT3DI3NH	moderate	Altered Expression	[955]
A1CF	OTJBKFA1	Strong	Genetic Variation	[229]
A2M	OTFTX90K	Strong	Altered Expression	[956]
ABHD14B	OTFIYC6Y	Strong	Altered Expression	[957]
ABI1	OT5H4M62	Strong	Altered Expression	[958]
ABI3	OTQTDSHP	Strong	Biomarker	[959]
ACTG2	OTRDWUO0	Strong	Biomarker	[960]
ACTR1B	OTGBCKLO	Strong	Biomarker	[354]
ADAM23	OTVWT6JZ	Strong	Altered Expression	[961]
ADAM28	OT3GBVHL	Strong	Altered Expression	[9]
ADAMTS2	OTTK22NO	Strong	Biomarker	[962]
ADCY10	OTYSTB0R	Strong	Altered Expression	[314]
ADGRE2	OTUYJVYG	Strong	Genetic Variation	[963]
ADGRE5	OTTSB84Q	Strong	Genetic Variation	[963]
ADGRF3	OTR8JBEW	Strong	Altered Expression	[218]
AGR3	OTONJPDP	Strong	Genetic Variation	[964]
AHNAK	OT6KH1WG	Strong	Biomarker	[965]
AIMP1	OTTA5C3U	Strong	Altered Expression	[966]
ALDH3A1	OTAYZZE6	Strong	Altered Expression	[88]
ALKBH1	OTADGU5D	Strong	Altered Expression	[967]
AMBP	OTLU8GU8	Strong	Altered Expression	[968]
AMOTL2	OTRCTKV9	Strong	Altered Expression	[293]
ANGPT4	OT881M3K	Strong	Biomarker	[969]
ANGPTL1	OTXIN6V5	Strong	Biomarker	[969]
ANGPTL2	OTB6JG41	Strong	Biomarker	[970]
ANKHD1	OTVYQ7ZL	Strong	Biomarker	[971]
ANKRD30A	OTJXYAE5	Strong	Biomarker	[972]
AP5Z1	OTXIPLFH	Strong	Biomarker	[973]
APLP1	OTD176ZS	Strong	Altered Expression	[974]
APLP2	OTTFE53M	Strong	Biomarker	[975]
ARF6	OTVV7KJO	Strong	Biomarker	[976]
ARHGAP24	OTCQCEZS	Strong	Altered Expression	[768]
ARHGEF4	OTR2VG0W	Strong	Biomarker	[976]
ARID4B	OTYLPILE	Strong	Biomarker	[977]
ARL6IP5	OTYZ6BEQ	Strong	Biomarker	[978]
ARNT	OTMSIEZY	Strong	Biomarker	[979]
ARR3	OTRZ00CH	Strong	Biomarker	[385]
ARSF	OTC0L12N	Strong	Altered Expression	[980]
ARTN	OTWIWGL6	Strong	Biomarker	[981]
ATN1	OTNZFLKY	Strong	Altered Expression	[553]
ATRX	OT77RSQW	Strong	Genetic Variation	[436]
B4GALNT1	OTCY80HS	Strong	Altered Expression	[982]
BAMBI	OTCEJ8W5	Strong	Altered Expression	[983]
BANP	OT1JMTBD	Strong	Biomarker	[984]
BATF2	OT4XBZC9	Strong	Altered Expression	[985]
BCAR1	OTKT2C2N	Strong	Altered Expression	[986]
BCL2L12	OTS6IFZY	Strong	Altered Expression	[987]
BHLHE22	OTZUQY5L	Strong	Biomarker	[988]
BLM	OTEJOAJX	Strong	Biomarker	[340]
BOK	OTDQPDIX	Strong	Altered Expression	[989]
BRMS1	OTV5A6LL	Strong	Altered Expression	[990]
BRMS1L	OTJIW47U	Strong	Biomarker	[991]
BTF3	OT5ZZFJL	Strong	Biomarker	[992]
BTG2	OTZF6K1H	Strong	Biomarker	[354]
BTRC	OT2EZDGR	Strong	Altered Expression	[993]
BUB1B	OT8KME51	Strong	Biomarker	[994]
BUD31	OTN3HZYF	Strong	Altered Expression	[995]
CALB2	OTSNMCG9	Strong	Biomarker	[996]
CALD1	OTNJKJ6Q	Strong	Altered Expression	[997]
CAMKMT	OTLJBRUW	Strong	Altered Expression	[998]
CBLL2	OTB4AD3V	Strong	Biomarker	[308]
CBX1	OT2L4XZX	Strong	Biomarker	[999]
CCL15	OTOGZ85M	Strong	Biomarker	[1000]
CCL18	OT7JYSK9	Strong	Altered Expression	[1001]
CCL19	OTQ2UJMH	Strong	Posttranslational Modification	[1002]
CCL28	OTY6XNQ7	Strong	Altered Expression	[309]
CCN3	OTOW5YL4	Strong	Altered Expression	[897]
CCN5	OTADU8JJ	Strong	Altered Expression	[1003]
CCNY	OTK1KG5W	Strong	Altered Expression	[1004]
CD177	OTS79FNF	Strong	Biomarker	[1005]
CD302	OTX580VU	Strong	Altered Expression	[1006]
CD3D	OTRBLP0R	Strong	Biomarker	[1007]
CD63	OT2UGZA9	Strong	Altered Expression	[1008]
CD68	OTOYEY3J	Strong	Biomarker	[1009]
CDC42	OT5QBC5M	Strong	Biomarker	[558]
CDCP1	OTD7RRWK	Strong	Biomarker	[1010]
CDH17	OT9EV2XK	Strong	Biomarker	[1011]
CDKN3	OTBE3H07	Strong	Biomarker	[1012]
CDSN	OTQW4HV6	Strong	Biomarker	[1013]
CEBPD	OTNBIPMY	Strong	Altered Expression	[1014]
CETN2	OTJTTGS0	Strong	Biomarker	[1015]
CFAP20	OTIG8TR5	Strong	Biomarker	[1016]
CHAF1A	OTXSSY4H	Strong	Altered Expression	[1017]
CHD1L	OT7CZK7C	Strong	Biomarker	[1018]
CHD4	OTBDEHDP	Strong	Biomarker	[1019]
CHD8	OTS7A6AF	Strong	Genetic Variation	[436]
CHI3L1	OT2Z7VJH	Strong	Biomarker	[1020]
CKAP4	OTDUC9ME	Strong	Biomarker	[426]
CKS1B	OTNUPLUJ	Strong	Biomarker	[1021]
CKS2	OTPTMHIV	Strong	Altered Expression	[1022]
CLCA2	OTF191LZ	Strong	Biomarker	[411]
CLCN4	OT4A2UWF	Strong	Biomarker	[1023]
CLDN3	OT71MN9S	Strong	Biomarker	[1024]
CLEC1B	OTO38TRG	Strong	Altered Expression	[1025]
COMP	OTS2FPMI	Strong	Biomarker	[1026]
CORO1C	OTXDF9T3	Strong	Altered Expression	[1027]
COTL1	OT6YCNLF	Strong	Biomarker	[1028]
CPEB4	OTW1SCZW	Strong	Altered Expression	[1029]
CREM	OTJIJ5AL	Strong	Biomarker	[1030]
CRIP1	OT0EICG3	Strong	Altered Expression	[1031]
CRISP3	OTBSWMPL	Strong	Altered Expression	[1032]
CRKL	OTOYSD1R	Strong	Biomarker	[1033]
CTNNBIP1	OTX9SBJG	Strong	Genetic Variation	[1034]
CTR9	OTP151PZ	Strong	Altered Expression	[1017]
CTSO	OTFL6VRO	Strong	Biomarker	[962]
CTTN	OTJRG4ES	Strong	Altered Expression	[1035]
CXADR	OT9ZP02A	Strong	Biomarker	[385]
CXCL16	OTD49T9R	Strong	Biomarker	[1036]
CXCL17	OTRCEVIZ	Strong	Altered Expression	[1037]
CXCL5	OTZOUPCA	Strong	Biomarker	[1038]
CXCL6	OTFTCQ4O	Strong	Biomarker	[1039]
DAB2IP	OTF456VC	Strong	Biomarker	[1040]
DACT1	OT19Z704	Strong	Posttranslational Modification	[1041]
DAP	OT5YLL7E	Strong	Genetic Variation	[1042]
DAXX	OTX6O7PL	Strong	Genetic Variation	[436]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[1043]
DCTN6	OTI8PIN9	Strong	Biomarker	[1044]
DCUN1D1	OT8UJLZU	Strong	Altered Expression	[1045]
DDX3X	OTDO4TRX	Strong	Biomarker	[1046]
DDX53	OTHK3EGZ	Strong	Biomarker	[1047]
DDX6	OTKWXVDY	Strong	Biomarker	[1048]
DEPDC5	OTE70JLY	Strong	Genetic Variation	[436]
DERL3	OTRZRT6Q	Strong	Genetic Variation	[463]
DGCR2	OTEGL17Z	Strong	Altered Expression	[1049]
DKK4	OTWCCVF6	Strong	Altered Expression	[1050]
DLD	OT378CU9	Strong	Biomarker	[1051]
DLEC1	OTMKKBUW	Strong	Altered Expression	[1052]
DLX6	OT0FIJHY	Strong	Altered Expression	[1053]
DNAJA3	OT61924T	Strong	Biomarker	[1054]
DNAJB4	OTUD01BK	Strong	Altered Expression	[1055]
DNER	OT2GH2E5	Strong	Biomarker	[1056]
DNLZ	OT48CG1W	Strong	Biomarker	[1057]
DPYSL3	OTINJV20	Strong	Biomarker	[1058]
DRAM2	OTBOCZH8	Strong	Altered Expression	[1059]
DRG1	OTIFYMI3	Strong	Altered Expression	[1060]
DSC2	OTODVH8K	Strong	Biomarker	[1061]
DSP	OTB2MOP8	Strong	Altered Expression	[1062]
DSPP	OT1TYNDN	Strong	Biomarker	[1063]
DYNLL1	OTR69LHT	Strong	Altered Expression	[1052]
EFS	OT06O7XL	Strong	Posttranslational Modification	[1064]
EGR3	OTGPJIRA	Strong	Biomarker	[1065]
EIF1AX	OTWG2LAB	Strong	Biomarker	[1066]
EIF3A	OTFABY9G	Strong	Altered Expression	[1067]
EIF3H	OT61RBF5	Strong	Altered Expression	[1068]
EIF3I	OTE07WND	Strong	Altered Expression	[1069]
EIF4A2	OT08H03R	Strong	Biomarker	[1070]
EIF4G1	OT2CF1E6	Strong	Biomarker	[1070]
ELP1	OTYEWBF7	Strong	Altered Expression	[1017]
EPB41L3	OTS6CHG2	Strong	Biomarker	[1071]
ERCC1	OTNPYQHI	Strong	Altered Expression	[1072]
ERCC5	OTQAKFJM	Strong	Genetic Variation	[1073]
ESAM	OTF518AI	Strong	Biomarker	[1074]
ESCO2	OTJEMAQU	Strong	Biomarker	[1075]
ETV5	OTE2OBM4	Strong	Biomarker	[1076]
EWSR1	OT7SRHV3	Strong	Biomarker	[1077]
EXOC7	OT4YA137	Strong	Biomarker	[1078]
FABP7	OTRE2H4G	Strong	Altered Expression	[1079]
FAIM2	OT6QINVO	Strong	Biomarker	[1080]
FAM210B	OT2QHEQ6	Strong	Biomarker	[1081]
FAT2	OTRGT3E8	Strong	Genetic Variation	[1082]
FBLIM1	OTFHXMON	Strong	Biomarker	[1083]
FBLN5	OTLVNZ8U	Strong	Altered Expression	[1084]
FGF17	OTAQSFZ2	Strong	Altered Expression	[1085]
FGF3	OT9PK2SI	Strong	Altered Expression	[1086]
FHL2	OT0OAYWT	Strong	Altered Expression	[682]
FMNL2	OT9OVWCV	Strong	Altered Expression	[1087]
FNBP1L	OTH1S2P2	Strong	Biomarker	[1088]
FNDC3B	OTBILGDR	Strong	Altered Expression	[1089]
FOXA1	OTEBY0TD	Strong	Altered Expression	[302]
FOXA2	OTJOCVOY	Strong	Biomarker	[1090]
FOXF1	OT2CJZ5K	Strong	Altered Expression	[1091]
FOXG1	OTAW57J4	Strong	Biomarker	[1092]
FOXO3	OTHXQG4P	Strong	Biomarker	[1093]
FSD1	OT8P6PT3	Strong	Altered Expression	[1094]
FSD1L	OTBQ48RF	Strong	Altered Expression	[1094]
FSIP1	OTYLL6GM	Strong	Biomarker	[1095]
FUCA1	OTW71IK4	Strong	Altered Expression	[1096]
FZD8	OTZ9IRFL	Strong	Biomarker	[1097]
GALNT5	OTCV61V1	Strong	Biomarker	[1098]
GEMIN2	OT4L6TLL	Strong	Biomarker	[1099]
GNA12	OT3IRZH3	Strong	Biomarker	[1100]
GNB3	OTA6HYBA	Strong	Genetic Variation	[1101]
GOLGA4	OTCMEHNJ	Strong	Biomarker	[1039]
GOPC	OTRBGH71	Strong	Biomarker	[1083]
GORASP1	OTQS91S7	Strong	Biomarker	[1102]
GPAT3	OTJUGPK0	Strong	Biomarker	[1103]
GPC6	OTNJBESF	Strong	Biomarker	[1104]
GPR160	OTMXJT73	Strong	Biomarker	[309]
GPR42	OTEB0ROY	Strong	Biomarker	[14]
GPR68	OT1NXSMN	Strong	Biomarker	[1105]
GPX3	OT6PK94R	Strong	Altered Expression	[155]
GRB7	OTF8Y9XY	Strong	Altered Expression	[1106]
GRP	OT8JDFNI	Strong	Biomarker	[1107]
GTF2I	OTUYL1TQ	Strong	Biomarker	[1108]
GTF2IRD1	OTEG9KU1	Strong	Biomarker	[1108]
GTPBP4	OT6ZHAWC	Strong	Biomarker	[1109]
HAS1	OTJIAG1W	Strong	Altered Expression	[1110]
HAS2	OTTD3PAL	Strong	Altered Expression	[1110]
HAS3	OTPM8IL8	Strong	Altered Expression	[1110]
HAVCR2	OTOL603T	Strong	Biomarker	[670]
HERPUD1	OT9EROL6	Strong	Altered Expression	[1111]
HES6	OTWO5SCF	Strong	Altered Expression	[1112]
HEYL	OTN7BH79	Strong	Altered Expression	[1113]
HINT2	OTW9GS0U	Strong	Altered Expression	[1114]
HIP1	OT7AKCFQ	Strong	Biomarker	[1115]
HLA-DRB3	OT5PM9N7	Strong	Genetic Variation	[1116]
HLA-E	OTX1CTFB	Strong	Biomarker	[73]
HLTF	OTRX2OSF	Strong	Altered Expression	[1045]
HMMR	OT4M0JTZ	Strong	Biomarker	[1117]
HNRNPK	OTNPRM8U	Strong	Biomarker	[1118]
HOXB7	OTC7WYU8	Strong	Biomarker	[1098]
HOXD8	OTJ5H7AT	Strong	Altered Expression	[1119]
HPSE2	OTGEPP8V	Strong	Biomarker	[1120]
HSD17B6	OTSB55D2	Strong	Altered Expression	[586]
HSPB2	OTS01646	Strong	Biomarker	[528]
HTRA3	OTXJ0H4X	Strong	Biomarker	[1121]
HUNK	OTZR4GBH	Strong	Altered Expression	[1122]
HYAL2	OTTVINXW	Strong	Altered Expression	[1110]
HYAL3	OTG6VUSP	Strong	Altered Expression	[1110]
IBSP	OT29944Y	Strong	Biomarker	[1123]
ID3	OTUULW5Z	Strong	Biomarker	[328]
IFI27	OTI2XGIT	Strong	Biomarker	[1044]
IGF2BP1	OT9G360P	Strong	Altered Expression	[1124]
IGF2BP3	OTB97VIK	Strong	Biomarker	[976]
IL2RG	OTRZ3OMY	Strong	Biomarker	[1125]
INA	OT1D33T4	Strong	Altered Expression	[1126]
IQSEC1	OTK1PBFD	Strong	Biomarker	[1127]
ITGA2B	OT4Y17PY	Strong	Biomarker	[1128]
ITGA3	OTBCH21D	Strong	Biomarker	[1129]
ITGA7	OTTBTAYW	Strong	Biomarker	[962]
ITGB4	OT28UK84	Strong	Biomarker	[1130]
ITIH5	OTP46PZM	Strong	Genetic Variation	[1131]
JARID2	OT14UM8H	Strong	Altered Expression	[1132]
JDP2	OTW35WKX	Strong	Biomarker	[1133]
KAZN	OTPM7BYM	Strong	Altered Expression	[1134]
KDM2B	OTDMCVW7	Strong	Altered Expression	[1135]
KDM4D	OTN6KAE6	Strong	Biomarker	[1136]
KIF5B	OTT34MT8	Strong	Biomarker	[1137]
KIFC1	OTNQDS00	Strong	Altered Expression	[1138]
KLF11	OTKVQDJD	Strong	Genetic Variation	[1139]
KLF9	OTBFEJRQ	Strong	Altered Expression	[1140]
KRIT1	OT58AP1I	Strong	Altered Expression	[998]
KRT13	OTTYSKGX	Strong	Altered Expression	[1141]
KRT18	OTVLQFIP	Strong	Biomarker	[1142]
KRT8	OTTM4X11	Strong	Biomarker	[1143]
LACTB	OTRWGNBF	Strong	Biomarker	[1144]
LAMP3	OTN0XL3W	Strong	Biomarker	[1145]
LAT	OTZC1XZ1	Strong	Altered Expression	[1146]
LDHB	OT9B1CT3	Strong	Altered Expression	[1147]
LGALS3BP	OT9AGQKH	Strong	Biomarker	[1148]
LGI1	OTPS77HO	Strong	Altered Expression	[1149]
LIMA1	OTONPC9R	Strong	Biomarker	[1150]
LMCD1	OT3AWE8O	Strong	Genetic Variation	[1151]
LMO4	OT5NDCT9	Strong	Altered Expression	[1091]
LORICRIN	OTFRPVEO	Strong	Biomarker	[1152]
LOXL4	OT6XY2JL	Strong	Biomarker	[1153]
LRPAP1	OT6DVD2Q	Strong	Biomarker	[1154]
LSAMP	OTYXVQX2	Strong	Biomarker	[1145]
LTO1	OTQ17ZDT	Strong	Biomarker	[1155]
LYPD5	OTGP7UKA	Strong	Biomarker	[540]
LZTFL1	OTIEIOEW	Strong	Altered Expression	[1156]
MAGEC3	OT0KDWZN	Strong	Altered Expression	[314]
MAGED2	OTMEWNSE	Strong	Biomarker	[1157]
MAGED4B	OTO37U7W	Strong	Biomarker	[360]
MAL2	OTVPEI80	Strong	Biomarker	[1158]
MAP1B	OTVXW089	Strong	Biomarker	[1159]
MARCKSL1	OT13J2FM	Strong	Biomarker	[1160]
MBD2	OTUQPP0R	Strong	Altered Expression	[1161]
MCAT	OTH07FIW	Strong	Altered Expression	[265]
MCRS1	OT8K2X8P	Strong	Altered Expression	[1162]
MCTS1	OT7SAOJP	Strong	Altered Expression	[265]
MDC1	OTEUQH4J	Strong	Biomarker	[1163]
MED19	OTT9RT5N	Strong	Biomarker	[1164]
MED23	OTKZQT0R	Strong	Altered Expression	[1165]
METTL3	OTSXP1M3	Strong	Biomarker	[1166]
MGAT5	OTU4DD4G	Strong	Altered Expression	[1167]
MGP	OTZWU3FU	Strong	Biomarker	[1168]
MIB1	OT5C404P	Strong	Biomarker	[1169]
MIP	OTEBLU3E	Strong	Altered Expression	[1170]
MLLT11	OTG5RVHC	Strong	Biomarker	[1171]
MMP28	OTHQZXM1	Strong	Biomarker	[1172]
MMRN2	OT4IRL0U	Strong	Altered Expression	[1173]
MRPL40	OTB2QZDY	Strong	Altered Expression	[1174]
MSH3	OTD3YPVL	Strong	Altered Expression	[1175]
MT1E	OTXJKU4Y	Strong	Posttranslational Modification	[1176]
MT1H	OT0MVBM6	Strong	Altered Expression	[1177]
MTMR3	OTBIT23O	Strong	Biomarker	[396]
MTSS1	OT5DTDO2	Strong	Altered Expression	[1178]
MUC2	OT3X4QVX	Strong	Altered Expression	[1179]
MUL1	OT2JC9YR	Strong	Biomarker	[308]
MYBL2	OTZ3JX8Q	Strong	Altered Expression	[1180]
MYCL	OT1MFQ5U	Strong	Biomarker	[1181]
MYH11	OTVNVWY3	Strong	Genetic Variation	[1134]
MYH9	OT94Z706	Strong	Genetic Variation	[1182]
MYO1C	OT69L39Y	Strong	Altered Expression	[1183]
MYO1E	OTM9YSIZ	Strong	Altered Expression	[1183]
MYOM2	OTD2UOXW	Strong	Genetic Variation	[1184]
NANOG	OTUEY1FM	Strong	Biomarker	[1185]
NAP1L1	OTI7WBZV	Strong	Biomarker	[1157]
ND6	OTG47B7B	Strong	Genetic Variation	[1186]
NDRG1	OTVO66BO	Strong	Biomarker	[1187]
NDRG2	OT5L6KD7	Strong	Altered Expression	[1188]
NECTIN1	OTTE5ZR6	Strong	Biomarker	[1189]
NEDD4L	OT1B19RU	Strong	Altered Expression	[1190]
NEU1	OTH9BY8Y	Strong	Biomarker	[1191]
NEURL1	OT2C4P70	Strong	Biomarker	[1191]
NEUROG1	OTMJZP9G	Strong	Altered Expression	[1192]
NFAT5	OTKIE59S	Strong	Altered Expression	[615]
NFATC2	OTK5T6HZ	Strong	Altered Expression	[1193]
NIBAN1	OTYOLI12	Strong	Biomarker	[963]
NKX2-1	OTCMEJTA	Strong	Genetic Variation	[1194]
NKX2-2	OTDCOYNG	Strong	Biomarker	[1195]
NLK	OT2LETFS	Strong	Posttranslational Modification	[1196]
NME2	OTCYGLHV	Strong	Biomarker	[1197]
NNAT	OTNRLO7G	Strong	Altered Expression	[1198]
NOC2L	OTNT7R33	Strong	Biomarker	[1199]
NONO	OTN36Q6U	Strong	Altered Expression	[1200]
NPC1	OTRIPICX	Strong	Biomarker	[1201]
NSD2	OTQ6SW4R	Strong	Altered Expression	[1202]
NTN4	OTDRRMP3	Strong	Biomarker	[1203]
NUBPL	OTQMCSXT	Strong	Biomarker	[1204]
OCLN	OTSUTVWL	Strong	Altered Expression	[1205]
OLIG2	OTMCN6D3	Strong	Altered Expression	[1206]
ONECUT1	OTK1QUQT	Strong	Altered Expression	[1207]
OPN1MW	OTPJ7LX4	Strong	Genetic Variation	[1208]
OPRPN	OT6K1ZD6	Strong	Altered Expression	[413]
OR51E1	OTB7Q65H	Strong	Biomarker	[1209]
ORM2	OTRJGZP8	Strong	Biomarker	[264]
OSBP	OT7R0OQQ	Strong	Altered Expression	[1210]
PADI2	OTT40K94	Strong	Altered Expression	[1211]
PAEP	OTQA0NV4	Strong	Biomarker	[1212]
PAFAH1B1	OT9T2TCJ	Strong	Biomarker	[1213]
PANX1	OTXPEDOK	Strong	Biomarker	[1214]
PAX2	OTKP1N8F	Strong	Biomarker	[1215]
PAX8	OTRPD9MI	Strong	Biomarker	[1216]
PBX3	OT8WMVM4	Strong	Altered Expression	[1217]
PCBP1	OTHN0TD7	Strong	Biomarker	[1218]
PCGF2	OTIY1J5L	Strong	Altered Expression	[1219]
PDLIM1	OT4EGCPG	Strong	Biomarker	[1220]
PEA15	OTKCKTSX	Strong	Biomarker	[1221]
PELP1	OTVXQNOT	Strong	Altered Expression	[1222]
PERP	OTP0YL53	Strong	Biomarker	[1223]
PFKFB4	OTQYEXL2	Strong	Biomarker	[1224]
PFN2	OT5SSSA7	Strong	Altered Expression	[1225]
PGK1	OT6V1ICH	Strong	Altered Expression	[1226]
PHGR1	OTY3GTEP	Strong	Altered Expression	[1227]
PHLDA1	OTFTWMIQ	Strong	Altered Expression	[1228]
PIGR	OT6GLSUL	Strong	Biomarker	[1229]
PIK3R4	OTRL8QP8	Strong	Altered Expression	[1017]
PIWIL1	OT7CRGZ3	Strong	Biomarker	[1230]
PIWIL4	OTDA9MY0	Strong	Biomarker	[1230]
PLPP5	OTHT51D6	Strong	Genetic Variation	[1231]
PLRG1	OTIVZ5LL	Strong	Altered Expression	[413]
PLXNB1	OTCA7JIT	Strong	Genetic Variation	[1232]
POT1	OTNBXJCQ	Strong	Altered Expression	[1233]
POU3F2	OT30NFOC	Strong	Biomarker	[1234]
POU3F4	OTKF5AF7	Strong	Genetic Variation	[1235]
POU5F1	OTDHHN7O	Strong	Altered Expression	[1236]
PPA1	OTHZK1QB	Strong	Altered Expression	[1237]
PPP1R14C	OTZ3F6D2	Strong	Altered Expression	[1238]
PPP1R1A	OTGTAGCV	Strong	Biomarker	[467]
PPP1R9B	OTDCTHTT	Strong	Altered Expression	[1239]
PPWD1	OTA7CG42	Strong	Altered Expression	[1006]
PRDM1	OTQLSVBS	Strong	Biomarker	[1240]
PRDM2	OT8L7CGX	Strong	Biomarker	[1241]
PRKAA2	OTU1KZPV	Strong	Biomarker	[15]
PROK1	OT8S7RUG	Strong	Biomarker	[399]
PROX1	OT68R6IO	Strong	Altered Expression	[1242]
PRUNE2	OTGW2974	Strong	Altered Expression	[1243]
PSMA5	OT38E6Y1	Strong	Biomarker	[973]
PSMD4	OTH1VZTM	Strong	Altered Expression	[980]
PSMD9	OT6Y5CC3	Strong	Biomarker	[1044]
PTPRT	OTV5TXNN	Strong	Biomarker	[1244]
PTRH2	OTBU39Q1	Strong	Biomarker	[1245]
PTTG1	OTIMYS4W	Strong	Altered Expression	[1246]
PTX3	OTPXHRKU	Strong	Altered Expression	[1247]
PVR	OT3N91T7	Strong	Altered Expression	[1248]
RAB11FIP3	OTDFFCZA	Strong	Altered Expression	[1249]
RAB11FIP4	OTIGHER7	Strong	Altered Expression	[1250]
RAB17	OT7NBUGQ	Strong	Biomarker	[1251]
RAB23	OTBAKFBR	Strong	Altered Expression	[1252]
RAB31	OTMLXQZ0	Strong	Biomarker	[1253]
RAB38	OTU0NZU0	Strong	Biomarker	[1254]
RAB3GAP2	OTQTE0GI	Strong	Altered Expression	[1017]
RAB5A	OTFR2KM4	Strong	Altered Expression	[1255]
RAB8A	OTPB54Y3	Strong	Biomarker	[1256]
RABGEF1	OTWC3Z3R	Strong	Altered Expression	[1255]
RAG2	OTG9UYTW	Strong	Biomarker	[1125]
RANBP1	OTQE226K	Strong	Altered Expression	[1257]
RASD1	OT2BAJHK	Strong	Genetic Variation	[1258]
RASGRF1	OTNWJ7EN	Strong	Altered Expression	[1255]
RASGRF2	OT67DAGF	Strong	Biomarker	[1259]
RB1CC1	OTZK8PFX	Strong	Altered Expression	[1260]
RBM47	OT6W67VM	Strong	Altered Expression	[1261]
RCAN1	OT1MVXC7	Strong	Biomarker	[1262]
RCOR3	OT5LATME	Strong	Altered Expression	[1263]
RETREG1	OTYOSLZX	Strong	Biomarker	[1264]
RGS19	OTBIELDO	Strong	Biomarker	[1265]
RGS22	OTCTFGW6	Strong	Altered Expression	[1266]
RGS5	OTUY0Q2I	Strong	Altered Expression	[1267]
RHBDF1	OTCQ7UDS	Strong	Altered Expression	[1268]
RNF111	OTO3QT6Q	Strong	Biomarker	[1269]
ROPN1L	OTRWZJ68	Strong	Genetic Variation	[229]
RTL1	OTOT33IM	Strong	Biomarker	[368]
RUNX1T1	OT30DED5	Strong	Altered Expression	[1270]
S100A1	OT1F2G4J	Strong	Biomarker	[1271]
S100A2	OTTGHJ1H	Strong	Posttranslational Modification	[1272]
S100A7	OTJFVJRF	Strong	Biomarker	[1273]
SATB2	OT2W80XC	Strong	Biomarker	[1274]
SCAF11	OTX59D0X	Strong	Biomarker	[1099]
SCARA5	OTOVA96E	Strong	Altered Expression	[986]
SCGB2A1	OT9L87U9	Strong	Biomarker	[1275]
SCTR	OTC80IMR	Strong	Biomarker	[1276]
SDC3	OT1P0LJM	Strong	Biomarker	[1244]
SEC14L2	OTJST64D	Strong	Biomarker	[840]
SEMA3E	OTD4S36H	Strong	Biomarker	[721]
SENP2	OTPQJXIR	Strong	Biomarker	[1277]
SEPTIN9	OT1VMRFQ	Strong	Biomarker	[1278]
SERPINE2	OTYF5340	Strong	Biomarker	[92]
SFRP1	OT0U9G41	Strong	Biomarker	[1279]
SH3GL2	OTOE443G	Strong	Biomarker	[1280]
SH3GLB2	OTF7BB9S	Strong	Altered Expression	[1281]
SIM1	OTYKFPKZ	Strong	Genetic Variation	[1139]
SIPA1	OTXY5RXC	Strong	Genetic Variation	[1282]
SLC16A4	OT1YXBKC	Strong	Altered Expression	[265]
SLC2A4RG	OTW3LX8D	Strong	Altered Expression	[1255]
SLC46A3	OTEMDLPS	Strong	Altered Expression	[1283]
SLURP1	OT89YD2E	Strong	Biomarker	[1284]
SMAD2	OTC6VB4K	Strong	Altered Expression	[1202]
SMAGP	OT57BZII	Strong	Altered Expression	[1285]
SMARCE1	OTAX4ITH	Strong	Altered Expression	[1286]
SMG1	OTTS3SXE	Strong	Altered Expression	[281]
SNAI2	OT7Y8EJ2	Strong	Altered Expression	[1287]
SNED1	OTBQVXY5	Strong	Altered Expression	[1288]
SNTA1	OTUICTGZ	Strong	Biomarker	[962]
SOX10	OTF25ULQ	Strong	Biomarker	[1289]
SOX4	OTSS40SS	Strong	Altered Expression	[1290]
SOX9	OTVDJFGN	Strong	Altered Expression	[1236]
SP7	OT07ETZT	Strong	Biomarker	[1291]
SPAM1	OTMPOB4E	Strong	Biomarker	[1292]
SPARCL1	OT74DWMV	Strong	Biomarker	[1293]
SPATA19	OT47CHQR	Strong	Altered Expression	[1281]
SPG7	OT8OY9ST	Strong	Biomarker	[385]
SPINK7	OTK3VOI3	Strong	Altered Expression	[1294]
SPON2	OTE7JLNM	Strong	Biomarker	[1295]
SPRED2	OTUX685J	Strong	Biomarker	[1166]
SPRR2A	OT62ZU6B	Strong	Biomarker	[1296]
SPSB3	OTHGEE2K	Strong	Altered Expression	[1297]
SPZ1	OTQH8HJ5	Strong	Biomarker	[1298]
SRSF1	OTF61HOV	Strong	Altered Expression	[980]
SRSF5	OTC5WP98	Strong	Biomarker	[1299]
SRSF6	OTGLOSYE	Strong	Altered Expression	[1300]
SS18	OTDKHN1E	Strong	Genetic Variation	[1301]
SSX1	OTZ7NRCY	Strong	Genetic Variation	[1301]
SSX2	OT2Z6RLL	Strong	Biomarker	[1302]
STAT5A	OTBSJGN3	Strong	Altered Expression	[1303]
STAT5B	OTZVPEBT	Strong	Altered Expression	[1303]
STIM1	OT8CLQ1W	Strong	Biomarker	[1304]
STK11	OT1YZSP3	Strong	Altered Expression	[1305]
STON2	OT01JHHE	Strong	Biomarker	[1306]
SYNJ2BP	OT2Q677P	Strong	Biomarker	[1307]
SYP	OTFJKMO4	Strong	Biomarker	[37]
SYT1	OTVTPOI6	Strong	Biomarker	[1102]
TAB3	OT1ECMDL	Strong	Altered Expression	[1308]
TAPBP	OTL81AVZ	Strong	Genetic Variation	[1309]
TBC1D9	OTSSCTB5	Strong	Genetic Variation	[1310]
TBX1	OTQLBPRA	Strong	Biomarker	[1311]
TCIM	OTARUXQF	Strong	Altered Expression	[1312]
TEX11	OTJDBGSS	Strong	Biomarker	[1313]
TFF3	OTJJDRTU	Strong	Biomarker	[1314]
THAP11	OTEMWLZ0	Strong	Altered Expression	[1315]
TICAM2	OTK7GIJ5	Strong	Biomarker	[1044]
TIMP1	OTOXC51H	Strong	Altered Expression	[371]
TIMP3	OTDGQAD1	Strong	Biomarker	[1316]
TM4SF5	OTPAV531	Strong	Biomarker	[1317]
TM7SF2	OTILU5S7	Strong	Altered Expression	[1318]
TMED3	OTNOPHHC	Strong	Biomarker	[1319]
TMED7	OTONO8E6	Strong	Biomarker	[1044]
TMEM106A	OTHTBYDN	Strong	Posttranslational Modification	[1320]
TMEM176A	OTOZDWXX	Strong	Posttranslational Modification	[1321]
TMEM8B	OTJZWPS6	Strong	Biomarker	[1322]
TNFRSF10C	OTVHOL9B	Strong	Altered Expression	[1323]
TNFRSF6B	OTKAN9G7	Strong	Altered Expression	[1324]
TOX3	OTC9NR4W	Strong	Biomarker	[88]
TP53BP2	OTOWJ2Y4	Strong	Altered Expression	[1325]
TP53INP1	OT2363Z9	Strong	Biomarker	[1326]
TP73	OT0LUO47	Strong	Altered Expression	[768]
TPPP3	OTU8VUIG	Strong	Biomarker	[1327]
TRAF4	OTJLRVMC	Strong	Altered Expression	[1328]
TRAIP	OTMPT9Y2	Strong	Altered Expression	[1045]
TRAP1	OTNG0L8J	Strong	Altered Expression	[1329]
TRIB3	OTG5OS7X	Strong	Altered Expression	[1330]
TRIM13	OTQIUACB	Strong	Biomarker	[385]
TRIM2	OT0V1YVC	Strong	Biomarker	[1331]
TRIM65	OTSQTK3A	Strong	Altered Expression	[1332]
TRIT1	OTCU9FS5	Strong	Altered Expression	[1333]
TSPAN8	OT1F68WQ	Strong	Biomarker	[1334]
TTF1	OT4K90WD	Strong	Biomarker	[1335]
ACTB	OT1MCP2F	Definitive	Biomarker	[1336]
API5	OTYX9YCZ	Definitive	Biomarker	[510]
ATG5	OT4T5SMS	Definitive	Altered Expression	[1337]
ATL1	OTR2788Y	Definitive	Altered Expression	[504]
BCL6B	OT1T5KM6	Definitive	Biomarker	[1338]
BMPR1A	OTQOA4ZH	Definitive	Biomarker	[1339]
CDR2	OTD3ZJST	Definitive	Genetic Variation	[1340]
CERS2	OTRAHYYP	Definitive	Biomarker	[1341]
CMPK2	OTOG90R0	Definitive	Altered Expression	[1342]
DDX49	OT13VWB7	Definitive	Biomarker	[1343]
ELF3	OTUTLEQO	Definitive	Biomarker	[1344]
EPB41L5	OTPPQPLU	Definitive	Biomarker	[1345]
ERG	OTOTX9VU	Definitive	Biomarker	[617]
GNA13	OTVDL515	Definitive	Altered Expression	[1346]
HJURP	OTWMV16B	Definitive	Biomarker	[1347]
HSPA4	OT5HR0AR	Definitive	Biomarker	[775]
KRT20	OT4RB40L	Definitive	Biomarker	[1348]
MACC1	OTV3DLX0	Definitive	Genetic Variation	[1349]
MYO7A	OTBZSPEL	Definitive	Biomarker	[1350]
PDC	OT1UUVYY	Definitive	Biomarker	[1351]
PDPN	OTBUV19I	Definitive	Altered Expression	[1352]
PLAG1	OTT9AJQY	Definitive	Biomarker	[543]
PLIN5	OTV8G50L	Definitive	Biomarker	[1009]
POFUT1	OTOBJZIT	Definitive	Biomarker	[1353]
PROS1	OTXQWNOI	Definitive	Biomarker	[543]
PTHLH	OTI1JF13	Definitive	Biomarker	[1354]
RAMP2	OTGQXLH5	Definitive	Biomarker	[1355]
RAMP3	OTX6XLLM	Definitive	Biomarker	[1355]
RNF2	OTFPLOIN	Definitive	Biomarker	[1356]
SNAI1	OTDPYAMC	Definitive	Biomarker	[1357]
TIMM8A	OTDX9687	Definitive	Biomarker	[1358]
------------------------------------------------------------------------------------


⏷ Show the Full List of 968 DOT(s)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1835).
3	ClinicalTrials.gov (NCT02923349) A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.
4	A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients. Gene Ther. 2009 Mar;16(3):376-82.
5	ClinicalTrials.gov (NCT03696030) HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
6	ClinicalTrials.gov (NCT02414269) Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
7	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
8	Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells.Front Oncol. 2018 Oct 10;8:376. doi: 10.3389/fonc.2018.00376. eCollection 2018.
9	Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results.Dis Markers. 2019 Sep 2;2019:5035234. doi: 10.1155/2019/5035234. eCollection 2019.
10	ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.Gastric Cancer. 2019 Mar;22(2):287-301. doi: 10.1007/s10120-018-0866-2. Epub 2018 Aug 13.
11	Immunostimulating and cancer-reductive experimental therapy with the oxazaphosphorine cytostatic SUM-IAP.Anticancer Drugs. 2018 Jun;29(5):411-415. doi: 10.1097/CAD.0000000000000608.
12	Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.Gynecol Oncol. 2018 Jan;148(1):197-203. doi: 10.1016/j.ygyno.2017.10.025. Epub 2017 Oct 31.
13	An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.Int J Cancer. 2019 Mar 1;144(5):1151-1159. doi: 10.1002/ijc.31906. Epub 2018 Dec 4.
14	Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells.Proc Natl Acad Sci U S A. 2014 May 27;111(21):E2182-90. doi: 10.1073/pnas.1404943111. Epub 2014 Apr 29.
15	The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.Mol Cell. 2018 Jan 4;69(1):87-99.e7. doi: 10.1016/j.molcel.2017.11.025. Epub 2017 Dec 14.
16	CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.J Clin Invest. 2019 Jul 22;129(8):3401-3406. doi: 10.1172/JCI126366. eCollection 2019 Jul 22.
17	CCR4 is a determinant of melanoma brain metastasis.Oncotarget. 2017 May 9;8(19):31079-31091. doi: 10.18632/oncotarget.16076.
18	CCR5 status and metastatic progression in colorectal cancer.Oncoimmunology. 2019 Jul 13;8(9):e1626193. doi: 10.1080/2162402X.2019.1626193. eCollection 2019.
19	Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden.Oncotarget. 2018 Jan 19;9(13):11020-11045. doi: 10.18632/oncotarget.24280. eCollection 2018 Feb 16.
20	DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877.
21	CDC20 associated with cancer metastasis and novel mushroomderived CDC20 inhibitors with antimetastatic activity.Int J Oncol. 2019 Jun;54(6):2250-2256. doi: 10.3892/ijo.2019.4791. Epub 2019 Apr 18.
22	Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.Clin Cancer Res. 2017 Apr 1;23(7):1829-1840. doi: 10.1158/1078-0432.CCR-16-0094. Epub 2016 Sep 27.
23	Carboxypeptidase E-N promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt--catenin pathway.Biochem Cell Biol. 2019 Aug;97(4):446-453. doi: 10.1139/bcb-2018-0236. Epub 2018 Dec 3.
24	Balanced Steady-State Free Precession Sequence (CISS/FIESTA/3D Driven Equilibrium Radiofrequency Reset Pulse) Increases the Diagnostic Yield for Spinal Drop Metastases in Children with Brain Tumors.AJNR Am J Neuroradiol. 2018 Jul;39(7):1355-1361. doi: 10.3174/ajnr.A5645. Epub 2018 May 17.
25	Sex-dependent correlation between survival and expression of genes related to the circadian oscillator in patients with colorectal cancer.Chronobiol Int. 2018 Sep;35(10):1423-1434. doi: 10.1080/07420528.2018.1488722. Epub 2018 Jun 28.
26	Immune targets and neoantigens for cancer immunotherapy and precision medicine.Cell Res. 2017 Jan;27(1):11-37. doi: 10.1038/cr.2016.155. Epub 2016 Dec 27.
27	Targeting CTCFL/BORIS for the immunotherapy of cancer. Cancer Immunol Immunother. 2018 Dec;67(12):1955-1965.
28	Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.Cell Death Differ. 2019 Nov;26(11):2447-2463. doi: 10.1038/s41418-019-0312-y. Epub 2019 Mar 8.
29	Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.Histol Histopathol. 2018 Jun;33(6):597-608. doi: 10.14670/HH-11-959. Epub 2018 Jan 3.
30	MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5687-5692. doi: 10.1073/pnas.1819869116. Epub 2019 Mar 6.
31	Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer.Theranostics. 2019 Jan 30;9(4):1001-1014. doi: 10.7150/thno.30056. eCollection 2019.
32	Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.Int J Cancer. 2018 May 1;142(9):1865-1877. doi: 10.1002/ijc.31210. Epub 2017 Dec 27.
33	Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.Nat Commun. 2018 May 18;9(1):1988. doi: 10.1038/s41467-018-04355-w.
34	Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14.
35	Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer.Theranostics. 2019 Apr 13;9(9):2727-2738. doi: 10.7150/thno.31225. eCollection 2019.
36	Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance.J Cancer. 2018 Nov 13;9(24):4586-4595. doi: 10.7150/jca.27672. eCollection 2018.
37	Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.Histopathology. 2019 Oct;75(4):568-577. doi: 10.1111/his.13899. Epub 2019 Jul 29.
38	Cytoplasmic HAX1 Is an Independent Risk Factor for Breast Cancer Metastasis.J Oncol. 2019 Apr 10;2019:6375025. doi: 10.1155/2019/6375025. eCollection 2019.
39	The homeostasis-maintaining metabolites from bacterial stress response to bacteriophage infection suppress tumor metastasis.Oncogene. 2018 Oct;37(43):5766-5779. doi: 10.1038/s41388-018-0376-z. Epub 2018 Jun 20.
40	TGF-1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.Oncotarget. 2015 Feb 10;6(4):2120-33. doi: 10.18632/oncotarget.2940.
41	5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/-catenin/MMP-7 signaling pathway.Oncotarget. 2015 Sep 22;6(28):25975-87. doi: 10.18632/oncotarget.4543.
42	Antitumor Activity of BRAF Inhibitor and IFN Combination in BRAF-Mutant Melanoma.J Natl Cancer Inst. 2016 Feb 5;108(7):djv435. doi: 10.1093/jnci/djv435. Print 2016 Jul.
43	Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.J Hematol Oncol. 2017 Feb 1;10(1):36. doi: 10.1186/s13045-017-0408-0.
44	Development of a novel class of interleukin-2 immunotherapies for metastatic cancer.Swiss Med Wkly. 2019 Jan 23;149:w14697. doi: 10.4414/smw.2019.14697. eCollection 2019 Jan 14.
45	Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.Sci Rep. 2019 May 6;9(1):6917. doi: 10.1038/s41598-019-43294-4.
46	ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner.Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2566-2578. doi: 10.1016/j.bbadis.2018.05.002. Epub 2018 May 3.
47	Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors.Nat Commun. 2019 May 24;10(1):2311. doi: 10.1038/s41467-019-10269-y.
48	Function and regulation of LAG3 on CD4(+)CD25(-) T cells in non-small cell lung cancer.Exp Cell Res. 2017 Nov 15;360(2):358-364. doi: 10.1016/j.yexcr.2017.09.026. Epub 2017 Sep 19.
49	LAMP1 Overexpression Predicts for Poor Prognosis in Diffuse Large B-cell Lymphoma.Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):749-754. doi: 10.1016/j.clml.2018.07.288. Epub 2018 Aug 3.
50	LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.Cell Physiol Biochem. 2017;41(3):1072-1082. doi: 10.1159/000464115. Epub 2017 Feb 27.
51	Asparaginyl endopeptidase induces endothelial permeability and tumor metastasis via downregulating zonula occludens protein ZO-1.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2267-2275. doi: 10.1016/j.bbadis.2019.05.003. Epub 2019 May 13.
52	Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.DNA Cell Biol. 2018 Aug;37(8):659-669. doi: 10.1089/dna.2017.4102. Epub 2018 Jun 14.
53	The stability and oncogenic function of LIN28A are regulated by USP28.Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):599-610. doi: 10.1016/j.bbadis.2018.12.006. Epub 2018 Dec 10.
54	Diesel exhaust particle promotes tumor lung metastasis via the induction of BLT1-mediated neutrophilic lung inflammation.Cytokine. 2018 Nov;111:530-540. doi: 10.1016/j.cyto.2018.05.024. Epub 2018 Jun 5.
55	Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer.Urol Oncol. 2018 Jun;36(6):307.e9-307.e14. doi: 10.1016/j.urolonc.2018.03.002. Epub 2018 Mar 27.
56	MALT1 is a critical mediator of PAR1-driven NF-B activation and metastasis in multiple tumor types.Oncogene. 2019 Dec;38(49):7384-7398. doi: 10.1038/s41388-019-0958-4. Epub 2019 Aug 16.
57	Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression.Hum Immunol. 2013 Apr;74(4):439-46. doi: 10.1016/j.humimm.2012.11.021. Epub 2012 Dec 8.
58	Enhanced Melanoma-Targeted Therapy by "Fru-Blocked" Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles.Adv Sci (Weinh). 2018 Jul 13;5(11):1800229. doi: 10.1002/advs.201800229. eCollection 2018 Nov.
59	NKp46 Receptor-Mediated Interferon- Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. Epub 2018 Jan 9.
60	Calcium signalling links MYC to NUAK1.Oncogene. 2018 Feb 22;37(8):982-992. doi: 10.1038/onc.2017.394. Epub 2017 Nov 6.
61	PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.Breast Cancer Res Treat. 2018 Nov;172(1):23-32. doi: 10.1007/s10549-018-4888-6. Epub 2018 Jul 23.
62	Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma.Br J Cancer. 2018 May;118(9):1238-1242. doi: 10.1038/s41416-018-0064-3. Epub 2018 Apr 20.
63	Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis.Oncotarget. 2017 Apr 25;8(17):27725-27739. doi: 10.18632/oncotarget.9486.
64	Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.Curr Med Sci. 2019 Jun;39(3):410-414. doi: 10.1007/s11596-019-2051-1. Epub 2019 Jun 17.
65	Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases.Oncogene. 2018 Sep;37(38):5248-5256. doi: 10.1038/s41388-018-0346-5. Epub 2018 May 30.
66	A novel cross-talk between CXCR4 and PI4KIII in prostate cancer cells.Oncogene. 2019 Jan;38(3):332-344. doi: 10.1038/s41388-018-0448-0. Epub 2018 Aug 15.
67	Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.Hum Pathol. 2017 Apr;62:115-121. doi: 10.1016/j.humpath.2016.12.023. Epub 2017 Jan 11.
68	Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.BMC Cancer. 2018 Jul 20;18(1):752. doi: 10.1186/s12885-018-4639-4.
69	PRKAR2B promotes prostate cancer metastasis by activating Wnt/-catenin and inducing epithelial-mesenchymal transition.J Cell Biochem. 2018 Sep;119(9):7319-7327. doi: 10.1002/jcb.27030. Epub 2018 May 15.
70	DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.Cancer Cell. 2015 Jul 13;28(1):97-113. doi: 10.1016/j.ccell.2015.06.004.
71	PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.Cell Physiol Biochem. 2018;47(4):1643-1654. doi: 10.1159/000490983. Epub 2018 Jun 23.
72	PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.Carcinogenesis. 2017 Oct 1;38(10):966-975. doi: 10.1093/carcin/bgx062.
73	Immunological differences between primary and metastatic breast cancer.Ann Oncol. 2018 Nov 1;29(11):2232-2239. doi: 10.1093/annonc/mdy399.
74	Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers.Cancer Lett. 2008 Apr 18;262(2):248-56. doi: 10.1016/j.canlet.2007.12.008. Epub 2008 Jan 10.
75	RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.Cancers (Basel). 2018 Jun 5;10(6):184. doi: 10.3390/cancers10060184.
76	ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.J Pathol. 2012 Jun;227(2):223-33. doi: 10.1002/path.3986. Epub 2012 Feb 17.
77	Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-B/MMP-7 signaling pathway.Cell Death Dis. 2017 Mar 23;8(3):e2691. doi: 10.1038/cddis.2017.118.
78	Significance of OCT1 Expression in Acute Myeloid Leukemia.Pathol Oncol Res. 2017 Jul;23(3):665-671. doi: 10.1007/s12253-016-0161-7. Epub 2016 Dec 26.
79	Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.Cancer Lett. 2017 May 1;393:8-15. doi: 10.1016/j.canlet.2017.01.036. Epub 2017 Feb 13.
80	Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.Biomed Pharmacother. 2018 Jun;102:531-538. doi: 10.1016/j.biopha.2018.03.079. Epub 2018 Mar 26.
81	Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.PLoS One. 2017 Jan 20;12(1):e0170536. doi: 10.1371/journal.pone.0170536. eCollection 2017.
82	Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.Biosci Rep. 2019 Apr 26;39(4):BSR20182057. doi: 10.1042/BSR20182057. Print 2019 Apr 30.
83	Transcriptional Induction of Periostin by a Sulfatase 2-TGF1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.Cancer Res. 2017 Feb 1;77(3):632-645. doi: 10.1158/0008-5472.CAN-15-2556. Epub 2016 Nov 21.
84	SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.PLoS One. 2014 Feb 11;9(2):e87610. doi: 10.1371/journal.pone.0087610. eCollection 2014.
85	Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.J Cancer Res Clin Oncol. 2017 Sep;143(9):1637-1647. doi: 10.1007/s00432-017-2420-8. Epub 2017 Apr 13.
86	CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.Oncogene. 2017 Aug 17;36(33):4739-4749. doi: 10.1038/onc.2017.87. Epub 2017 Apr 10.
87	Expression of immune checkpoint receptors Indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma.Cancer Med. 2019 Jun;8(6):2784-2792. doi: 10.1002/cam4.2167. Epub 2019 Apr 16.
88	Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Oncotarget. 2017 Mar 28;8(13):20925-20938. doi: 10.18632/oncotarget.14995.
89	High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma.Sci Rep. 2018 Oct 25;8(1):15792. doi: 10.1038/s41598-018-34094-3.
90	Prostate cancer cell phenotypes based on AGR2 and CD10 expression.Mod Pathol. 2013 Jun;26(6):849-59. doi: 10.1038/modpathol.2012.238. Epub 2013 Jan 25.
91	A novel human anti-AXL monoclonal antibody attenuates tumour cell migration.Scand J Immunol. 2019 Aug;90(2):e12777. doi: 10.1111/sji.12777. Epub 2019 Jun 7.
92	SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.Cancer Lett. 2020 Jan 28;469:390-398. doi: 10.1016/j.canlet.2019.11.011. Epub 2019 Nov 12.
93	Effect of recombinant human endostatin on the expression of c-Myc and bFGF in mouse gastric cancer cells.Genet Mol Res. 2015 May 18;14(2):5258-65. doi: 10.4238/2015.May.18.17.
94	FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.J Exp Med. 2015 Aug 24;212(9):1433-48. doi: 10.1084/jem.20141555. Epub 2015 Aug 10.
95	Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer.Cancer Lett. 2019 Dec 28;467:72-84. doi: 10.1016/j.canlet.2019.09.001. Epub 2019 Sep 6.
96	Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.Oncotarget. 2016 Apr 26;7(17):24348-60. doi: 10.18632/oncotarget.8324.
97	Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.J Med Chem. 2018 Mar 8;61(5):2052-2061. doi: 10.1021/acs.jmedchem.7b01837. Epub 2018 Feb 27.
98	Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.BMC Cancer. 2019 Jun 14;19(1):584. doi: 10.1186/s12885-019-5757-3.
99	Extragonadal FSHR Expression and Function-Is It Real?.Front Endocrinol (Lausanne). 2019 Feb 4;10:32. doi: 10.3389/fendo.2019.00032. eCollection 2019.
100	Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway.Oxid Med Cell Longev. 2019 Aug 19;2019:8781690. doi: 10.1155/2019/8781690. eCollection 2019.
101	Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.J Nutr Biochem. 2012 Apr;23(4):368-78. doi: 10.1016/j.jnutbio.2011.01.002. Epub 2011 May 2.
102	p-AKT overexpression in primary renal cell carcinomas and their metastases.Clin Exp Metastasis. 2010 Dec;27(8):611-7. doi: 10.1007/s10585-010-9351-y. Epub 2010 Sep 16.
103	Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.Neoplasia. 2018 Dec;20(12):1198-1208. doi: 10.1016/j.neo.2018.10.001. Epub 2018 Nov 4.
104	Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas.Cell Death Dis. 2017 Aug 3;8(8):e2969. doi: 10.1038/cddis.2017.359.
105	Expression of T-lymphoma invasion and metastasis factor on the occurrence of oral squamous cell carcinoma.J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):289-295.
106	Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.Oncogene. 2009 Nov 12;28(45):3971-82. doi: 10.1038/onc.2009.254. Epub 2009 Aug 24.
107	Vitamin D-VDR Signaling Inhibits Wnt/-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.Cancer Res. 2019 Dec 1;79(23):5986-5998. doi: 10.1158/0008-5472.CAN-18-3927. Epub 2019 Nov 5.
108	ACR Appropriateness Criteria() Suspected LiverMetastases.J Am Coll Radiol. 2017 May;14(5S):S314-S325. doi: 10.1016/j.jacr.2017.01.037.
109	Does the expression of the ACVR2A gene affect the development of colorectal cancer?.Genet Mol Biol. 2019 Jan-Mar;42(1):32-39. doi: 10.1590/1678-4685-GMB-2017-0332. Epub 2019 Mar 11.
110	Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.Tumour Biol. 2017 Jun;39(6):1010428317709128. doi: 10.1177/1010428317709128.
111	Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion.Prostate. 2019 Sep;79(13):1530-1542. doi: 10.1002/pros.23874. Epub 2019 Aug 2.
112	Transcriptional activation of ANO1 promotes gastric cancer progression.Biochem Biophys Res Commun. 2019 Apr 23;512(1):131-136. doi: 10.1016/j.bbrc.2019.03.001. Epub 2019 Mar 12.
113	Identification of core genes and outcome in gastric cancer using bioinformatics analysis.Oncotarget. 2017 Aug 9;8(41):70271-70280. doi: 10.18632/oncotarget.20082. eCollection 2017 Sep 19.
114	Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.Cancer Immunol Immunother. 2016 Aug;65(8):995-1002. doi: 10.1007/s00262-016-1862-1. Epub 2016 Jul 1.
115	Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.
116	pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.Clin Cancer Res. 2015 Feb 15;21(4):889-98. doi: 10.1158/1078-0432.CCR-14-1425.
117	Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients.Tumour Biol. 2017 Jun;39(6):1010428317711895. doi: 10.1177/1010428317711895.
118	Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.Tumour Biol. 2015 Sep;36(9):6701-14. doi: 10.1007/s13277-015-3354-x. Epub 2015 Mar 29.
119	CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.Cancer Res. 2018 Dec 1;78(23):6594-6606. doi: 10.1158/0008-5472.CAN-18-1583. Epub 2018 Sep 5.
120	High-throughput sequencing of the melanoma genome.Exp Dermatol. 2013 Jan;22(1):10-7. doi: 10.1111/exd.12054. Epub 2012 Nov 22.
121	Choline Kinase Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.Gastroenterology. 2017 Apr;152(5):1187-1202. doi: 10.1053/j.gastro.2016.12.033. Epub 2017 Jan 5.
122	Chloride channel-3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival.Oncotarget. 2015 Feb 10;6(4):2434-50. doi: 10.18632/oncotarget.2966.
123	Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.Br J Cancer. 2019 Jul;121(3):257-263. doi: 10.1038/s41416-019-0508-4. Epub 2019 Jun 25.
124	Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma.Cancer Res. 2006 Mar 1;66(5):2553-61. doi: 10.1158/0008-5472.CAN-05-2645.
125	Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.World Neurosurg. 2016 Jan;85:42-8. doi: 10.1016/j.wneu.2015.07.068. Epub 2015 Aug 7.
126	CSPG4 as a prognostic biomarker in chordoma.Spine J. 2016 Jun;16(6):722-7. doi: 10.1016/j.spinee.2015.11.059. Epub 2015 Dec 9.
127	Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells.Cell Death Dis. 2017 Oct 5;8(10):e3089. doi: 10.1038/cddis.2017.459.
128	CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.Int J Oncol. 2018 Oct;53(4):1544-1556. doi: 10.3892/ijo.2018.4487. Epub 2018 Jul 18.
129	Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.Gastroenterology. 2015 Oct;149(4):1053-67.e14. doi: 10.1053/j.gastro.2015.05.058. Epub 2015 Jun 9.
130	CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies.Int J Mol Sci. 2014 Oct 20;15(10):19000-17. doi: 10.3390/ijms151019000.
131	DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors.BMC Cancer. 2015 Apr 9;15:242. doi: 10.1186/s12885-015-1192-2.
132	Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.Asian Pac J Cancer Prev. 2015;16(9):4065-9. doi: 10.7314/apjcp.2015.16.9.4065.
133	Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.J Pathol. 2017 Nov;243(3):307-319. doi: 10.1002/path.4950. Epub 2017 Sep 28.
134	The role of NK cells and CD39 in the immunological control of tumor metastases.Oncoimmunology. 2019 Apr 2;8(6):e1593809. doi: 10.1080/2162402X.2019.1593809. eCollection 2019.
135	Elevated epiregulin expression predicts poor prognosis in gastric cancer.Pathol Res Pract. 2019 May;215(5):873-879. doi: 10.1016/j.prp.2019.01.030. Epub 2019 Jan 28.
136	The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.Cell Death Dis. 2017 Jul 13;8(7):e2928. doi: 10.1038/cddis.2017.325.
137	Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.J Exp Clin Cancer Res. 2017 Oct 10;36(1):139. doi: 10.1186/s13046-017-0609-y.
138	MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.PLoS One. 2015 Apr 9;10(4):e0122851. doi: 10.1371/journal.pone.0122851. eCollection 2015.
139	Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.Breast Cancer Res. 2017 Jun 5;19(1):66. doi: 10.1186/s13058-017-0857-y.
140	Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis.PLoS One. 2015 Oct 28;10(10):e0141602. doi: 10.1371/journal.pone.0141602. eCollection 2015.
141	Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF- signaling.Oncotarget. 2016 Dec 20;7(51):84314-84325. doi: 10.18632/oncotarget.12604.
142	Growth hormone receptor promotes osteosarcoma cell growth and metastases.FEBS Open Bio. 2020 Jan;10(1):127-134. doi: 10.1002/2211-5463.12761. Epub 2019 Dec 18.
143	Downregulated connexin32 promotes EMT through the Wnt/-catenin pathway by targeting Snail expression in hepatocellular carcinoma.Int J Oncol. 2017 Jun;50(6):1977-1988. doi: 10.3892/ijo.2017.3985. Epub 2017 May 8.
144	Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.Cell Rep. 2017 Aug 15;20(7):1654-1666. doi: 10.1016/j.celrep.2017.07.054.
145	Mutation stability in primary and metastatic melanoma: what we know and what we don't.Histol Histopathol. 2015 Jul;30(7):763-70. doi: 10.14670/HH-11-584. Epub 2015 Jan 13.
146	Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.J Cell Physiol. 2018 Jan;233(1):409-421. doi: 10.1002/jcp.25900. Epub 2017 Apr 25.
147	Cannabidiol, a novel inverse agonist for GPR12.Biochem Biophys Res Commun. 2017 Nov 4;493(1):451-454. doi: 10.1016/j.bbrc.2017.09.001. Epub 2017 Sep 6.
148	Biodegradable Mesoporous Silica Achieved via Carbon Nanodots-Incorporated Framework Swelling for Debris-Mediated Photothermal Synergistic Immunotherapy.Nano Lett. 2019 Dec 11;19(12):8409-8417. doi: 10.1021/acs.nanolett.9b02448. Epub 2019 Nov 19.
149	Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.Cell Biochem Funct. 2016 Jun;34(4):274-85. doi: 10.1002/cbf.3189.
150	Heat shock transcription factor 1 affects kidney tubular cell migration by regulating the TGF?Smad2/3 signaling pathway.Mol Med Rep. 2019 Nov;20(5):4323-4330. doi: 10.3892/mmr.2019.10689. Epub 2019 Sep 16.
151	Elevated Mortalin correlates with poor outcome in hepatocellular carcinoma.Ann Diagn Pathol. 2019 Oct;42:59-63. doi: 10.1016/j.anndiagpath.2019.06.011. Epub 2019 Jul 4.
152	Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis.Nat Commun. 2016 Apr 18;7:11311. doi: 10.1038/ncomms11311.
153	IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.Endocrine. 2017 Nov;58(2):360-367. doi: 10.1007/s12020-017-1249-x. Epub 2017 Feb 17.
154	Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.J Cell Mol Med. 2018 Apr;22(4):2220-2230. doi: 10.1111/jcmm.13502. Epub 2018 Jan 29.
155	Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.Gynecol Oncol. 2015 Oct;139(1):30-9. doi: 10.1016/j.ygyno.2015.07.107. Epub 2015 Jul 29.
156	Bone-Induced Expression of Integrin 3 Enables Targeted Nanotherapy of Breast Cancer Metastases.Cancer Res. 2017 Nov 15;77(22):6299-6312. doi: 10.1158/0008-5472.CAN-17-1225. Epub 2017 Aug 30.
157	MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.Breast Cancer Res. 2017 Jun 21;19(1):73. doi: 10.1186/s13058-017-0858-x.
158	Germline genetics of cancer of unknown primary (CUP) and its specific subtypes.Oncotarget. 2016 Apr 19;7(16):22140-9. doi: 10.18632/oncotarget.7903.
159	Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.Neoplasia. 2017 May;19(5):396-411. doi: 10.1016/j.neo.2017.02.003. Epub 2017 Apr 18.
160	SET8 induces epithelialmesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.Mol Med Rep. 2016 Feb;13(2):1681-8. doi: 10.3892/mmr.2015.4733. Epub 2015 Dec 30.
161	The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.Cell Prolif. 2017 Jun;50(3):e12340. doi: 10.1111/cpr.12340. Epub 2017 Mar 1.
162	Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 predicts poor prognosis in hepatocellular carcinoma.Saudi J Biol Sci. 2018 Jul;25(5):904-908. doi: 10.1016/j.sjbs.2017.12.014. Epub 2017 Dec 30.
163	LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.Br J Cancer. 2017 Aug 8;117(4):563-571. doi: 10.1038/bjc.2017.193. Epub 2017 Jun 29.
164	Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal(-/-) Mice.Am J Pathol. 2015 Sep;185(9):2379-89. doi: 10.1016/j.ajpath.2015.05.021. Epub 2015 Jul 26.
165	Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.Clin Exp Med. 2015 Aug;15(3):371-80. doi: 10.1007/s10238-014-0306-5. Epub 2014 Sep 11.
166	LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis.Nat Commun. 2015 Apr 22;6:6906. doi: 10.1038/ncomms7906.
167	Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.Oncotarget. 2016 Aug 23;7(34):55677-55689. doi: 10.18632/oncotarget.10972.
168	TAK1 regulates endothelial cell necroptosis and tumor metastasis.Cell Death Differ. 2019 Oct;26(10):1987-1997. doi: 10.1038/s41418-018-0271-8. Epub 2019 Jan 25.
169	L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.Sci Rep. 2017 Nov 3;7(1):14979. doi: 10.1038/s41598-017-15135-9.
170	Sphingolipid metabolism in cancer signalling and therapy.Nat Rev Cancer. 2018 Jan;18(1):33-50. doi: 10.1038/nrc.2017.96. Epub 2017 Nov 17.
171	Maternal embryonic leucine zipper kinase inhibits epithelial-mesenchymal transition by regulating transforming growth factor- signaling.Oncol Lett. 2017 Jun;13(6):4794-4798. doi: 10.3892/ol.2017.6081. Epub 2017 Apr 24.
172	Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 asa candidate to predict metastases.Oral Oncol. 2017 Oct;73:56-64. doi: 10.1016/j.oraloncology.2017.08.003. Epub 2017 Aug 12.
173	Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.Sci Rep. 2017 Aug 18;7(1):8710. doi: 10.1038/s41598-017-09504-7.
174	Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.Am J Surg Pathol. 2005 Nov;29(11):1497-504. doi: 10.1097/01.pas.0000170349.47680.e8.
175	Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett. 2008 Nov 8;270(2):312-27. doi: 10.1016/j.canlet.2008.05.028. Epub 2008 Aug 16.
176	The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.Mol Cancer. 2018 Feb 19;17(1):24. doi: 10.1186/s12943-018-0784-2.
177	DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.Cell Death Dis. 2015 Jan 22;6(1):e1602. doi: 10.1038/cddis.2014.532.
178	NOTCH3 expression is linked to breast cancer seeding and distant metastasis.Breast Cancer Res. 2018 Sep 4;20(1):105. doi: 10.1186/s13058-018-1020-0.
179	p53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis.Cell Death Dis. 2017 Aug 10;8(8):e2995. doi: 10.1038/cddis.2017.376.
180	Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases.Int J Mol Sci. 2019 Apr 7;20(7):1721. doi: 10.3390/ijms20071721.
181	Hypoxia-induced upregulation of Orai1 drives colon cancer invasiveness and angiogenesis.Eur J Pharmacol. 2018 Aug 5;832:1-10. doi: 10.1016/j.ejphar.2018.05.008. Epub 2018 May 9.
182	PARG regulates the proliferation and differentiation of DCs and Tcells via PARP/NFB in tumour metastases of colon carcinoma.Oncol Rep. 2019 May;41(5):2657-2666. doi: 10.3892/or.2019.7051. Epub 2019 Mar 7.
183	Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.Oncotarget. 2016 Oct 25;7(43):70669-70684. doi: 10.18632/oncotarget.12204.
184	PDGF-D/PDGFR promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.Biochem Biophys Res Commun. 2016 Sep 16;478(2):845-51. doi: 10.1016/j.bbrc.2016.08.035. Epub 2016 Aug 6.
185	JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.Gastroenterology. 2018 Apr;154(5):1480-1493. doi: 10.1053/j.gastro.2017.12.004. Epub 2017 Dec 14.
186	Pin2/TRF1binding proteinX1 inhibits colorectal cancer cell migration and invasion invitro and metastasis invivo via the nuclear factorB signaling pathway.Oncol Rep. 2018 Sep;40(3):1533-1544. doi: 10.3892/or.2018.6570. Epub 2018 Jul 13.
187	Therapeutic effects of protein kinase N3 small interfering RNA and doxorubicin combination therapy on liver and lung metastases.Oncol Lett. 2017 Nov;14(5):5157-5166. doi: 10.3892/ol.2017.6830. Epub 2017 Aug 25.
188	Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.Oncotarget. 2016 Aug 23;7(34):55473-55490. doi: 10.18632/oncotarget.10980.
189	Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.Pathol Oncol Res. 2015 Jan;21(1):219-24. doi: 10.1007/s12253-014-9811-9. Epub 2014 Jun 28.
190	A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?.Med Hypotheses. 2019 May;126:109-128. doi: 10.1016/j.mehy.2019.03.019. Epub 2019 Mar 25.
191	microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer.Biosci Rep. 2020 Jan 31;40(1):BSR20193176. doi: 10.1042/BSR20193176.
192	O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes its Degradation and Increases Metastasis of Gastric Tumours.Biochem Biophys Res Commun. 2016 Sep 30;478(4):1497-502. doi: 10.1016/j.bbrc.2016.08.074. Epub 2016 Aug 13.
193	Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells.Oncol Lett. 2018 Apr;15(4):4432-4438. doi: 10.3892/ol.2018.7834. Epub 2018 Jan 22.
194	Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.Pediatr Blood Cancer. 2015 Sep;62(9):1550-1554. doi: 10.1002/pbc.25516. Epub 2015 Mar 19.
195	Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-/Smads Pathway.Cells. 2019 Jun 25;8(6):635. doi: 10.3390/cells8060635.
196	Upregulated expression of ROCK1 promotes cell proliferation by functioning as a target of miR-335-5p in non-small cell lung cancer.J Cell Physiol. 2019 May 29. doi: 10.1002/jcp.28886. Online ahead of print.
197	RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.Oncogene. 2016 Oct 13;35(41):5412-5421. doi: 10.1038/onc.2016.79. Epub 2016 Apr 4.
198	Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.PLoS One. 2016 Feb 24;11(2):e0150151. doi: 10.1371/journal.pone.0150151. eCollection 2016.
199	Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.Pathol Oncol Res. 2016 Oct;22(4):817-23. doi: 10.1007/s12253-016-0064-7. Epub 2016 May 13.
200	Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4.
201	SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer.Eur J Pharmacol. 2017 Feb 15;797:1-8. doi: 10.1016/j.ejphar.2017.01.008. Epub 2017 Jan 12.
202	The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.Curr Cancer Drug Targets. 2019;19(11):863-876. doi: 10.2174/1568009619666190802135714.
203	Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets.Clin Exp Metastasis. 2017 Jan;34(1):25-35. doi: 10.1007/s10585-016-9826-6. Epub 2016 Oct 15.
204	SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition.Oncotarget. 2017 Nov 6;9(13):10891-10904. doi: 10.18632/oncotarget.22443. eCollection 2018 Feb 16.
205	Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.BMC Cancer. 2016 Feb 4;16:55. doi: 10.1186/s12885-016-2105-8.
206	(68)Ga-PSMA I&T PET/CT for primary staging of prostate cancer.Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):168-177. doi: 10.1007/s00259-019-04524-z. Epub 2019 Sep 16.
207	Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.Oncotarget. 2016 May 10;7(19):27584-98. doi: 10.18632/oncotarget.8488.
208	Expression of Telomere Repeat Binding Factor 1 and TRF2 in Prostate Cancer and Correlation with Clinical Parameters.Biomed Res Int. 2017;2017:9764752. doi: 10.1155/2017/9764752. Epub 2017 Jul 20.
209	Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.Oncotarget. 2017 Sep 16;8(46):80139-80155. doi: 10.18632/oncotarget.20960. eCollection 2017 Oct 6.
210	Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.World J Urol. 2015 Oct;33(10):1403-9. doi: 10.1007/s00345-014-1473-4. Epub 2015 Jan 9.
211	Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.JAMA Oncol. 2017 Jul 1;3(7):969-973. doi: 10.1001/jamaoncol.2016.6007.
212	Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins.J Invest Dermatol. 2015 Nov;135(11):2794-2804. doi: 10.1038/jid.2015.250. Epub 2015 Jul 2.
213	Fibroblast Growth Factor-Inducible 14: Multiple Roles in Tumor Metastasis.Curr Mol Med. 2015;15(10):892-904. doi: 10.2174/1566524016666151123105752.
214	Overexpression of TrpC5 promotes tumor metastasis via the HIF-1-Twist signaling pathway in colon cancer.Clin Sci (Lond). 2017 Sep 22;131(19):2439-2450. doi: 10.1042/CS20171069. Print 2017 Oct 1.
215	KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.J Environ Pathol Toxicol Oncol. 2017;36(3):269-275. doi: 10.1615/JEnvironPatholToxicolOncol.2017024619.
216	Partial agonist activity of 1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.PLoS One. 2018 Sep 24;13(9):e0204041. doi: 10.1371/journal.pone.0204041. eCollection 2018.
217	ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-B/MMP-13 signaling axis.Anticancer Drugs. 2019 Aug;30(7):e0790. doi: 10.1097/CAD.0000000000000790.
218	Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.Ann Surg Oncol. 2013 Dec;20 Suppl 3(0 3):S739-S746. doi: 10.1245/s10434-013-3318-6. Epub 2013 Oct 10.
219	Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.Gastroenterology. 2019 May;156(6):1862-1876.e9. doi: 10.1053/j.gastro.2019.01.251. Epub 2019 Jan 31.
220	Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF- via activate p38 MAPK signaling pathway.Breast Cancer Res Treat. 2012 Feb;131(3):891-8. doi: 10.1007/s10549-011-1519-x. Epub 2011 Apr 21.
221	Downregulation of CD166 inhibits invasion, migration, and EMT in the radio-resistant human nasopharyngeal carcinoma cell line CNE-2R.Cancer Manag Res. 2019 Apr 26;11:3593-3602. doi: 10.2147/CMAR.S194685. eCollection 2019.
222	Expression of 15-lipoxygenase-1 in Merkel cell carcinoma is linked to advanced disease.Clin Otolaryngol. 2018 Oct;43(5):1335-1344. doi: 10.1111/coa.13191. Epub 2018 Jul 30.
223	alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.Am J Pathol. 2002 Sep;161(3):841-8. doi: 10.1016/s0002-9440(10)64244-7.
224	Angiogenin in age-related macular degeneration.Mol Vis. 2011 Feb 23;17:576-82.
225	Angiopoietin-1 deficiency increases tumor metastasis in mice.BMC Cancer. 2017 Aug 11;17(1):539. doi: 10.1186/s12885-017-3531-y.
226	Targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs.Mol Cancer. 2018 Oct 20;17(1):152. doi: 10.1186/s12943-018-0904-z.
227	Annexin A2 could enhance multidrug resistance by regulating NF-B signaling pathway in pediatric neuroblastoma.J Exp Clin Cancer Res. 2017 Aug 16;36(1):111. doi: 10.1186/s13046-017-0581-6.
228	Endothelin A receptor drives invadopodia function and cell motility through the -arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.Oncogene. 2016 Jun 30;35(26):3432-42. doi: 10.1038/onc.2015.403. Epub 2015 Nov 2.
229	Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer.Med Oncol. 2014 Oct;31(10):176. doi: 10.1007/s12032-014-0176-4. Epub 2014 Aug 31.
230	ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.Int J Oncol. 2020 Jan;56(1):219-231. doi: 10.3892/ijo.2019.4913. Epub 2019 Nov 14.
231	Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell ... Sci Rep. 2018 Nov 30;8(1):17477.
232	AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.Biochem Biophys Res Commun. 2017 Apr 29;486(2):514-520. doi: 10.1016/j.bbrc.2017.03.075. Epub 2017 Mar 18.
233	Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.Cancer Immunol Immunother. 2017 Jan;66(1):119-128. doi: 10.1007/s00262-016-1925-3. Epub 2016 Nov 16.
234	BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.Cancer Lett. 2019 Mar 31;445:45-56. doi: 10.1016/j.canlet.2019.01.003. Epub 2019 Jan 14.
235	Mutations of the BAK gene are infrequent in advanced gastric adenocarcinomas in Koreans.Cancer Lett. 2003 May 30;195(1):87-91. doi: 10.1016/s0304-3835(02)00585-2.
236	Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.Neuro Oncol. 2008 Oct;10(5):648-60. doi: 10.1215/15228517-2008-032. Epub 2008 Jun 24.
237	Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3398-403. doi: 10.1073/pnas.0530311100. Epub 2003 Mar 7.
238	Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.Cancer Res. 1997 Oct 1;57(19):4427-31.
239	Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.Cell Oncol (Dordr). 2019 Aug;42(4):537-554. doi: 10.1007/s13402-019-00444-0. Epub 2019 Apr 23.
240	Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.Laryngoscope. 2014 Sep;124(9):E354-60. doi: 10.1002/lary.24700. Epub 2014 May 27.
241	BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.Oncotarget. 2015 Aug 14;6(23):19685-705. doi: 10.18632/oncotarget.4081.
242	Low BUB1 expression is an adverse prognostic marker in gastric adenocarcinoma.Oncotarget. 2017 Jul 18;8(44):76329-76339. doi: 10.18632/oncotarget.19357. eCollection 2017 Sep 29.
243	Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.Lung Cancer. 2013 Aug;81(2):259-65. doi: 10.1016/j.lungcan.2013.04.020. Epub 2013 May 23.
244	Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.Cancer Sci. 2007 Mar;98(3):329-33. doi: 10.1111/j.1349-7006.2007.00396.x. Epub 2007 Jan 12.
245	Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : Aretrospective study and literature review.Strahlenther Onkol. 2018 Feb;194(2):156-163. doi: 10.1007/s00066-017-1217-7. Epub 2017 Oct 19.
246	CCR6(+) B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis.Am J Cancer Res. 2017 May 1;7(5):1151-1163. eCollection 2017.
247	Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.Gastroenterology. 2013 Nov;145(5):1064-1075.e11. doi: 10.1053/j.gastro.2013.07.033. Epub 2013 Jul 25.
248	Ets-1 enhances tumor migration through regulation of CCR7 expression.BMB Rep. 2019 Sep;52(9):548-553. doi: 10.5483/BMBRep.2019.52.9.232.
249	Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.Clin Cancer Res. 2008 Feb 1;14(3):638-45. doi: 10.1158/1078-0432.CCR-07-2025.
250	CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.Histopathology. 2008 Jan;52(2):203-12. doi: 10.1111/j.1365-2559.2007.02919.x.
251	Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6.Breast Cancer Res Treat. 2012 Nov;136(1):117-27. doi: 10.1007/s10549-012-2258-3. Epub 2012 Sep 28.
252	Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastases.Mol Cancer Ther. 2010 Jun;9(6):1872-83. doi: 10.1158/1535-7163.MCT-10-0203. Epub 2010 Jun 8.
253	Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.Clin Transl Oncol. 2013 Jul;15(7):541-7. doi: 10.1007/s12094-012-0961-5. Epub 2012 Nov 10.
254	Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.Mol Pharm. 2019 Jan 7;16(1):339-348. doi: 10.1021/acs.molpharmaceut.8b00997. Epub 2018 Nov 30.
255	Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/-catenin pathway.Onco Targets Ther. 2018 Dec 7;11:8875-8883. doi: 10.2147/OTT.S185521. eCollection 2018.
256	Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens.Int J Cancer. 1991 Jun 19;48(4):502-10. doi: 10.1002/ijc.2910480405.
257	Relationship of TGF-1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis.APMIS. 2013 Oct;121(10):967-75. doi: 10.1111/apm.12096. Epub 2013 Sep 2.
258	Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.Cancer Res. 1995 Sep 15;55(18):4127-31.
259	Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.J Urol. 2014 Feb;191(2):479-86. doi: 10.1016/j.juro.2013.08.052. Epub 2013 Sep 5.
260	The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma.Cancer. 2004 Sep 1;101(5):963-8. doi: 10.1002/cncr.20479.
261	ATR-FTIR spectroscopy and CDKN1C gene expression in the prediction of lymph nodes metastases in papillary thyroid carcinoma.Spectrochim Acta A Mol Biomol Spectrosc. 2020 Mar 5;228:117693. doi: 10.1016/j.saa.2019.117693. Epub 2019 Oct 24.
262	Colorectal cancer in the cotton top tamarin (Saguinus oedipus): how do they evade liver metastasis?.Dig Dis Sci. 2011 Feb;56(2):397-405. doi: 10.1007/s10620-010-1314-2. Epub 2010 Jul 20.
263	Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer.Theranostics. 2018 Jul 30;8(15):4247-4261. doi: 10.7150/thno.25131. eCollection 2018.
264	Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein in hepatocellular carcinomas.Oncotarget. 2015 Jun 30;6(18):16106-19. doi: 10.18632/oncotarget.3867.
265	Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.Oncotarget. 2017 Apr 4;8(14):22894-22902. doi: 10.18632/oncotarget.15284.
266	Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA.Comput Biol Chem. 2005 Jun;29(3):183-95. doi: 10.1016/j.compbiolchem.2005.04.005.
267	CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Cancer Cell. 2016 Jun 13;29(6):832-845. doi: 10.1016/j.ccell.2016.04.014. Epub 2016 Jun 2.
268	The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.Breast Cancer (Auckl). 2019 Oct 3;13:1178223419873628. doi: 10.1177/1178223419873628. eCollection 2019.
269	Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.Eur J Med Chem. 2020 Jan 1;185:111823. doi: 10.1016/j.ejmech.2019.111823. Epub 2019 Oct 30.
270	CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.Oncol Rep. 2017 Jun;37(6):3279-3286. doi: 10.3892/or.2017.5598. Epub 2017 Apr 25.
271	-Dystroglycan hypoglycosylation affects cell migration by influencing -dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2182-2191. doi: 10.1016/j.bbadis.2017.05.025. Epub 2017 May 29.
272	Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.Hum Gene Ther. 2019 Feb;30(2):197-210. doi: 10.1089/hum.2018.055. Epub 2018 Oct 2.
273	DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.Int J Cancer. 2005 Jun 10;115(2):224-30. doi: 10.1002/ijc.20885.
274	Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.J Pediatr. 2009 May;154(5):688-93. doi: 10.1016/j.jpeds.2008.11.030. Epub 2009 Jan 21.
275	miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.Clin Cancer Res. 2014 Dec 15;20(24):6559-69. doi: 10.1158/1078-0432.CCR-14-1784. Epub 2014 Oct 16.
276	Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.Medicine (Baltimore). 2018 Dec;97(52):e13817. doi: 10.1097/MD.0000000000013817.
277	Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study.Oncotarget. 2015 Oct 20;6(32):34004-13. doi: 10.18632/oncotarget.5227.
278	EGF promotes HIF-1 expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3. Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1055-1062. doi: 10.26355/eurrev_201902_16993.
279	PERK-Phosphorylated eIF2 Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.Cancer Biother Radiopharm. 2017 Oct;32(8):282-287. doi: 10.1089/cbr.2017.2237.
280	The MAP kinase-interacting kinases (MNKs) as targets in oncology.Expert Opin Ther Targets. 2019 Mar;23(3):187-199. doi: 10.1080/14728222.2019.1571043. Epub 2019 Jan 24.
281	Expression of autotaxin mRNA in human hepatocellular carcinoma.Chin Med J (Engl). 1999 Apr;112(4):330-2.
282	MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer.Cell Biol Int. 2018 Sep;42(9):1115-1123. doi: 10.1002/cbin.10974. Epub 2018 Jul 11.
283	Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.Mol Cancer Res. 2013 Aug;11(8):952-63. doi: 10.1158/1541-7786.MCR-13-0003-T. Epub 2013 May 22.
284	EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration.Cancer Res. 2011 Feb 1;71(3):1156-66. doi: 10.1158/0008-5472.CAN-10-0717. Epub 2011 Jan 25.
285	EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells.Tumour Biol. 2012 Oct;33(5):1419-27. doi: 10.1007/s13277-012-0392-5. Epub 2012 Apr 24.
286	The enhanced expression of estrogen-related receptor in human bladder cancer tissues and the effects of estrogen-related receptor knockdown on bladder cancer cells.J Cell Biochem. 2019 Aug;120(8):13841-13852. doi: 10.1002/jcb.28657. Epub 2019 Apr 11.
287	An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis.Cancer Res. 2010 Feb 15;70(4):1323-33. doi: 10.1158/0008-5472.CAN-09-1474. Epub 2010 Feb 9.
288	Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1 translational pathway in colorectal cancer cells.J Cell Physiol. 2011 Apr;226(4):1060-8. doi: 10.1002/jcp.22428.
289	A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.J Cancer Res Clin Oncol. 2013 Jun;139(6):1015-23. doi: 10.1007/s00432-013-1417-1. Epub 2013 Mar 15.
290	MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
291	G protein-coupled receptor 40 expression in human melanoma - correlation with tumour thickness, AJCC stage and survival.J Eur Acad Dermatol Venereol. 2020 Feb;34(2):285-292. doi: 10.1111/jdv.15924. Epub 2019 Oct 31.
292	Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.Cancer Res. 2008 Aug 1;68(15):6281-91. doi: 10.1158/0008-5472.CAN-08-0094.
293	Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy.Int J Mol Sci. 2017 Apr 22;18(4):891. doi: 10.3390/ijms18040891.
294	CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.Theranostics. 2019 May 9;9(10):2950-2966. doi: 10.7150/thno.29617. eCollection 2019.
295	p38-regulated FOXC1 stability is required for colorectal cancer metastasis.J Pathol. 2020 Feb;250(2):217-230. doi: 10.1002/path.5362. Epub 2019 Nov 28.
296	Crystal Structure of FOXC2 in Complex with DNA Target.ACS Omega. 2019 Jun 24;4(6):10906-10914. doi: 10.1021/acsomega.9b00756. eCollection 2019 Jun 30.
297	Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem. 2012 Aug;113(8):2729-37.
298	Establishment of monoclonal HCC cell lines with organ site-specific tropisms.BMC Cancer. 2015 Oct 12;15:678. doi: 10.1186/s12885-015-1692-0.
299	Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines.Endocrinology. 2008 Aug;149(8):3817-31. doi: 10.1210/en.2007-0989. Epub 2008 May 8.
300	Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides.Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13789-94. doi: 10.1073/pnas.212456599. Epub 2002 Oct 7.
301	Overexpression of FZD7 is associated with poor survival in patients with colon cancer.Pathol Res Pract. 2019 Aug;215(8):152478. doi: 10.1016/j.prp.2019.152478. Epub 2019 May 27.
302	The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).BMC Cancer. 2019 Feb 28;19(1):187. doi: 10.1186/s12885-019-5373-2.
303	MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1.Cancer Res. 2019 Oct 1;79(19):4978-4993. doi: 10.1158/0008-5472.CAN-19-1402. Epub 2019 Aug 20.
304	Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.J Pathol. 2004 Oct;204(2):121-30. doi: 10.1002/path.1625.
305	Genetic and clinico-pathologic analysis of metastatic uveal melanoma.Mod Pathol. 2014 Feb;27(2):175-83. doi: 10.1038/modpathol.2013.138. Epub 2013 Jul 26.
306	Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.Cancer Res. 2005 Jul 1;65(13):5857-63. doi: 10.1158/0008-5472.CAN-04-3816.
307	Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.Endocr Relat Cancer. 2014;21(6):903-14. doi: 10.1530/ERC-14-0402. Epub 2014 Oct 6.
308	Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance.Mol Pharmacol. 2019 Nov;96(5):641-654. doi: 10.1124/mol.119.117069. Epub 2019 Sep 6.
309	Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target.Pigment Cell Melanoma Res. 2011 Feb;24(1):207-18. doi: 10.1111/j.1755-148X.2010.00781.x. Epub 2010 Oct 21.
310	GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.Am J Transl Res. 2017 Sep 15;9(9):4217-4226. eCollection 2017.
311	Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases.Exp Dermatol. 2012 Oct;21(10):786-8. doi: 10.1111/j.1600-0625.2012.01560.x. Epub 2012 Aug 7.
312	Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.Hum Pathol. 2019 May;87:103-114. doi: 10.1016/j.humpath.2018.11.032. Epub 2019 Feb 2.
313	Annexin-directed -glucuronidase for the targeted treatment of solid tumors.Protein Eng Des Sel. 2017 Feb;30(2):85-94. doi: 10.1093/protein/gzw063. Epub 2016 Dec 15.
314	Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.Oncoimmunology. 2017 Oct 26;7(2):e1386828. doi: 10.1080/2162402X.2017.1386828. eCollection 2018.
315	Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.Cancer Res. 2011 May 1;71(9):3341-51. doi: 10.1158/0008-5472.CAN-10-3473. Epub 2011 Mar 17.
316	Inhibition of the prohormone convertase subtilisin-kexin isoenzyme-1 induces apoptosis in human melanoma cells.J Invest Dermatol. 2014 Jan;134(1):168-175. doi: 10.1038/jid.2013.282. Epub 2013 Jun 27.
317	Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.J Immunother Cancer. 2016 Nov 15;4:78. doi: 10.1186/s40425-016-0184-3. eCollection 2016.
318	Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.Biochem Biophys Res Commun. 2013 Apr 26;434(1):70-4. doi: 10.1016/j.bbrc.2013.03.064. Epub 2013 Mar 29.
319	The protein secretion modulator TMED9 drives CNIH4/TGF/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.Oncogene. 2019 Jul;38(29):5817-5837. doi: 10.1038/s41388-019-0845-z. Epub 2019 Jun 28.
320	HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.J Cancer. 2017 Apr 9;8(6):1071-1081. doi: 10.7150/jca.17295. eCollection 2017.
321	HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.APMIS. 2016 Mar;124(3):188-93. doi: 10.1111/apm.12483. Epub 2015 Nov 20.
322	Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.Cancer Res. 2006 Apr 1;66(7):3611-9. doi: 10.1158/0008-5472.CAN-05-2983.
323	The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1. Oncotarget. 2015 Mar 30;6(9):6811-24.
324	Extracellular Hsp90 and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.J Cell Sci. 2019 Jul 31;132(15):jcs228213. doi: 10.1242/jcs.228213.
325	Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.Int J Oncol. 2004 Aug;25(2):259-68.
326	Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.Cancer Res. 2010 Apr 15;70(8):3109-18. doi: 10.1158/0008-5472.CAN-09-3557. Epub 2010 Apr 13.
327	CAG repeat size in Huntingtin alleles is associated with cancer prognosis.Eur J Hum Genet. 2016 Aug;24(9):1310-5. doi: 10.1038/ejhg.2016.13. Epub 2016 Mar 16.
328	Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.J Transl Med. 2013 Jan 11;11:13. doi: 10.1186/1479-5876-11-13.
329	IGFBP2 promotes salivary adenoid cystic carcinoma metastasis by activating the NF-B/ZEB1 signaling pathway.Cancer Lett. 2018 Sep 28;432:38-46. doi: 10.1016/j.canlet.2018.06.008. Epub 2018 Jun 6.
330	Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.Oncogene. 2011 Sep 15;30(37):3907-17. doi: 10.1038/onc.2011.97. Epub 2011 Apr 4.
331	Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):a028530. doi: 10.1101/cshperspect.a028530.
332	mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of 1 integrin function.Mol Cancer Res. 2013 Jun;11(6):593-603. doi: 10.1158/1541-7786.MCR-12-0496. Epub 2013 Mar 6.
333	Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.J Biol Chem. 2011 Aug 19;286(33):29249-29260. doi: 10.1074/jbc.M111.235689. Epub 2011 Jun 16.
334	Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.Clin Transl Oncol. 2014 Oct;16(10):906-13. doi: 10.1007/s12094-014-1167-9. Epub 2014 Mar 22.
335	Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.Chin Med J (Engl). 2011 Nov;124(22):3778-85.
336	HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.Clin Cancer Res. 2017 Jul 1;23(13):3461-3473. doi: 10.1158/1078-0432.CCR-16-2180. Epub 2017 Jan 24.
337	Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin 5 in hepatocellular carcinoma.Cell Death Dis. 2019 May 29;10(6):425. doi: 10.1038/s41419-019-1622-1.
338	Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha6 subunit expression. Int J Cancer. 1996 Feb 8;65(4):519-24.
339	The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.Int J Cancer. 2016 Jun 1;138(11):2688-99. doi: 10.1002/ijc.29998. Epub 2016 Jan 25.
340	The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression.Int J Cancer. 2001 Apr 15;92(2):176-80. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1173>3.0.co;2-l.
341	Toxicological effects of bisphenol A exposure-induced cancer cells migration via activating directly integrin 1.Chemosphere. 2019 Apr;220:783-792. doi: 10.1016/j.chemosphere.2018.12.120. Epub 2018 Dec 19.
342	Therapeutic targeting of integrin v6 in breast cancer.J Natl Cancer Inst. 2014 Jun 28;106(8):dju169. doi: 10.1093/jnci/dju169. Print 2014 Aug.
343	Alteration in metastasis potential and gene expression in human lung cancer cell lines by ITGB8 silencing.Anat Rec (Hoboken). 2012 Sep;295(9):1446-54. doi: 10.1002/ar.22521. Epub 2012 Jul 2.
344	KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.Int J Biol Macromol. 2019 Apr 1;126:318-325. doi: 10.1016/j.ijbiomac.2018.12.105. Epub 2018 Dec 20.
345	Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.Mod Pathol. 2005 Sep;18(9):1249-57. doi: 10.1038/modpathol.3800413.
346	KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer. Oncogene. 2017 Oct 5;36(40):5609-5619.
347	KISS1 and KISS1R expression in primary and metastatic colorectal cancer.J BUON. 2018 May-Jun;23(3):598-603.
348	Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.Cell Cycle. 2018;17(23):2577-2592. doi: 10.1080/15384101.2018.1553335. Epub 2018 Dec 4.
349	Restoration of KLF4 Inhibits Invasion and Metastases of Lung Adenocarcinoma through Suppressing MMP2.J Cancer. 2017 Sep 27;8(17):3480-3489. doi: 10.7150/jca.21241. eCollection 2017.
350	Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.Clin Chem. 2009 Apr;55(4):765-73. doi: 10.1373/clinchem.2008.117952. Epub 2009 Feb 20.
351	MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4.Neoplasma. 2020 Jan;67(1):85-92. doi: 10.4149/neo_2019_190306N191. Epub 2019 Dec 9.
352	Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.Cancer Sci. 2009 Apr;100(4):601-7. doi: 10.1111/j.1349-7006.2009.01090.x.
353	Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8(+) T Cells and Histone Acetyltransferases.Cancer Immunol Res. 2017 Apr;5(4):300-311. doi: 10.1158/2326-6066.CIR-16-0234. Epub 2017 Feb 21.
354	Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.Mol Immunol. 2009 Sep;46(15):2876-84. doi: 10.1016/j.molimm.2009.06.016. Epub 2009 Jul 29.
355	L1 Cell Adhesion Molecule in Cancer, a Systematic Review on Domain-Specific Functions.Int J Mol Sci. 2019 Aug 26;20(17):4180. doi: 10.3390/ijms20174180.
356	Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma.J Transl Med. 2019 Jul 3;17(1):216. doi: 10.1186/s12967-019-1963-7.
357	GPR48, a poor prognostic factor, promotes tumor metastasis and activates -catenin/TCF signaling in colorectal cancer.Carcinogenesis. 2013 Dec;34(12):2861-9. doi: 10.1093/carcin/bgt229. Epub 2013 Jun 26.
358	LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.J Cell Mol Med. 2019 Feb;23(2):1363-1374. doi: 10.1111/jcmm.14039. Epub 2018 Dec 1.
359	Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target.Oncotarget. 2018 May 4;9(34):23462-23481. doi: 10.18632/oncotarget.25231. eCollection 2018 May 4.
360	Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.J Exp Med. 2000 May 15;191(10):1699-708. doi: 10.1084/jem.191.10.1699.
361	MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma.Med Oncol. 2012 Jun;29(2):994-9. doi: 10.1007/s12032-011-9917-9. Epub 2011 Mar 31.
362	Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.J Cancer Res Clin Oncol. 2009 Dec;135(12):1655-63. doi: 10.1007/s00432-009-0612-6. Epub 2009 Jun 10.
363	Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.Mol Cancer Res. 2013 Nov;11(11):1375-86. doi: 10.1158/1541-7786.MCR-13-0101-T. Epub 2013 Aug 27.
364	GHGKHKNK octapeptide (P-5m) inhibits metastasis of HCCLM3 cell lines via regulation of MMP-2 expression in in vitro and in vivo studies.Molecules. 2012 Feb 2;17(2):1357-72. doi: 10.3390/molecules17021357.
365	ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.Mol Pharm. 2017 Oct 2;14(10):3239-3247. doi: 10.1021/acs.molpharmaceut.7b00216. Epub 2017 Sep 6.
366	Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer.Medicine (Baltimore). 2018 Sep;97(36):e12242. doi: 10.1097/MD.0000000000012242.
367	Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.J Clin Invest. 2014 Nov;124(11):4737-52. doi: 10.1172/JCI76375. Epub 2014 Sep 24.
368	Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.Oncology. 2011;80(1-2):57-62. doi: 10.1159/000328283. Epub 2011 May 31.
369	A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.Histopathology. 2012 Feb;60(3):416-26. doi: 10.1111/j.1365-2559.2011.04126.x.
370	The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.Arch Iran Med. 2018 May 1;21(5):185-190.
371	Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.Clin Otolaryngol. 2020 Jan;45(1):55-62. doi: 10.1111/coa.13466. Epub 2019 Nov 13.
372	Primary Ovarian Tumors With Lymphogenic and Hematogenic Metastasis Express High MMP-14, Which Colocalizes With Highly Sulfated Chondroitin Sulfate in the Stroma.Int J Gynecol Pathol. 2020 Mar;39(2):184-192. doi: 10.1097/PGP.0000000000000587.
373	MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.Oncotarget. 2017 Aug 7;8(42):72197-72204. doi: 10.18632/oncotarget.20060. eCollection 2017 Sep 22.
374	Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression.Cancer Res. 2004 Mar 1;64(5):1687-94. doi: 10.1158/0008-5472.can-03-2047.
375	Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.Mol Cancer Res. 2020 Feb;18(2):229-239. doi: 10.1158/1541-7786.MCR-19-0688. Epub 2019 Nov 1.
376	Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.Carcinogenesis. 2000 Aug;21(8):1507-12.
377	Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.J Cell Physiol. 2020 Jun;235(6):5084-5095. doi: 10.1002/jcp.29377. Epub 2019 Nov 6.
378	Prognostic factors in Krukenberg tumor.Arch Gynecol Obstet. 2019 Nov;300(5):1155-1165. doi: 10.1007/s00404-019-05301-x. Epub 2019 Sep 21.
379	Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4.Cancer Commun (Lond). 2018 Aug 13;38(1):53. doi: 10.1186/s40880-018-0320-1.
380	GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.Oncogene. 2014 Jun 12;33(24):3195-204. doi: 10.1038/onc.2013.271. Epub 2013 Jul 15.
381	Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.Front Med (Lausanne). 2019 Sep 13;6:200. doi: 10.3389/fmed.2019.00200. eCollection 2019.
382	E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases.Oncol Lett. 2019 Mar;17(3):2881-2889. doi: 10.3892/ol.2019.9917. Epub 2019 Jan 10.
383	Frequent Loss of NISCH Promotes Tumor Proliferation and Invasion in Ovarian Cancer via Inhibiting the FAK Signal Pathway.Mol Cancer Ther. 2015 May;14(5):1202-12. doi: 10.1158/1535-7163.MCT-14-0911. Epub 2015 Feb 27.
384	Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.Cancer Res. 2014 Sep 1;74(17):4796-810. doi: 10.1158/0008-5472.CAN-14-0210. Epub 2014 Jun 24.
385	Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.JCI Insight. 2018 Apr 5;3(7):e99573. doi: 10.1172/jci.insight.99573. eCollection 2018 Apr 5.
386	An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue.J Pathol. 1998 Jun;185(2):175-83. doi: 10.1002/(SICI)1096-9896(199806)185:2<175::AID-PATH69>3.0.CO;2-U.
387	Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis.J Pharm Sci. 2016 Nov;105(11):3440-3452. doi: 10.1016/j.xphs.2016.08.013. Epub 2016 Sep 21.
388	CD73 expression in lymph node metastases in patients with head and neck cancer.Acta Otolaryngol. 2018 Feb;138(2):180-184. doi: 10.1080/00016489.2017.1378436. Epub 2017 Sep 22.
389	Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.PLoS One. 2019 Jul 8;14(7):e0219494. doi: 10.1371/journal.pone.0219494. eCollection 2019.
390	OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.Breast Cancer Res. 2018 Jun 14;20(1):53. doi: 10.1186/s13058-018-0971-5.
391	Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells.Cancer J. 2018 Mar/Apr;24(2):84-92. doi: 10.1097/PPO.0000000000000312.
392	The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.Tumour Biol. 2016 Apr;37(4):5375-83. doi: 10.1007/s13277-015-4363-5. Epub 2015 Nov 12.
393	Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).PLoS One. 2013 May 13;8(5):e64145. doi: 10.1371/journal.pone.0064145. Print 2013.
394	Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis.Front Oncol. 2019 Feb 13;9:47. doi: 10.3389/fonc.2019.00047. eCollection 2019.
395	Integrative PDGF/PDGFR and focal adhesion pathways are downregulated in ERCC1-defective non-small cell lung cancer undergoing sodium glycididazole-sensitized cisplatin treatment.Gene. 2019 Apr 5;691:70-76. doi: 10.1016/j.gene.2018.12.028. Epub 2018 Dec 22.
396	PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1.Biochem J. 2014 Aug 1;461(3):383-90. doi: 10.1042/BJ20140132.
397	Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization.Cell Oncol. 2005;27(4):215-23. doi: 10.1155/2005/108490.
398	Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-B in Human Gallbladder Cancer.Ann Surg Oncol. 2019 Mar;26(3):907-917. doi: 10.1245/s10434-018-07132-7. Epub 2019 Jan 4.
399	PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.Oncotarget. 2014 Dec 30;5(24):12646-64. doi: 10.18632/oncotarget.2653.
400	Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.Neoplasia. 2009 Jun;11(6):518-28, 4 p following 528. doi: 10.1593/neo.81674.
401	PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.BMC Cancer. 2019 Jul 30;19(1):747. doi: 10.1186/s12885-019-5949-x.
402	PLEKHA5 regulates tumor growth in metastatic melanoma.Cancer. 2020 Mar 1;126(5):1016-1030. doi: 10.1002/cncr.32611. Epub 2019 Nov 26.
403	The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.Cancers (Basel). 2017 Sep 27;9(10):131. doi: 10.3390/cancers9100131.
404	Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.Cancer Discov. 2013 Oct;3(10):1190-205. doi: 10.1158/2159-8290.CD-13-0118. Epub 2013 Aug 1.
405	PPM1A is a RelA phosphatase with tumor suppressor-like activity.Oncogene. 2014 May 29;33(22):2918-27. doi: 10.1038/onc.2013.246. Epub 2013 Jul 1.
406	Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.Am J Surg Pathol. 2020 Apr;44(4):503-508. doi: 10.1097/PAS.0000000000001393.
407	PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma.Cell Physiol Biochem. 2016;40(3-4):757-769. doi: 10.1159/000453136. Epub 2016 Dec 5.
408	RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.Prostate. 2016 Feb;76(2):184-98. doi: 10.1002/pros.23110. Epub 2015 Oct 19.
409	Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions.Int J Oncol. 2004 Dec;25(6):1625-9.
410	Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.Cancer Sci. 2009 Dec;100(12):2318-24. doi: 10.1111/j.1349-7006.2009.01322.x. Epub 2009 Aug 25.
411	Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.J Exp Clin Cancer Res. 2018 Feb 20;37(1):34. doi: 10.1186/s13046-018-0692-8.
412	PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation.Cancer Res. 2016 Aug 1;76(15):4406-17. doi: 10.1158/0008-5472.CAN-15-3445. Epub 2016 Jun 14.
413	Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma.Oncotarget. 2014 Jun 15;5(11):3685-96. doi: 10.18632/oncotarget.1986.
414	Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.Cancer Res. 2010 Nov 1;70(21):8959-67. doi: 10.1158/0008-5472.CAN-10-2041. Epub 2010 Sep 14.
415	PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition.Cell Death Dis. 2019 Apr 30;10(5):352. doi: 10.1038/s41419-019-1554-9.
416	Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.Melanoma Res. 1999 Jun;9(3):249-52. doi: 10.1097/00008390-199906000-00006.
417	Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.Chin Med J (Engl). 2017 Feb 5;130(3):280-287. doi: 10.4103/0366-6999.198932.
418	RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ. 2020 Jan;27(1):161-175.
419	Curcumin suppresses wilms' tumor metastasis by inhibiting RECK methylation.Biomed Pharmacother. 2019 Mar;111:1204-1212. doi: 10.1016/j.biopha.2018.12.111. Epub 2019 Jan 15.
420	Paratesticular neuroblastoma with N-myc activation.J Pediatr Surg. 1993 Dec;28(12):1612-4. doi: 10.1016/0022-3468(93)90117-4.
421	Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.J Invest Dermatol. 2002 Nov;119(5):1172-6. doi: 10.1046/j.1523-1747.2002.19519.x.
422	Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer.Oncol Res. 2010;18(11-12):583-91. doi: 10.3727/096504010x12767359113767.
423	miR?0a inhibits epithelialmesenchymal transition and metastasis in triplenegative breast cancer by targeting ROR1.Oncol Rep. 2018 Jun;39(6):2635-2643. doi: 10.3892/or.2018.6379. Epub 2018 Apr 18.
424	Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model.J Cancer Res Clin Oncol. 2013 Jul;139(7):1169-78. doi: 10.1007/s00432-013-1424-2. Epub 2013 Apr 7.
425	Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer.Clin Lung Cancer. 2020 Mar;21(2):153-159.e3. doi: 10.1016/j.cllc.2019.10.006. Epub 2019 Oct 16.
426	A double dealing tale of p63: an oncogene or a tumor suppressor.Cell Mol Life Sci. 2018 Mar;75(6):965-973. doi: 10.1007/s00018-017-2666-y. Epub 2017 Oct 3.
427	An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis.Oncogene. 2011 Aug 11;30(32):3513-21. doi: 10.1038/onc.2011.61. Epub 2011 Mar 21.
428	Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.Clin Sci (Lond). 2013 May;124(9):567-78. doi: 10.1042/CS20120240.
429	Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.Gynecol Oncol. 2006 Dec;103(3):814-9. doi: 10.1016/j.ygyno.2006.05.042. Epub 2006 Jul 17.
430	Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity (18) F-FDG injection.Med Phys. 2018 May;45(5):2179-2185. doi: 10.1002/mp.12836. Epub 2018 Mar 23.
431	miR-301a promotes lung tumorigenesis by suppressing Runx3.Mol Cancer. 2019 May 23;18(1):99. doi: 10.1186/s12943-019-1024-0.
432	lncRNA NEF inhibits glioma by downregulating TGF-1.Exp Ther Med. 2019 Jul;18(1):692-698. doi: 10.3892/etm.2019.7602. Epub 2019 May 23.
433	Mammaglobin 1: not only a breast-specific and tumour-specific marker, but also a hormone-responsive endometrial protein.Histopathology. 2012 Nov;61(5):955-65. doi: 10.1111/j.1365-2559.2012.04290.x. Epub 2012 Sep 20.
434	Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5421-5426. doi: 10.1210/jc.2019-00202.
435	Activated platelets interact with lung cancer cells through P-selectin glycoprotein ligand-1.Pathol Oncol Res. 2012 Oct;18(4):989-96. doi: 10.1007/s12253-012-9531-y. Epub 2012 Apr 26.
436	Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.Gastroenterology. 2018 Jun;154(8):2060-2063.e8. doi: 10.1053/j.gastro.2018.02.026. Epub 2018 Mar 2.
437	Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients.Oncogene. 2017 Nov 16;36(46):6432-6445. doi: 10.1038/onc.2017.253. Epub 2017 Jul 24.
438	miR?37?p inhibits gastric tumor metastasis by targeting ARHGAP10.Mol Med Rep. 2020 Feb;21(2):705-719. doi: 10.3892/mmr.2019.10856. Epub 2019 Nov 29.
439	Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype.Breast Cancer Res. 2003;5(3):R65-70. doi: 10.1186/bcr587. Epub 2003 Mar 6.
440	Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis. Mol Cancer Res. 2015 Jun;13(6):1044-55.
441	Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.PLoS One. 2017 Jun 28;12(6):e0180097. doi: 10.1371/journal.pone.0180097. eCollection 2017.
442	SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction.Cell Physiol Biochem. 2018;47(6):2484-2497. doi: 10.1159/000491622. Epub 2018 Jul 10.
443	Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancer.Pathology. 2018 Apr;50(3):269-275. doi: 10.1016/j.pathol.2017.10.016. Epub 2018 Feb 16.
444	Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes. Sci Rep. 2016 Jul 20;6:29930.
445	Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.Int J Cancer. 2004 Jul 20;110(6):914-20. doi: 10.1002/ijc.20182.
446	Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That RegulateMetastasis.Gastroenterology. 2017 Jun;152(8):1985-1997.e12. doi: 10.1053/j.gastro.2017.02.006. Epub 2017 Feb 14.
447	Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer. Yonsei Med J. 2017 Jan;58(1):27-34.
448	Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility.Int J Oncol. 2014 Jan;44(1):78-90. doi: 10.3892/ijo.2013.2158. Epub 2013 Oct 31.
449	Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):619-27. doi: 10.1158/1055-9965.EPI-10-1023. Epub 2011 Jan 25.
450	SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.Int J Cancer. 2020 Mar 15;146(6):1553-1567. doi: 10.1002/ijc.32673. Epub 2019 Oct 30.
451	Gamma synuclein is a novel Twist1 target that promotes TGF--induced cancer cell migration and invasion.Cell Death Dis. 2018 May 24;9(6):625. doi: 10.1038/s41419-018-0657-z.
452	Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.JCI Insight. 2019 Apr 9;5(9):e125543. doi: 10.1172/jci.insight.125543.
453	The transcription factor SPDEF suppresses prostate tumor metastasis. J Biol Chem. 2012 Aug 24;287(35):29968-78.
454	MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer.J Cancer. 2019 Jan 1;10(2):547-555. doi: 10.7150/jca.27748. eCollection 2019.
455	5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.Pharmacogenetics. 2002 Jun;12(4):307-12. doi: 10.1097/00008571-200206000-00006.
456	SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1.Cell Physiol Biochem. 2018;48(6):2429-2440. doi: 10.1159/000492657. Epub 2018 Aug 17.
457	Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.Neuroendocrinology. 2012;95(3):232-47. doi: 10.1159/000330616. Epub 2011 Dec 13.
458	Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin.Glycobiology. 2004 Feb;14(2):139-46. doi: 10.1093/glycob/cwh013. Epub 2003 Oct 9.
459	STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.Cancer Res. 2013 Feb 15;73(4):1287-97. doi: 10.1158/0008-5472.CAN-12-1875. Epub 2012 Dec 14.
460	Role of serine/threonine kinase 33 methylation in colorectal cancer and its clinical significance.Oncol Lett. 2018 Feb;15(2):2153-2160. doi: 10.3892/ol.2017.7614. Epub 2017 Dec 14.
461	Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions.Melanoma Res. 2019 Apr;29(2):157-162. doi: 10.1097/CMR.0000000000000550.
462	STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.Sci Rep. 2016 Sep 15;6:33205. doi: 10.1038/srep33205.
463	Unbalanced chromosomal rearrangements in a metastasizing salivary gland tumor with benign histology.Cancer Genet Cytogenet. 1998 Apr 1;102(1):59-64. doi: 10.1016/s0165-4608(97)00301-4.
464	The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated -catenin in gastric cancer.Cancer Med. 2019 Mar;8(3):1135-1147. doi: 10.1002/cam4.1934. Epub 2019 Jan 11.
465	TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.Cancer Gene Ther. 2020 Apr;27(3-4):136-146. doi: 10.1038/s41417-019-0111-0. Epub 2019 Jun 27.
466	The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2(Hi) Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.Mol Cancer Ther. 2017 Nov;16(11):2486-2501. doi: 10.1158/1535-7163.MCT-17-0241. Epub 2017 Aug 24.
467	Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.Biomed Res Int. 2017;2017:8983763. doi: 10.1155/2017/8983763. Epub 2017 Jan 26.
468	Somatic acquisition and signaling of TGFBR1*6A in cancer.JAMA. 2005 Oct 5;294(13):1634-46. doi: 10.1001/jama.294.13.1634.
469	The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.Am J Cancer Res. 2019 Mar 1;9(3):597-607. eCollection 2019.
470	Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.Int J Oncol. 2007 Jan;30(1):91-5.
471	Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.Prostate. 2014 Dec;74(16):1647-54. doi: 10.1002/pros.22882. Epub 2014 Sep 22.
472	Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis.EMBO Mol Med. 2018 Oct;10(10):e9003. doi: 10.15252/emmm.201809003.
473	The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases.Cancers (Basel). 2018 Oct 24;10(11):398. doi: 10.3390/cancers10110398.
474	Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb. J Cancer Res Clin Oncol. 2013 Feb;139(2):315-25.
475	LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.Cancer Res. 2017 Apr 15;77(8):1880-1891. doi: 10.1158/0008-5472.CAN-16-1655. Epub 2017 Mar 1.
476	Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer.Oncotarget. 2017 Aug 5;8(53):90825-90841. doi: 10.18632/oncotarget.19967. eCollection 2017 Oct 31.
477	Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.J Pathol. 2006 Oct;210(2):181-91. doi: 10.1002/path.2045.
478	TOP2A induces malignant character of pancreatic cancer through activating -catenin signaling pathway.Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):197-207. doi: 10.1016/j.bbadis.2017.10.019. Epub 2017 Oct 16.
479	Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.Clin Endocrinol (Oxf). 2009 Apr;70(4):629-35. doi: 10.1111/j.1365-2265.2008.03376.x. Epub 2008 Aug 15.
480	The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells.J Proteome Res. 2010 Jan;9(1):40-9. doi: 10.1021/pr9001367.
481	Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines.PLoS One. 2014 Jul 1;9(7):e101040. doi: 10.1371/journal.pone.0101040. eCollection 2014.
482	TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.Aging (Albany NY). 2019 Oct 10;11(19):8623-8641. doi: 10.18632/aging.102351. Epub 2019 Oct 10.
483	TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.Mol Oncol. 2019 Nov;13(11):2393-2405. doi: 10.1002/1878-0261.12566. Epub 2019 Sep 12.
484	Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.Asian Pac J Cancer Prev. 2014;15(9):3955-8. doi: 10.7314/apjcp.2014.15.9.3955.
485	Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.Cancer Res. 2010 Feb 1;70(3):1225-35. doi: 10.1158/0008-5472.CAN-09-2205. Epub 2010 Jan 26.
486	Clinical implications of aberrant TSG101 transcripts in acute myeloblastic leukemia.Leuk Lymphoma. 2000 Feb;36(5-6):463-6. doi: 10.3109/10428190009148393.
487	Targeting the TSH receptor in thyroid cancer.Endocr Relat Cancer. 2017 Jun;24(6):R191-R202. doi: 10.1530/ERC-17-0010. Epub 2017 Mar 28.
488	IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.Oncogene. 2014 Jun 26;33(26):3374-82. doi: 10.1038/onc.2013.337. Epub 2013 Aug 26.
489	Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy.Eur J Cancer. 2010 Dec;46(18):3358-64. doi: 10.1016/j.ejca.2010.07.011. Epub 2010 Aug 18.
490	Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.Anticancer Res. 2014 Sep;34(9):4949-62.
491	GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.PLoS One. 2013 Apr 24;8(4):e61873. doi: 10.1371/journal.pone.0061873. Print 2013.
492	SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.Br J Cancer. 2015 Jun 30;113(1):91-8. doi: 10.1038/bjc.2015.194. Epub 2015 Jun 11.
493	Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.Pathol Oncol Res. 2014 Jul;20(3):529-33. doi: 10.1007/s12253-013-9724-z. Epub 2013 Dec 5.
494	HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.Sci Rep. 2019 Apr 1;9(1):5407. doi: 10.1038/s41598-019-41900-z.
495	Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling.Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419861600. doi: 10.1177/2058738419861600.
496	Emerging Roles for von Willebrand Factor in Cancer Cell Biology.Semin Thromb Hemost. 2018 Mar;44(2):159-166. doi: 10.1055/s-0037-1607352. Epub 2017 Nov 17.
497	Loss of miR-155 upregulates WEE1 in metastatic melanoma.Melanoma Res. 2019 Apr;29(2):216-219. doi: 10.1097/CMR.0000000000000545.
498	ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.Cancer Res. 2012 Jul 15;72(14):3593-606. doi: 10.1158/0008-5472.CAN-11-3095. Epub 2012 May 16.
499	Brain accumulation of osimertinib and its active metabolite AZ5104 is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein).Pharmacol Res. 2019 Aug;146:104297. doi: 10.1016/j.phrs.2019.104297. Epub 2019 Jun 5.
500	Distinct Epitopes on CD13 Mediate Opposite Consequences for Cell Adhesion.Biomed Res Int. 2018 Mar 29;2018:4093435. doi: 10.1155/2018/4093435. eCollection 2018.
501	Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640. doi: 10.1073/pnas.1808834116. Epub 2018 Dec 21.
502	Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer.Cancer Med. 2017 May;6(5):994-1001. doi: 10.1002/cam4.1018. Epub 2017 Mar 3.
503	HER2 Upregulates ATF4 to Promote Cell Migration via Activation of ZEB1 and Downregulation of E-Cadherin.Int J Mol Sci. 2019 May 6;20(9):2223. doi: 10.3390/ijms20092223.
504	BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.Mol Oncol. 2015 Jan;9(1):179-91. doi: 10.1016/j.molonc.2014.08.004. Epub 2014 Aug 23.
505	Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.Sci Rep. 2019 Oct 17;9(1):14907. doi: 10.1038/s41598-019-51445-w.
506	Sentinel lymph node biopsy in medullary thyroid microcarcinomas.Endocr J. 2020 Mar 28;67(3):295-304. doi: 10.1507/endocrj.EJ19-0409. Epub 2019 Dec 3.
507	Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer.Gastric Cancer. 2019 Mar;22(2):302-313. doi: 10.1007/s10120-018-0872-4. Epub 2018 Sep 3.
508	CD36 tango in cancer: signaling pathways and functions.Theranostics. 2019 Jul 9;9(17):4893-4908. doi: 10.7150/thno.36037. eCollection 2019.
509	The role of cadherin-11 in microcystin-LR-induced migration and invasion in colorectal carcinoma cells.Oncol Lett. 2018 Feb;15(2):1417-1422. doi: 10.3892/ol.2017.7458. Epub 2017 Nov 21.
510	Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients.Med Sci Monit. 2010 Aug;16(8):CR357-64.
511	Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.Adv Mater. 2019 Mar;31(10):e1802228. doi: 10.1002/adma.201802228. Epub 2019 Jan 21.
512	CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition.Cell Commun Signal. 2019 Sep 10;17(1):118. doi: 10.1186/s12964-019-0434-3.
513	Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.Int J Cancer. 2001 Sep 1;93(5):653-61. doi: 10.1002/ijc.1381.
514	Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4558-4566. doi: 10.1073/pnas.1815515116. Epub 2019 Jan 30.
515	Overexpression of Growth-Related Oncogene- Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer.Dis Markers. 2015;2015:387382. doi: 10.1155/2015/387382. Epub 2015 Apr 30.
516	DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs.Elife. 2019 May 30;8:e45508. doi: 10.7554/eLife.45508.
517	Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases.Clin Exp Metastasis. 2018 Dec;35(8):763-775. doi: 10.1007/s10585-018-9937-3. Epub 2018 Sep 20.
518	CD26/DPP4 - a potential biomarker and target for cancer therapy.Pharmacol Ther. 2019 Jun;198:135-159. doi: 10.1016/j.pharmthera.2019.02.015. Epub 2019 Feb 26.
519	KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.Int J Cancer. 2018 Jun 1;142(11):2323-2334. doi: 10.1002/ijc.31248. Epub 2018 Jan 21.
520	Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer.Oncol Res. 2018 Dec 27;27(1):99-106. doi: 10.3727/096504018X15195193936573. Epub 2018 Mar 1.
521	Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.Cardiovasc Diagn Ther. 2018 Oct;8(5):581-593. doi: 10.21037/cdt.2018.10.14.
522	The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells.Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):914-920. doi: 10.1093/abbs/gmy080.
523	Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group.Cancer Med. 2019 Oct;8(14):6437-6448. doi: 10.1002/cam4.2504. Epub 2019 Aug 27.
524	Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.Gynecol Oncol. 2019 May;153(2):405-415. doi: 10.1016/j.ygyno.2019.01.020. Epub 2019 Feb 20.
525	Frizzled-10 and cancer progression: Is it a new prognostic marker?.Oncotarget. 2017 Dec 12;9(1):824-830. doi: 10.18632/oncotarget.23159. eCollection 2018 Jan 2.
526	Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.BMC Cancer. 2019 Jan 15;19(1):74. doi: 10.1186/s12885-019-5278-0.
527	Role of heparanase in tumor progression: Molecular aspects and therapeutic options.Semin Cancer Biol. 2020 May;62:86-98. doi: 10.1016/j.semcancer.2019.07.014. Epub 2019 Jul 23.
528	HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer.Anticancer Res. 2018 Nov;38(11):6551-6560. doi: 10.21873/anticanres.13021.
529	Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells.Biomater Sci. 2019 Mar 26;7(4):1345-1357. doi: 10.1039/c8bm01556b.
530	MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/-catenin signalling.Cell Death Dis. 2019 Jun 11;10(6):454. doi: 10.1038/s41419-019-1685-z.
531	VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1.J Cell Sci. 2019 Oct 28;132(20):jcs232645. doi: 10.1242/jcs.232645.
532	KiSS1 in regulation of metastasis and response to antitumor drugs.Drug Resist Updat. 2019 Jan;42:12-21. doi: 10.1016/j.drup.2019.02.001. Epub 2019 Feb 11.
533	Lactate and cancer: spinal metastases and potential therapeutic targets (part 2).Ann Transl Med. 2019 May;7(10):221. doi: 10.21037/atm.2019.01.85.
534	MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.Oncotarget. 2017 Sep 7;8(48):83384-83406. doi: 10.18632/oncotarget.20698. eCollection 2017 Oct 13.
535	A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection.Nanoscale Res Lett. 2019 Jul 9;14(1):228. doi: 10.1186/s11671-019-3049-0.
536	Melanocortin 1 Receptor-Targeted -Particle Therapy for Metastatic Uveal Melanoma.J Nucl Med. 2019 Aug;60(8):1124-1133. doi: 10.2967/jnumed.118.217240. Epub 2019 Feb 7.
537	ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin 31 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.Gastroenterology. 2020 Feb;158(3):679-692.e1. doi: 10.1053/j.gastro.2019.10.038. Epub 2019 Nov 9.
538	Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases.Cell Death Dis. 2018 Mar 7;9(3):382. doi: 10.1038/s41419-018-0425-0.
539	Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.Int J Oncol. 2018 Sep;53(3):1279-1288. doi: 10.3892/ijo.2018.4464. Epub 2018 Jun 29.
540	Metastasis-Associated Protein 1 Is Involved in Angiogenesis after Transarterial Chemoembolization Treatment.Biomed Res Int. 2017;2017:6757898. doi: 10.1155/2017/6757898. Epub 2017 May 15.
541	Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report.J Neurosurg Pediatr. 2019 Oct 25;25(2):121-130. doi: 10.3171/2019.8.PEDS18664.
542	Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma.Cells. 2019 Sep 28;8(10):1167. doi: 10.3390/cells8101167.
543	Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.Clin Cancer Res. 2019 Dec 15;25(24):7448-7454. doi: 10.1158/1078-0432.CCR-19-1050. Epub 2019 Sep 11.
544	SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.Cancer Lett. 2018 Mar 1;416:11-23. doi: 10.1016/j.canlet.2017.12.008. Epub 2017 Dec 13.
545	Angiotropism in primary cutaneous melanoma is associated with disease progression and distant metastases: A retrospective study of 179 cases.J Cutan Pathol. 2019 Jul;46(7):498-507. doi: 10.1111/cup.13461. Epub 2019 Apr 14.
546	Prognostic value of (18)F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging.Hell J Nucl Med. 2019 Jan-Apr;22(1):25-35. doi: 10.1967/s002449910956. Epub 2019 Mar 7.
547	Orthotopic Patient-Derived Xenografts of Gastric Cancer to Decipher Drugs Effects on Cancer Stem Cells and Metastatic Dissemination.Cancers (Basel). 2019 Apr 19;11(4):560. doi: 10.3390/cancers11040560.
548	Overexpression of periostin is positively associated with gastric cancer metastasis through promoting tumor metastasis and invasion.J Cell Biochem. 2019 Jun;120(6):9927-9935. doi: 10.1002/jcb.28275. Epub 2019 Jan 13.
549	Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b(+)Gr1(+)MDSCs from bone marrow.Biomed Pharmacother. 2020 Jan;121:109581. doi: 10.1016/j.biopha.2019.109581. Epub 2019 Nov 10.
550	Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.Gene. 2012 Dec 15;511(2):169-76. doi: 10.1016/j.gene.2012.09.079. Epub 2012 Oct 2.
551	Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.J Immunother Cancer. 2019 Dec 5;7(1):343. doi: 10.1186/s40425-019-0828-1.
552	SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma.Oral Dis. 2017 Mar;23(2):247-254. doi: 10.1111/odi.12602. Epub 2016 Nov 28.
553	Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes.Exp Dermatol. 2019 Nov;28(11):1258-1269. doi: 10.1111/exd.14023. Epub 2019 Sep 9.
554	Oncogenic signaling in uveal melanoma.Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672. doi: 10.1111/pcmr.12708. Epub 2018 May 23.
555	Clinical guidance for radioiodine refractory differentiated thyroid cancer.Clin Endocrinol (Oxf). 2018 Apr;88(4):529-537. doi: 10.1111/cen.13508. Epub 2017 Nov 24.
556	Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts.Mol Genet Metab. 2018 Apr;123(4):463-471. doi: 10.1016/j.ymgme.2018.02.010. Epub 2018 Feb 16.
557	A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone.J Bone Miner Res. 2020 Jan;35(1):155-166. doi: 10.1002/jbmr.3869. Epub 2019 Oct 31.
558	Knockdown of activated Cdc42-associated kinase inhibits human extravillous trophoblast migration and invasion and decreases protein expression of pho-Akt and matrix metalloproteinase.J Matern Fetal Neonatal Med. 2020 Apr;33(7):1125-1133. doi: 10.1080/14767058.2018.1515196. Epub 2018 Oct 3.
559	Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis.Cancers (Basel). 2019 Jan 11;11(1):76. doi: 10.3390/cancers11010076.
560	Development of radioiodine labeled acetaminophen for specific, high-contrast imaging of malignant melanoma.Nucl Med Biol. 2018 Apr;59:16-21. doi: 10.1016/j.nucmedbio.2017.12.008. Epub 2018 Jan 3.
561	Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.J Cell Mol Med. 2020 Jan;24(2):1370-1382. doi: 10.1111/jcmm.14813. Epub 2019 Dec 17.
562	LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer.Cell Death Dis. 2018 Nov 21;9(12):1158. doi: 10.1038/s41419-018-1170-0.
563	Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.Theranostics. 2019 Apr 13;9(9):2526-2540. doi: 10.7150/thno.32915. eCollection 2019.
564	Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle.Nat Med. 2018 Jun;24(6):770-781. doi: 10.1038/s41591-018-0054-2. Epub 2018 Jun 6.
565	PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF- expression levels.Oncotarget. 2016 Sep 20;7(38):62159-62176. doi: 10.18632/oncotarget.11398.
566	Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.Oncotarget. 2017 Jan 3;8(1):846-862. doi: 10.18632/oncotarget.13666.
567	Differential expression and prognostic role of selected genes in colorectal cancer patients.Anticancer Res. 2013 Nov;33(11):4855-65.
568	SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer.Sci Rep. 2017 Aug 3;7(1):7211. doi: 10.1038/s41598-017-07830-4.
569	Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7).Int J Cancer. 2013 Mar 15;132(6):1288-99. doi: 10.1002/ijc.27782. Epub 2012 Sep 7.
570	E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.Mol Cancer Ther. 2011 Jul;10(7):1218-28. doi: 10.1158/1535-7163.MCT-10-0707. Epub 2011 May 6.
571	The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.Biochem J. 2005 Jun 15;388(Pt 3):967-72. doi: 10.1042/BJ20041066.
572	Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.Breast Cancer Res. 2018 Nov 28;20(1):145. doi: 10.1186/s13058-018-1068-x.
573	Effect of Human Fat Graft on Breast Cancer Metastasis in a Murine Model.Plast Reconstr Surg. 2017 May;139(5):1119-1128. doi: 10.1097/PRS.0000000000003274.
574	Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.JAMA Oncol. 2018 Apr 1;4(4):558-562. doi: 10.1001/jamaoncol.2017.3164.
575	Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression.J Cell Biochem. 2019 Mar;120(3):3611-3620. doi: 10.1002/jcb.27638. Epub 2018 Nov 11.
576	Thyroid carcinoma surgery in children and adolescents - 15 years experience surgery of pediatric thyroid carcinoma.Int J Pediatr Otorhinolaryngol. 2014 Jul;78(7):990-4. doi: 10.1016/j.ijporl.2014.03.005. Epub 2014 Apr 1.
577	UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.Nature. 2019 Jul;571(7763):127-131. doi: 10.1038/s41586-019-1340-y. Epub 2019 Jun 26.
578	Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer. J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):85-93.
579	Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.Endocrinology. 2016 Dec;157(12):4526-4533. doi: 10.1210/en.2016-1606. Epub 2016 Oct 26.
580	Steroid-converting enzymes in human ovarian carcinomas.Mol Cell Endocrinol. 2009 Mar 25;301(1-2):51-8. doi: 10.1016/j.mce.2008.07.015. Epub 2008 Aug 3.
581	Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.Oncol Rep. 2015 Feb;33(2):599-606. doi: 10.3892/or.2014.3666. Epub 2014 Dec 11.
582	Tryptophanyl-tRNA synthetase (WARS) expression in uveal melanoma - possible contributor during uveal melanoma progression.Biosci Biotechnol Biochem. 2020 Mar;84(3):471-480. doi: 10.1080/09168451.2019.1686967. Epub 2019 Nov 6.
583	AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.Theranostics. 2018 Jan 1;8(3):676-692. doi: 10.7150/thno.21463. eCollection 2018.
584	Nucleotide-dependent self-assembly of Nucleoside Diphosphate Kinase (NDPK) in vitro.Biochim Biophys Acta. 2008 Dec;1784(12):2045-51. doi: 10.1016/j.bbapap.2008.07.011. Epub 2008 Aug 6.
585	Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.Cancer Invest. 2008 Nov;26(9):905-12. doi: 10.1080/07357900802146154.
586	Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.PLoS One. 2013 Nov 7;8(11):e77407. doi: 10.1371/journal.pone.0077407. eCollection 2013.
587	Establishment and characterization of two new human renal cancer cell lines (DNT-11 and DNT-63) derived from metastases.Anticancer Res. 1994 Jan-Feb;14(1A):173-6.
588	Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice.J Lipid Res. 2014 Nov;55(11):2389-400. doi: 10.1194/jlr.M053462. Epub 2014 Sep 10.
589	Expression of enzymatically active sucrase-isomaltase is a ubiquitous property of colon adenocarcinomas.Gastroenterology. 1991 May;100(5 Pt 1):1266-78.
590	The thiopurines: an update.Invest New Drugs. 2005 Dec;23(6):523-32. doi: 10.1007/s10637-005-4020-8.
591	Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.World J Gastroenterol. 2005 Jun 7;11(21):3250-4. doi: 10.3748/wjg.v11.i21.3250.
592	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.J Clin Endocrinol Metab. 2012 Mar;97(3):E428-32. doi: 10.1210/jc.2011-2064. Epub 2011 Dec 14.
593	Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.Clin Cancer Res. 2000 Aug;6(8):3166-71.
594	NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Mol Cell Proteomics. 2015 Nov;14(11):2988-99. doi: 10.1074/mcp.M115.050385. Epub 2015 Sep 8.
595	ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma.Pathol Res Pract. 2018 Sep;214(9):1356-1361. doi: 10.1016/j.prp.2018.05.028. Epub 2018 Jun 7.
596	AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-B pathway and predicts poor outcome of the patients.Sci Rep. 2018 Aug 10;8(1):11955. doi: 10.1038/s41598-018-29878-6.
597	Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29.
598	AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.Cancer Biother Radiopharm. 2019 Dec;34(10):626-633. doi: 10.1089/cbr.2019.2778. Epub 2019 Oct 17.
599	Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.Cell Death Dis. 2018 Jan 26;9(2):126. doi: 10.1038/s41419-017-0143-z.
600	Progressive APOBEC3B mRNA expression in distant breast cancer metastases.PLoS One. 2017 Jan 31;12(1):e0171343. doi: 10.1371/journal.pone.0171343. eCollection 2017.
601	ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells.Int J Oncol. 2018 Nov;53(5):1980-1996. doi: 10.3892/ijo.2018.4535. Epub 2018 Aug 22.
602	Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.Nat Commun. 2015 Jul 2;6:7353. doi: 10.1038/ncomms8353.
603	Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex.Cancer Sci. 2019 Dec;110(12):3788-3801. doi: 10.1111/cas.14205. Epub 2019 Nov 15.
604	A Ca(2+)-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.Mol Cancer Res. 2019 Aug;17(8):1735-1747. doi: 10.1158/1541-7786.MCR-19-0070. Epub 2019 May 10.
605	Silencing of vacuolar ATPase csubunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.Oncol Rep. 2018 Jan;39(1):298-306. doi: 10.3892/or.2017.6092. Epub 2017 Nov 10.
606	BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.Br J Cancer. 2009 Jan 13;100(1):123-33. doi: 10.1038/sj.bjc.6604809. Epub 2008 Dec 9.
607	MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.Biomed Pharmacother. 2018 Jul;103:645-652. doi: 10.1016/j.biopha.2018.04.037. Epub 2018 Apr 24.
608	Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells.Int J Biol Macromol. 2018 Feb;107(Pt A):349-362. doi: 10.1016/j.ijbiomac.2017.08.178. Epub 2017 Sep 9.
609	Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma.J Clin Pathol. 2017 Jul;70(7):619-624. doi: 10.1136/jclinpath-2016-204028. Epub 2016 Dec 15.
610	CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):273-279. doi: 10.1007/s12253-018-0450-4. Epub 2018 Jul 26.
611	Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.Mol Cancer Res. 2020 Feb;18(2):240-252. doi: 10.1158/1541-7786.MCR-19-0722. Epub 2019 Nov 6.
612	CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.Int J Biochem Cell Biol. 2018 Feb;95:1-8. doi: 10.1016/j.biocel.2017.12.006. Epub 2017 Dec 8.
613	WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.J Biol Chem. 2019 Apr 5;294(14):5261-5280. doi: 10.1074/jbc.RA118.006122. Epub 2019 Feb 5.
614	p53 and -Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma.Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e385-e392. doi: 10.1016/j.clml.2019.03.030. Epub 2019 Apr 5.
615	Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.Breast Cancer Res. 2014 Oct 14;16(5):454. doi: 10.1186/s13058-014-0454-2.
616	Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients.Int Ophthalmol. 2019 Dec;39(12):2825-2832. doi: 10.1007/s10792-019-01129-1. Epub 2019 Jun 3.
617	Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.J Neurooncol. 2019 Apr;142(2):319-325. doi: 10.1007/s11060-019-03099-x. Epub 2019 Jan 17.
618	Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.Viruses. 2015 Jun 10;7(6):2965-79. doi: 10.3390/v7062755.
619	Cell confluence regulates claudin-2 expression: possible role for ZO-1 and Rac.Am J Physiol Cell Physiol. 2018 Mar 1;314(3):C366-C378. doi: 10.1152/ajpcell.00234.2017. Epub 2017 Nov 29.
620	Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.Am J Transl Res. 2019 Sep 15;11(9):5546-5559. eCollection 2019.
621	The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.Endocr Relat Cancer. 2015 Oct;22(5):819-30. doi: 10.1530/ERC-14-0502. Epub 2015 Jul 28.
622	C-type lectins facilitate tumor metastasis.Oncol Lett. 2017 Jan;13(1):13-21. doi: 10.3892/ol.2016.5431. Epub 2016 Nov 24.
623	CMTM8 is Frequently Downregulated in Multiple Solid Tumors.Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):122-128. doi: 10.1097/PAI.0000000000000274.
624	Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.J Exp Clin Cancer Res. 2018 Jul 3;37(1):135. doi: 10.1186/s13046-018-0791-6.
625	CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression.Oncotarget. 2016 Dec 26;8(32):52432-52444. doi: 10.18632/oncotarget.14194. eCollection 2017 Aug 8.
626	Breast carcinoma in pregnancy with spheroid-like placental metastases-a case report.APMIS. 2018 May;126(5):448-452. doi: 10.1111/apm.12827. Epub 2018 Apr 17.
627	Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.Cell Death Dis. 2017 Mar 16;8(3):e2682. doi: 10.1038/cddis.2017.100.
628	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.Oncotarget. 2014 Mar 30;5(6):1609-20. doi: 10.18632/oncotarget.1707.
629	Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.J Pathol. 2008 Feb;214(3):337-46. doi: 10.1002/path.2265.
630	CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.Eur J Cancer. 2015 Nov;51(17):2624-33. doi: 10.1016/j.ejca.2015.08.020. Epub 2015 Sep 28.
631	Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.Neoplasma. 2018;65(2):292-295. doi: 10.4149/neo_2018_170318N194.
632	Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast.Biochem Pharmacol. 2017 Dec 15;146:174-187. doi: 10.1016/j.bcp.2017.09.011. Epub 2017 Sep 23.
633	Changes in Brain Metastasis During Radiosurgical Planning.Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):727-733. doi: 10.1016/j.ijrobp.2018.06.021. Epub 2018 Jun 25.
634	FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.Oncogene. 2018 Feb 8;37(6):697-709. doi: 10.1038/onc.2017.358. Epub 2017 Oct 23.
635	CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation.Oncoimmunology. 2019 Feb 18;8(5):e1577126. doi: 10.1080/2162402X.2019.1577126. eCollection 2019.
636	Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.Clin Breast Cancer. 2018 Oct;18(5):e875-e882. doi: 10.1016/j.clbc.2018.01.011. Epub 2018 Feb 2.
637	Progenitors from the central nervous system drive neurogenesis in cancer.Nature. 2019 May;569(7758):672-678. doi: 10.1038/s41586-019-1219-y. Epub 2019 May 15.
638	Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion.Oncotarget. 2015 Jul 30;6(21):18577-89. doi: 10.18632/oncotarget.4094.
639	Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.J Pathol. 2017 Apr;241(5):638-648. doi: 10.1002/path.4868.
640	Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.Lung Cancer. 2008 Nov;62(2):181-92. doi: 10.1016/j.lungcan.2008.06.018. Epub 2008 Aug 9.
641	Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer.J Korean Med Sci. 2016 Oct;31(10):1586-94. doi: 10.3346/jkms.2016.31.10.1586.
642	Eps8 expression is significantly lower in p16(+) head and neck squamous cell carcinomas (HNSCCs) compared with p16(-) HNSCCs.Hum Pathol. 2018 Feb;72:45-51. doi: 10.1016/j.humpath.2017.10.021. Epub 2017 Oct 28.
643	Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases.Transl Oncol. 2019 Mar;12(3):550-560. doi: 10.1016/j.tranon.2018.12.007. Epub 2019 Jan 9.
644	EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma.Am J Transl Res. 2019 Apr 15;11(4):2328-2338. eCollection 2019.
645	FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.Aging (Albany NY). 2019 Aug 24;11(16):6069-6088. doi: 10.18632/aging.102163. Epub 2019 Aug 24.
646	Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.Oncotarget. 2018 May 1;9(33):22929-22944. doi: 10.18632/oncotarget.25149. eCollection 2018 May 1.
647	Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.Jpn J Clin Oncol. 2019 Sep 1;49(9):870-876. doi: 10.1093/jjco/hyz068.
648	Low FAT4 expression is associated with a poor prognosis in gastric cancer patients.Oncotarget. 2017 Dec 26;9(4):5137-5154. doi: 10.18632/oncotarget.23702. eCollection 2018 Jan 12.
649	Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.Pharmacol Res. 2015 Sep;99:11-5. doi: 10.1016/j.phrs.2015.05.001. Epub 2015 May 12.
650	FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.Cancers (Basel). 2019 Jun 17;11(6):836. doi: 10.3390/cancers11060836.
651	C4orf7 contributes to ovarian cancer metastasis by promoting cancer cell migration and invasion.Oncol Rep. 2010 Oct;24(4):933-9.
652	Change in FGF-2 circulating levels after arterial embolization in patients with bone metastases.Neoplasma. 2018;65(2):262-268. doi: 10.4149/neo_2018_170204N74.
653	Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases.J Biol Chem. 2015 Sep 4;290(36):22127-42. doi: 10.1074/jbc.M115.652222. Epub 2015 Jul 16.
654	A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.Genome Biol. 2018 Dec 11;19(1):218. doi: 10.1186/s13059-018-1594-y.
655	Follistatin-like 1 in development and human diseases.Cell Mol Life Sci. 2018 Jul;75(13):2339-2354. doi: 10.1007/s00018-018-2805-0. Epub 2018 Mar 29.
656	Alpha1,3 fucosyltransferase VII plays a role in colorectal carcinoma metastases by promoting the carbohydration of glycoprotein CD24.Oncol Rep. 2010 Jun;23(6):1609-17. doi: 10.3892/or_00000802.
657	MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8.Clin Exp Pharmacol Physiol. 2019 Oct;46(10):955-967. doi: 10.1111/1440-1681.13154. Epub 2019 Aug 30.
658	Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.Gynecol Oncol. 2016 Mar;140(3):512-7. doi: 10.1016/j.ygyno.2016.01.001. Epub 2016 Jan 6.
659	FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.Clin Cancer Res. 2018 Feb 15;24(4):916-926. doi: 10.1158/1078-0432.CCR-17-1347. Epub 2017 Dec 7.
660	Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.J Cell Mol Med. 2018 Apr;22(4):2177-2189. doi: 10.1111/jcmm.13493. Epub 2018 Jan 29.
661	GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.J Exp Clin Cancer Res. 2019 May 22;38(1):214. doi: 10.1186/s13046-019-1218-8.
662	GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.Cell Death Dis. 2016 Jul 14;7(7):e2294. doi: 10.1038/cddis.2016.169.
663	H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma.Int J Oncol. 2018 Apr;52(4):1235-1245. doi: 10.3892/ijo.2018.4292. Epub 2018 Feb 28.
664	Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation.Front Oncol. 2019 May 8;9:373. doi: 10.3389/fonc.2019.00373. eCollection 2019.
665	The E3Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the+TIP ACF7 for Degradation.Cell Rep. 2018 Jan 23;22(4):1016-1030. doi: 10.1016/j.celrep.2017.12.096. Epub 2018 Jan 28.
666	Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer.J Cancer. 2018 Nov 24;9(24):4642-4649. doi: 10.7150/jca.27686. eCollection 2018.
667	Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.Nephron. 2019;141(4):256-264. doi: 10.1159/000495887. Epub 2019 Jan 2.
668	miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/-Catenin Axis.Theranostics. 2018 Nov 10;8(21):5801-5813. doi: 10.7150/thno.29380. eCollection 2018.
669	The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.Onco Targets Ther. 2018 Oct 25;11:7459-7469. doi: 10.2147/OTT.S166878. eCollection 2018.
670	Altered frequency and function of spleen CTLA-4+Tim-3+ T cells are associated with miscarriage?"Wang S. Sun F
671	Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.Genes Dev. 2014 Jun 1;28(11):1191-203. doi: 10.1101/gad.241968.114. Epub 2014 May 19.
672	HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.J Cancer Res Clin Oncol. 2017 Mar;143(3):385-397. doi: 10.1007/s00432-016-2283-4. Epub 2016 Oct 19.
673	Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.Anticancer Res. 2017 Oct;37(10):5777-5783. doi: 10.21873/anticanres.12019.
674	Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.Eur Urol. 2017 Jan;71(1):46-52. doi: 10.1016/j.eururo.2016.03.026. Epub 2016 Apr 13.
675	IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.Oncogene. 2017 May 25;36(21):2969-2980. doi: 10.1038/onc.2016.448. Epub 2017 Jan 16.
676	Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data.Int J Mol Med. 2018 Jun;41(6):3597-3603. doi: 10.3892/ijmm.2018.3514. Epub 2018 Feb 27.
677	Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.PLoS One. 2018 Feb 12;13(2):e0192525. doi: 10.1371/journal.pone.0192525. eCollection 2018.
678	KDM4B promotes gastric cancer metastasis by regulating miR-125b-mediated activation of Wnt signaling.J Cell Biochem. 2019 May;120(5):7897-7906. doi: 10.1002/jcb.28065. Epub 2018 Nov 28.
679	Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.Dis Markers. 2019 Oct 22;2019:6383685. doi: 10.1155/2019/6383685. eCollection 2019.
680	KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras(G12D) p53(flox/flox) model.Oncogene. 2017 Sep 28;36(39):5532-5543. doi: 10.1038/onc.2017.155. Epub 2017 Jun 5.
681	MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.Mol Cancer. 2017 Jan 17;16(1):11. doi: 10.1186/s12943-017-0582-2.
682	Krppel-like factor 8 induces epithelial-to-mesenchymal transition and promotes invasion of pancreatic cancer cells through transcriptional activation of four and a half LIM-only protein 2.Oncol Lett. 2017 Oct;14(4):4883-4889. doi: 10.3892/ol.2017.6734. Epub 2017 Aug 9.
683	MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.EBioMedicine. 2019 Jun;44:439-451. doi: 10.1016/j.ebiom.2019.05.041. Epub 2019 May 23.
684	LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.Tumour Biol. 2017 Feb;39(2):1010428317691188. doi: 10.1177/1010428317691188.
685	Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer.J Cancer. 2019 Jul 23;10(18):4397-4407. doi: 10.7150/jca.27590. eCollection 2019.
686	ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6836-6841. doi: 10.1073/pnas.1817473116. Epub 2019 Mar 19.
687	Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer.Cancer Res. 2014 Jun 1;74(11):2928-35. doi: 10.1158/0008-5472.CAN-13-2112.
688	High expression of leucinerich repeatcontaining8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.Oncol Rep. 2018 Sep;40(3):1275-1286. doi: 10.3892/or.2018.6556. Epub 2018 Jul 10.
689	Analysis of HSP27 and the Autophagy Marker LC3B(+) Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients.Mol Cancer Ther. 2018 Jun;17(6):1315-1323. doi: 10.1158/1535-7163.MCT-17-0901. Epub 2018 Mar 28.
690	Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience.Dermatol Surg. 2018 Dec;44(12):1501-1508. doi: 10.1097/DSS.0000000000001603.
691	Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.Clin Lung Cancer. 2017 Jan;18(1):e13-e20. doi: 10.1016/j.cllc.2016.06.005. Epub 2016 Jun 23.
692	Myoglobin does not predict local toxicity in isolated limb perfusion.Int J Hyperthermia. 2017 Sep;33(6):679-683. doi: 10.1080/02656736.2017.1309082. Epub 2017 Apr 10.
693	Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.Front Med (Lausanne). 2017 Mar 17;4:30. doi: 10.3389/fmed.2017.00030. eCollection 2017.
694	Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer.EBioMedicine. 2019 Oct;48:353-363. doi: 10.1016/j.ebiom.2019.09.017. Epub 2019 Sep 18.
695	Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.Sci Rep. 2018 May 29;8(1):8267. doi: 10.1038/s41598-018-26636-6.
696	Reduced N-acetylglucosaminyltransferase III expression via Smad3 and Erk signaling in TGF-1-induced HCC EMT model.Discov Med. 2017 Jan;23(124):7-17.
697	MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.Scand J Gastroenterol. 2018 Aug;53(8):964-971. doi: 10.1080/00365521.2018.1481521. Epub 2018 Aug 13.
698	Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression.Br J Cancer. 2014 Feb 4;110(3):715-23. doi: 10.1038/bjc.2013.765. Epub 2013 Dec 24.
699	Identification of key candidate genes involved in melanoma metastasis.Mol Med Rep. 2019 Aug;20(2):903-914. doi: 10.3892/mmr.2019.10314. Epub 2019 May 30.
700	Novel Triazole-Piperazine Hybrid Molecules Induce Apoptosis via Activation of the Mitochondrial Pathway and Exhibit Antitumor Efficacy in Osteosarcoma Xenograft Nude Mice Model.ACS Chem Biol. 2017 Mar 17;12(3):753-768. doi: 10.1021/acschembio.6b01007. Epub 2017 Jan 26.
701	Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).J Clin Oncol. 2018 Jan 20;36(3):244-253. doi: 10.1200/JCO.2017.74.4946. Epub 2017 Nov 17.
702	Reciprocal loop of hypoxia-inducible factor-1 (HIF-1) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.J Pathol. 2018 Jul;245(3):349-360. doi: 10.1002/path.5089. Epub 2018 Jun 1.
703	MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFN/STAT1 signaling.J Exp Clin Cancer Res. 2019 May 21;38(1):206. doi: 10.1186/s13046-019-1186-z.
704	MUC13 promotes intrahepatic cholangiocarcinoma progression viaEGFR/PI3K/AKT pathways.J Hepatol. 2020 Apr;72(4):761-773. doi: 10.1016/j.jhep.2019.11.021. Epub 2019 Dec 16.
705	Tumor Progression Is Mediated by Thymosin-4 through a TGF/MRTF Signaling Axis.Mol Cancer Res. 2018 May;16(5):880-893. doi: 10.1158/1541-7786.MCR-17-0715. Epub 2018 Jan 12.
706	The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.Histopathology. 2019 May;74(6):933-943. doi: 10.1111/his.13819. Epub 2019 Apr 4.
707	Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.Cancer Med. 2018 Apr;7(4):1183-1193. doi: 10.1002/cam4.1322. Epub 2018 Feb 26.
708	B7-H6 expression in human hepatocellular carcinoma and its clinical significance [corrected].Cancer Cell Int. 2018 Sep 4;18:126. doi: 10.1186/s12935-018-0627-7. eCollection 2018.
709	Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo.FASEB J. 2019 Apr;33(4):4802-4813. doi: 10.1096/fj.201802004R. Epub 2018 Dec 28.
710	Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin.Cancer Discov. 2018 Oct;8(10):1316-1331. doi: 10.1158/2159-8290.CD-17-0987. Epub 2018 Sep 18.
711	The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.Cancers (Basel). 2019 Sep 30;11(10):1477. doi: 10.3390/cancers11101477.
712	NPNT promotes early-stage bone metastases in breast cancer by regulation of the osteogenic niche.J Bone Oncol. 2018 Sep 27;13:91-96. doi: 10.1016/j.jbo.2018.09.006. eCollection 2018 Nov.
713	The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor.Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):75-80.
714	A double helical motif in OCIAD2 is essential for its localization, interactions and STAT3 activation.Sci Rep. 2018 May 9;8(1):7362. doi: 10.1038/s41598-018-25667-3.
715	Association between the overexpression of PBOV1 and the prognosis of patients with hepatocellular carcinoma.Oncol Lett. 2018 Sep;16(3):3401-3407. doi: 10.3892/ol.2018.9013. Epub 2018 Jun 25.
716	Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1.J Biol Chem. 2019 Jun 28;294(26):10236-10252. doi: 10.1074/jbc.RA118.006733. Epub 2019 May 17.
717	The role of histopathologic testing on apocrine carcinoma of the breast.Curr Probl Cancer. 2020 Apr;44(2):100501. doi: 10.1016/j.currproblcancer.2019.100501. Epub 2019 Sep 7.
718	Expression of PIWIL3 in primary and metastatic melanoma.J Cancer Res Clin Oncol. 2017 Mar;143(3):433-437. doi: 10.1007/s00432-016-2305-2. Epub 2016 Nov 17.
719	Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.BMC Cancer. 2018 Nov 12;18(1):1107. doi: 10.1186/s12885-018-4965-6.
720	PLOD3 promotes lung metastasis via regulation of STAT3.Cell Death Dis. 2018 Nov 15;9(12):1138. doi: 10.1038/s41419-018-1186-5.
721	Divergent roles of Plexin D1 in cancer.Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):103-110. doi: 10.1016/j.bbcan.2019.05.004. Epub 2019 May 30.
722	POH1 contributes to hyperactivation of TGF- signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF- receptors and caveolin-1.EBioMedicine. 2019 Mar;41:320-332. doi: 10.1016/j.ebiom.2019.01.058. Epub 2019 Feb 7.
723	Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.Oncotarget. 2017 Jan 17;8(3):4342-4351. doi: 10.18632/oncotarget.14027.
724	Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.Oncotarget. 2017 Jul 22;8(35):59165-59180. doi: 10.18632/oncotarget.19467. eCollection 2017 Aug 29.
725	PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.Endocr Connect. 2019 Aug 1;8(8):1126-1135. doi: 10.1530/EC-19-0279.
726	RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells.Int J Oncol. 2017 Mar;50(3):920-932. doi: 10.3892/ijo.2017.3872. Epub 2017 Feb 10.
727	Low expression of Rap1GAP is associated with epithelial-mesenchymal transition (EMT) and poor prognosis in gastric cancer.Oncotarget. 2017 Jan 31;8(5):8057-8068. doi: 10.18632/oncotarget.14074.
728	A somatic mutation of RasGRP3 decreases Na(+)/I(-) symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.Am J Cancer Res. 2018 Sep 1;8(9):1847-1855. eCollection 2018.
729	RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.J Exp Clin Cancer Res. 2018 Feb 9;37(1):22. doi: 10.1186/s13046-018-0687-5.
730	Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.J Control Release. 2018 Nov 10;289:79-93. doi: 10.1016/j.jconrel.2018.07.042. Epub 2018 Aug 24.
731	RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients.Cancer Cell Int. 2018 Oct 25;18:170. doi: 10.1186/s12935-018-0658-0. eCollection 2018.
732	Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.EBioMedicine. 2018 Nov;37:47-55. doi: 10.1016/j.ebiom.2018.10.002. Epub 2018 Oct 6.
733	Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.Gastroenterology. 2019 Sep;157(3):838-850.e6. doi: 10.1053/j.gastro.2019.05.065. Epub 2019 Jun 1.
734	Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?.Int J Mol Sci. 2018 Dec 30;20(1):124. doi: 10.3390/ijms20010124.
735	Advances in nanomedicine for cancer starvation therapy.Theranostics. 2019 Oct 17;9(26):8026-8047. doi: 10.7150/thno.38261. eCollection 2019.
736	SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.Cell Death Dis. 2019 Jan 25;10(2):58. doi: 10.1038/s41419-019-1325-7.
737	Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer.J Ovarian Res. 2019 May 21;12(1):47. doi: 10.1186/s13048-019-0524-2.
738	SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGF1 response and breast cancer metastasis.Oncogene. 2017 Jul 6;36(27):3903-3914. doi: 10.1038/onc.2017.30. Epub 2017 Mar 6.
739	Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.Am J Pathol. 2019 Jun;189(6):1180-1189. doi: 10.1016/j.ajpath.2019.02.009. Epub 2019 May 9.
740	SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug.Oncotarget. 2017 Feb 7;8(6):9108-9122. doi: 10.18632/oncotarget.12851.
741	SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer.Onco Targets Ther. 2019 Oct 7;12:8275-8286. doi: 10.2147/OTT.S220536. eCollection 2019.
742	R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.Elife. 2019 Jul 30;8:e43026. doi: 10.7554/eLife.43026.
743	Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.Lancet Oncol. 2018 Oct;19(10):1404-1416. doi: 10.1016/S1470-2045(18)30456-X. Epub 2018 Sep 10.
744	Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.Cancer Cell. 2019 Jul 8;36(1):17-34.e7. doi: 10.1016/j.ccell.2019.06.005.
745	Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/-catenin signaling pathway.J Exp Clin Cancer Res. 2018 Jan 15;37(1):6. doi: 10.1186/s13046-018-0676-8.
746	Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.Redox Biol. 2019 Sep;26:101233. doi: 10.1016/j.redox.2019.101233. Epub 2019 Jun 4.
747	Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells.Oncoimmunology. 2018 Mar 13;7(7):e1440166. doi: 10.1080/2162402X.2018.1440166. eCollection 2018.
748	Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.Mol Cancer. 2019 May 20;18(1):96. doi: 10.1186/s12943-019-1023-1.
749	Expression of transmembrane protein 41A is associated with metastasis via the modulation of Ecadherin in radically resected gastric cancer.Mol Med Rep. 2018 Sep;18(3):2963-2972. doi: 10.3892/mmr.2018.9241. Epub 2018 Jul 3.
750	Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.Breast Cancer Res. 2017 Feb 8;19(1):15. doi: 10.1186/s13058-016-0785-2.
751	Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-B pathway.Oncol Rep. 2014 Sep;32(3):1149-55. doi: 10.3892/or.2014.3291. Epub 2014 Jun 25.
752	Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects.Oncoimmunology. 2019 Sep 6;8(12):e1651622. doi: 10.1080/2162402X.2019.1651622. eCollection 2019.
753	Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of non-small cell lung cancer.Lung Cancer. 2004 Oct;46(1):21-8. doi: 10.1016/j.lungcan.2004.03.009.
754	High expression of tumor necrosis factor receptor-associated factor 2 promotes tumor metastasis and is associated with unfavorable prognosis in gastric cancer.J Gastroenterol Hepatol. 2018 Feb;33(2):431-442. doi: 10.1111/jgh.13818.
755	Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis.Exp Cell Res. 2018 Jul 1;368(1):59-66. doi: 10.1016/j.yexcr.2018.04.013. Epub 2018 Apr 14.
756	TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.J Exp Clin Cancer Res. 2019 Mar 28;38(1):137. doi: 10.1186/s13046-019-1138-7.
757	Serum Levels of TRIM72 Are Lower among Patients with Colon Cancer: Identification of a Potential Diagnostic Marker.Tohoku J Exp Med. 2018 May;245(1):61-68. doi: 10.1620/tjem.245.61.
758	TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.Oncogene. 2000 Nov 23;19(50):5817-20. doi: 10.1038/sj.onc.1203961.
759	Prospective Immunophenotyping of CD8(+) T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT.Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):229-240. doi: 10.1016/j.ijrobp.2018.09.001. Epub 2018 Sep 8.
760	Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes.Sci Rep. 2019 Mar 7;9(1):3828. doi: 10.1038/s41598-019-40565-y.
761	Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.Ann Surg. 2021 Feb 1;273(2):341-349. doi: 10.1097/SLA.0000000000003284.
762	Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.Med Sci Monit. 2019 Mar 26;25:2228-2237. doi: 10.12659/MSM.913091.
763	CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2018 Mar 5;37(1):46. doi: 10.1186/s13046-018-0699-1.
764	Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.Invest Radiol. 2019 Sep;54(9):549-558. doi: 10.1097/RLI.0000000000000572.
765	Interaction of CD200 Overexpression on Tumor Cells with CD200R1 Overexpression on Stromal Cells: An Escape from the Host Immune Response in Rectal Cancer Patients.J Oncol. 2019 Jan 21;2019:5689464. doi: 10.1155/2019/5689464. eCollection 2019.
766	A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.Clin Cancer Res. 2019 Jul 15;25(14):4431-4442. doi: 10.1158/1078-0432.CCR-18-3032. Epub 2019 Apr 19.
767	Pathway crosstalk analysis in prostate cancer based on protein-protein network data.Neoplasma. 2017;64(1):22-31. doi: 10.4149/neo_2017_103.
768	Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.Mol Cancer. 2015 May 14;14:102. doi: 10.1186/s12943-015-0370-9.
769	Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.Kaohsiung J Med Sci. 2019 Jun;35(6):332-340. doi: 10.1002/kjm2.12058. Epub 2019 Mar 23.
770	Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.Gynecol Oncol. 2019 Feb;152(2):368-374. doi: 10.1016/j.ygyno.2018.11.014. Epub 2018 Nov 15.
771	Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.Gastroenterology. 2019 Feb;156(3):676-691.e11. doi: 10.1053/j.gastro.2018.10.054. Epub 2018 Nov 13.
772	Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.Pathol Res Pract. 2020 Jan;216(1):152733. doi: 10.1016/j.prp.2019.152733. Epub 2019 Nov 11.
773	GAGE7B promotes tumor metastasis and growth via activating the p38/pMAPKAPK2/pHSP27 pathway in gastric cancer.J Exp Clin Cancer Res. 2019 Mar 11;38(1):124. doi: 10.1186/s13046-019-1125-z.
774	IMP1 KH1 and KH2 domains create a structural platform with unique RNA recognition and re-modelling properties.Nucleic Acids Res. 2019 May 7;47(8):4334-4348. doi: 10.1093/nar/gkz136.
775	Gene expression profile analysis of ENO1 knockdown in gastric cancer cell line MGC-803.Oncol Lett. 2019 Apr;17(4):3881-3889. doi: 10.3892/ol.2019.10053. Epub 2019 Feb 19.
776	PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.Mol Biol Rep. 2019 Jun;46(3):3333-3347. doi: 10.1007/s11033-019-04795-7. Epub 2019 Apr 12.
777	Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis.Transl Oncol. 2019 Feb;12(2):236-244. doi: 10.1016/j.tranon.2018.10.009. Epub 2018 Nov 11.
778	Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.Cell Death Dis. 2019 Feb 13;10(2):145. doi: 10.1038/s41419-019-1351-5.
779	Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.Clin Exp Metastasis. 2012 Jun;29(5):397-408. doi: 10.1007/s10585-011-9448-y. Epub 2012 Feb 21.
780	MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers.Cell Death Differ. 2019 Dec;26(12):2594-2606. doi: 10.1038/s41418-019-0322-9. Epub 2019 Mar 22.
781	Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling.J Transl Med. 2014 Nov 4;12:309. doi: 10.1186/s12967-014-0309-8.
782	Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.Neuropathol Appl Neurobiol. 2007 Feb;33(1):77-85. doi: 10.1111/j.1365-2990.2006.00786.x.
783	Expression of OPN3 in lung adenocarcinoma promotes epithelial-mesenchymal transition and tumor metastasis.Thorac Cancer. 2020 Feb;11(2):286-294. doi: 10.1111/1759-7714.13254. Epub 2019 Dec 5.
784	PARP10 suppresses tumor metastasis through regulation of Aurora A activity.Oncogene. 2018 May;37(22):2921-2935. doi: 10.1038/s41388-018-0168-5. Epub 2018 Mar 8.
785	PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-1/Smad signaling pathway and is associated with good prognosis.Am J Transl Res. 2019 Feb 15;11(2):1116-1128. eCollection 2019.
786	High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.Hum Pathol. 2019 Mar;85:92-100. doi: 10.1016/j.humpath.2018.11.001. Epub 2018 Nov 15.
787	High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.J Surg Oncol. 2019 Jun;119(8):1108-1121. doi: 10.1002/jso.25448. Epub 2019 Mar 25.
788	Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma.Biochimie. 2019 Feb;157:26-37. doi: 10.1016/j.biochi.2018.10.019. Epub 2018 Oct 30.
789	Interferon-regulated suprabasin is essential for stress-induced stem-like cell conversion and therapy resistance of human malignancies.Mol Oncol. 2019 Jul;13(7):1467-1489. doi: 10.1002/1878-0261.12480. Epub 2019 Jun 10.
790	Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.J Transl Med. 2014 Sep 2;12:237. doi: 10.1186/s12967-014-0237-7.
791	Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis.Oncogene. 2019 Apr;38(16):3061-3076. doi: 10.1038/s41388-018-0645-x. Epub 2019 Jan 7.
792	The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell-Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth.Front Oncol. 2018 Feb 1;8:8. doi: 10.3389/fonc.2018.00008. eCollection 2018.
793	Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin 3 recycling, cell migration and cancer metastasis.Oncogene. 2017 Oct 12;36(41):5757-5767. doi: 10.1038/onc.2017.183. Epub 2017 Jun 12.
794	Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma.Tumour Biol. 2015 Aug;36(8):5965-70. doi: 10.1007/s13277-015-3271-z. Epub 2015 Mar 4.
795	Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.Tumour Biol. 2016 Jul;37(7):9343-55. doi: 10.1007/s13277-016-4823-6. Epub 2016 Jan 16.
796	AQP5 promotes hepatocellular carcinoma metastasis via NF-B-regulated epithelial-mesenchymal transition.Biochem Biophys Res Commun. 2017 Aug 19;490(2):343-348. doi: 10.1016/j.bbrc.2017.06.046. Epub 2017 Jun 12.
797	High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.Int Urol Nephrol. 2017 May;49(5):817-823. doi: 10.1007/s11255-017-1545-7. Epub 2017 Feb 17.
798	A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells.Mol Ther Nucleic Acids. 2017 Sep 15;8:370-382. doi: 10.1016/j.omtn.2017.07.005. Epub 2017 Jul 8.
799	ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.Oncotarget. 2016 Jun 28;7(26):39279-39292. doi: 10.18632/oncotarget.9827.
800	Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.Oncotarget. 2016 Dec 13;7(50):83378-83391. doi: 10.18632/oncotarget.13092.
801	Primary pulmonary adenoid cystic carcinoma: clinicopathological analyses of 12 cases.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7619-26. eCollection 2015.
802	WBSCR22 confers oxaliplatin resistance in human colorectal cancer.Sci Rep. 2017 Nov 13;7(1):15443. doi: 10.1038/s41598-017-15749-z.
803	Calpain-3 impairs cell proliferation and stimulates oxidative stress-mediated cell death in melanoma cells.PLoS One. 2015 Feb 6;10(2):e0117258. doi: 10.1371/journal.pone.0117258. eCollection 2015.
804	The CBM Complex Underwrites NF-B Activation to Promote HER2-Associated Tumor Malignancy.Mol Cancer Res. 2016 Jan;14(1):93-102. doi: 10.1158/1541-7786.MCR-15-0229-T. Epub 2015 Sep 21.
805	miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.Oncotarget. 2015 Mar 10;6(7):4920-35. doi: 10.18632/oncotarget.3025.
806	CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma.Theranostics. 2017 Aug 15;7(14):3478-3488. doi: 10.7150/thno.20717. eCollection 2017.
807	STAT3 protein up-regulates G-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.J Biol Chem. 2012 Dec 7;287(50):41667-83. doi: 10.1074/jbc.M112.390781. Epub 2012 Oct 12.
808	CD81 Promotes a Migratory Phenotype in Neuronal-Like Cells.Microsc Microanal. 2019 Feb;25(1):229-235. doi: 10.1017/S1431927618015532. Epub 2019 Feb 4.
809	A signal-based method for finding driver modules of breast cancer metastasis to the lung.Sci Rep. 2017 Aug 30;7(1):10023. doi: 10.1038/s41598-017-09951-2.
810	KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.Oncogene. 2019 Feb;38(7):935-949. doi: 10.1038/s41388-018-0493-8. Epub 2018 Sep 10.
811	Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.Oncogene. 2017 Apr 6;36(14):1978-1990. doi: 10.1038/onc.2016.357. Epub 2016 Oct 17.
812	Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.Anticancer Res. 2016 Aug;36(8):4013-8.
813	Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.Oncotarget. 2016 May 17;7(20):29507-19. doi: 10.18632/oncotarget.8789.
814	miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells.Oncol Res. 2018 Jan 19;26(1):1-8. doi: 10.3727/096504016X14772410356982. Epub 2017 Nov 29.
815	CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.Clin Exp Metastasis. 2019 Aug;36(4):351-363. doi: 10.1007/s10585-019-09971-4. Epub 2019 May 22.
816	P120 Catenin Isoforms Differentially Associate with Breast Cancer Invasion and Metastasis.Cancers (Basel). 2019 Sep 29;11(10):1459. doi: 10.3390/cancers11101459.
817	Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.Int J Immunopathol Pharmacol. 2015 Jun;28(2):263-9. doi: 10.1177/0394632015586656. Epub 2015 Jun 8.
818	CYC1 Predicts Poor Prognosis in Patients with Breast Cancer.Dis Markers. 2016;2016:3528064. doi: 10.1155/2016/3528064. Epub 2016 Apr 28.
819	Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-B regulatory genes.Mod Pathol. 2016 Jan;29(1):67-74. doi: 10.1038/modpathol.2015.130. Epub 2015 Nov 13.
820	Cell cycle-coupled expansion of AR activity promotes cancer progression.Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26.
821	Exosomes in Nasopharyngeal Carcinoma.J Cancer. 2018 Feb 11;9(5):767-777. doi: 10.7150/jca.22505. eCollection 2018.
822	DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-1 signaling.Exp Cell Res. 2020 Jan 15;386(2):111732. doi: 10.1016/j.yexcr.2019.111732. Epub 2019 Nov 23.
823	DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53.Med Sci Monit. 2016 Jan 19;22:197-205. doi: 10.12659/msm.896545.
824	MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.Cancer Biol Ther. 2018 May 4;19(5):427-435. doi: 10.1080/15384047.2018.1423925. Epub 2018 Mar 6.
825	A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression.Breast Cancer Res Treat. 2016 Nov;160(2):249-259. doi: 10.1007/s10549-016-4000-z. Epub 2016 Oct 5.
826	Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin 4/FAK/SOX2/HIF-1 signaling pathway in gastric cancer.Oncogene. 2018 Feb 8;37(6):744-755. doi: 10.1038/onc.2017.363. Epub 2017 Oct 23.
827	Counter regulation of ECRG4 gene expression by hypermethylation-dependent inhibition and the Sp1 transcription factor-dependent stimulation of the c2orf40 promoter.Gene. 2017 Dec 15;636:103-111. doi: 10.1016/j.gene.2017.08.041. Epub 2017 Sep 1.
828	Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.Med Sci Monit. 2017 Aug 10;23:3861-3868. doi: 10.12659/msm.905951.
829	Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.Oncogene. 2018 Oct;37(40):5416-5434. doi: 10.1038/s41388-018-0286-0. Epub 2018 Jun 4.
830	EMP2 is a novel therapeutic target for endometrial cancer stem cells.Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.
831	The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.BMC Cancer. 2017 Feb 2;17(1):96. doi: 10.1186/s12885-017-3070-6.
832	Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma.Am J Pathol. 2018 Aug;188(8):1882-1894. doi: 10.1016/j.ajpath.2018.04.012. Epub 2018 May 24.
833	miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.BMC Cancer. 2017 Nov 10;17(1):745. doi: 10.1186/s12885-017-3674-x.
834	Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.PLoS One. 2017 May 17;12(5):e0177830. doi: 10.1371/journal.pone.0177830. eCollection 2017.
835	Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Oncotarget. 2016 Oct 11;7(41):66790-66808. doi: 10.18632/oncotarget.11053.
836	Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.PLoS One. 2016 Dec 15;11(12):e0167857. doi: 10.1371/journal.pone.0167857. eCollection 2016.
837	FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.Nat Commun. 2017 Nov 15;8(1):1523. doi: 10.1038/s41467-017-01366-x.
838	Regulation of FBXO4-mediated ICAM-1 protein stability in metastatic breast cancer.Oncotarget. 2017 Sep 15;8(47):83100-83113. doi: 10.18632/oncotarget.20912. eCollection 2017 Oct 10.
839	FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.Oncotarget. 2016 Jun 28;7(26):39872-39884. doi: 10.18632/oncotarget.9524.
840	Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: Asingle-centre retrospective study.Eur J Surg Oncol. 2019 Jul;45(7):1274-1280. doi: 10.1016/j.ejso.2019.02.002. Epub 2019 Feb 5.
841	MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.Genet Mol Res. 2017 Aug 17;16(3). doi: 10.4238/gmr16038971.
842	Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.Oncotarget. 2016 Aug 9;7(32):51150-51162. doi: 10.18632/oncotarget.9457.
843	Novel role of forkhead box O 4 transcription factor in cancer: Bringing out the good or the bad.Semin Cancer Biol. 2018 Jun;50:1-12. doi: 10.1016/j.semcancer.2018.04.007. Epub 2018 Apr 30.
844	Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.Oncol Rep. 2016 Aug;36(2):803-10. doi: 10.3892/or.2016.4885. Epub 2016 Jun 17.
845	FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma.Int J Biol Sci. 2019 Aug 24;15(11):2330-2339. doi: 10.7150/ijbs.33881. eCollection 2019.
846	Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.Nat Cell Biol. 2015 May;17(5):678-88. doi: 10.1038/ncb3157. Epub 2015 Apr 20.
847	GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.Nat Commun. 2016 Dec 16;7:13796. doi: 10.1038/ncomms13796.
848	LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.Endocr Pract. 2019 May;25(5):427-437. doi: 10.4158/EP-2018-0465. Epub 2019 Jan 18.
849	Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.Oncotarget. 2016 Jun 21;7(25):38427-39. doi: 10.18632/oncotarget.9538.
850	Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma.Cancer Biomark. 2019;26(4):421-430. doi: 10.3233/CBM-190301.
851	Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6623-E6631. doi: 10.1073/pnas.1706055114. Epub 2017 Jul 24.
852	The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progression.Oncogene. 2012 Sep 6;31(36):4012-21. doi: 10.1038/onc.2011.569. Epub 2011 Dec 12.
853	Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.J Cell Biochem. 2019 Oct;120(10):17779-17790. doi: 10.1002/jcb.29045. Epub 2019 May 24.
854	miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer.Oncotarget. 2017 Jul 12;8(38):63935-63948. doi: 10.18632/oncotarget.19212. eCollection 2017 Sep 8.
855	Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotype.Oncotarget. 2015 Feb 20;6(5):3306-18. doi: 10.18632/oncotarget.2494.
856	IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling.FEBS Open Bio. 2018 Jun 28;8(8):1299-1311. doi: 10.1002/2211-5463.12479. eCollection 2018 Aug.
857	TGF-1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.EMBO Mol Med. 2017 Dec;9(12):1660-1680. doi: 10.15252/emmm.201606914.
858	Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?.Chem Biol Drug Des. 2016 Mar;87(3):321-34. doi: 10.1111/cbdd.12634. Epub 2016 Jan 13.
859	MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1.Cancer Gene Ther. 2015 Apr;22(3):122-9. doi: 10.1038/cgt.2014.75. Epub 2015 Jan 23.
860	The expression of inhibitor of growth 4 is reduced in cervical cancer tissues.Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3178-85.
861	INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma.Onco Targets Ther. 2019 May 7;12:3491-3507. doi: 10.2147/OTT.S196832. eCollection 2019.
862	Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.Mod Pathol. 2019 Jan;32(1):100-109. doi: 10.1038/s41379-018-0122-7. Epub 2018 Aug 28.
863	Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes.Int J Cancer. 2019 Sep 15;145(6):1648-1659. doi: 10.1002/ijc.32196. Epub 2019 Feb 20.
864	Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.J Pathol. 2017 Aug;242(4):500-510. doi: 10.1002/path.4925. Epub 2017 Jul 12.
865	MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.Cell Rep. 2016 Jun 21;15(12):2665-78. doi: 10.1016/j.celrep.2016.05.050. Epub 2016 Jun 9.
866	Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.Genes Chromosomes Cancer. 2015 May;54(5):267-75. doi: 10.1002/gcc.22240. Epub 2015 Feb 23.
867	Interleukin-12 from CD103(+) Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis.Cancer Immunol Res. 2017 Dec;5(12):1098-1108. doi: 10.1158/2326-6066.CIR-17-0341. Epub 2017 Oct 25.
868	Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63. doi: 10.1073/pnas.1508541113. Epub 2016 Feb 1.
869	Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.Cancer Manag Res. 2019 Sep 9;11:8209-8218. doi: 10.2147/CMAR.S218676. eCollection 2019.
870	Basement membrane protein ladinin-1 and the MIF-CD44-1 integrin signaling axis are implicated in laryngeal cancer metastasis.Biochim Biophys Acta. 2016 Oct;1862(10):1938-54. doi: 10.1016/j.bbadis.2016.07.014. Epub 2016 Jul 25.
871	Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.Oncol Rep. 2017 Jul;38(1):427-439. doi: 10.3892/or.2017.5642. Epub 2017 May 15.
872	microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.Cancer Sci. 2017 Oct;108(10):1985-1995. doi: 10.1111/cas.13338. Epub 2017 Aug 29.
873	Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.Diagn Pathol. 2019 Jun 22;14(1):64. doi: 10.1186/s13000-019-0837-x.
874	METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing.Hepatology. 2017 Feb;65(2):529-543. doi: 10.1002/hep.28885. Epub 2016 Dec 24.
875	MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.Mol Cancer. 2015 Aug 15;14:156. doi: 10.1186/s12943-015-0428-8.
876	PKC phosphorylates MIIP and promotes colorectal cancer metastasis through inhibition of RelA deacetylation.Nat Commun. 2017 Oct 16;8(1):939. doi: 10.1038/s41467-017-01024-2.
877	Expression of minichromosome maintenance genes in renal cell carcinoma.Cancer Manag Res. 2017 Nov 15;9:637-647. doi: 10.2147/CMAR.S146528. eCollection 2017.
878	Silencing of advanced glycosylation and glycosylation and product-specific receptor (RAGE) inhibits the metastasis and growth of non-small cell lung cancer.Am J Transl Res. 2017 Jun 15;9(6):2760-2774. eCollection 2017.
879	Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis.Oncotarget. 2016 Nov 29;7(48):79262-79273. doi: 10.18632/oncotarget.13021.
880	Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein(MVP).Breast Cancer Res. 2019 Jan 17;21(1):7. doi: 10.1186/s13058-018-1088-6.
881	Brachmann-Cornelia de Lange syndrome with a papilloma of the choroid plexus: analyses of molecular genetic characteristics of the patient and the tumor. A single-case study.Childs Nerv Syst. 2015 Jan;31(1):141-6. doi: 10.1007/s00381-014-2504-6. Epub 2014 Jul 27.
882	Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.Oncogene. 2017 Apr;36(15):2116-2130. doi: 10.1038/onc.2016.369. Epub 2016 Oct 24.
883	NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases.Brain Tumor Pathol. 2015 Oct;32(4):268-74. doi: 10.1007/s10014-015-0220-x. Epub 2015 Apr 18.
884	Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.Clin Cancer Res. 2016 Aug 1;22(15):3937-49. doi: 10.1158/1078-0432.CCR-15-1983. Epub 2016 Mar 11.
885	Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.Oncotarget. 2016 Nov 29;7(48):78859-78871. doi: 10.18632/oncotarget.12889.
886	MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.Oncol Rep. 2015 May;33(5):2309-18. doi: 10.3892/or.2015.3840. Epub 2015 Mar 6.
887	Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: prospective evaluation with matched-pair analysis.Clin Genitourin Cancer. 2015 Apr;13(2):e55-64. doi: 10.1016/j.clgc.2014.08.004. Epub 2014 Aug 9.
888	Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.Int J Biol Sci. 2016 Mar 3;12(5):545-57. doi: 10.7150/ijbs.13540. eCollection 2016.
889	An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.Oncotarget. 2015 Jan 1;6(1):26-42. doi: 10.18632/oncotarget.3083.
890	Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.Cell Death Dis. 2018 Jul 23;9(8):802. doi: 10.1038/s41419-018-0817-1.
891	Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.Mol Cancer Ther. 2016 Sep;15(9):2220-31. doi: 10.1158/1535-7163.MCT-16-0092. Epub 2016 Aug 5.
892	Class II phosphoinositide 3-kinase C2 regulates a novel signaling pathway involved in breast cancer progression.Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761.
893	Phosphatidylinositol transfer protein- in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis.Nat Commun. 2017 Oct 31;8(1):1216. doi: 10.1038/s41467-017-01181-4.
894	PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.PLoS One. 2015 May 18;10(5):e0127236. doi: 10.1371/journal.pone.0127236. eCollection 2015.
895	PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.Anticancer Res. 2016 Feb;36(2):617-24.
896	Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.Oncotarget. 2016 Aug 16;7(33):53339-53349. doi: 10.18632/oncotarget.10801.
897	Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.Oncotarget. 2017 Apr 18;8(16):26231-26244. doi: 10.18632/oncotarget.15439.
898	miR?9a?p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.Mol Med Rep. 2016 May;13(5):4030-8. doi: 10.3892/mmr.2016.5033. Epub 2016 Mar 21.
899	Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.Breast Cancer Res. 2015 Mar 27;17(1):46. doi: 10.1186/s13058-015-0562-7.
900	CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.Am J Surg Pathol. 2005 Mar;29(3):390-9. doi: 10.1097/00000478-200503000-00014.
901	The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.J Surg Oncol. 2020 Apr;121(5):906-916. doi: 10.1002/jso.25737. Epub 2019 Oct 25.
902	POU2F2-oriented network promotes human gastric cancer metastasis.Gut. 2016 Sep;65(9):1427-38. doi: 10.1136/gutjnl-2014-308932. Epub 2015 May 27.
903	LncRNA POU3F3 promotes cancer cell migration and invasion in nasopharyngeal carcinoma by up-regulating TGF-1.Biosci Rep. 2019 Jan 25;39(1):BSR20181632. doi: 10.1042/BSR20181632. Print 2019 Jan 31.
904	Colorectal Cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing.PLoS One. 2016 Mar 29;11(3):e0152673. doi: 10.1371/journal.pone.0152673. eCollection 2016.
905	Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?.Endocrine. 2016 Aug;53(2):395-401. doi: 10.1007/s12020-016-0944-3. Epub 2016 Apr 5.
906	Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.Biomed Pharmacother. 2016 Dec;84:244-251. doi: 10.1016/j.biopha.2016.09.008. Epub 2016 Sep 21.
907	Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells.Oncotarget. 2017 Dec 23;9(9):8290-8302. doi: 10.18632/oncotarget.23662. eCollection 2018 Feb 2.
908	Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.EBioMedicine. 2019 Mar;41:310-319. doi: 10.1016/j.ebiom.2019.01.001. Epub 2019 Jan 18.
909	Assessment of long-term risks of secondary cancer in paediatric patients with brain tumours after boron neutron capture therapy.J Radiol Prot. 2019 Sep;39(3):838-853. doi: 10.1088/1361-6498/ab29a3. Epub 2019 Jun 13.
910	Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.Anticancer Res. 2017 Aug;37(8):4255-4268. doi: 10.21873/anticanres.11818.
911	VAMP8, a vesicle-SNARE required for RAB37-mediated exocytosis, possesses a tumor metastasis suppressor function.Cancer Lett. 2018 Nov 28;437:79-88. doi: 10.1016/j.canlet.2018.08.023. Epub 2018 Aug 27.
912	High expression of small GTPase Rab3D promotes cancer progression and metastasis.Oncotarget. 2015 May 10;6(13):11125-38. doi: 10.18632/oncotarget.3575.
913	Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.Anticancer Res. 2016 Mar;36(3):1295-303.
914	MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer.J Cell Physiol. 2020 Feb;235(2):1469-1479. doi: 10.1002/jcp.29066. Epub 2019 Jul 4.
915	Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer.J Environ Pathol Toxicol Oncol. 2017;36(2):99-105. doi: 10.1615/JEnvironPatholToxicolOncol.2017019366.
916	RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.Biochem Biophys Res Commun. 2019 Aug 27;516(3):999-1006. doi: 10.1016/j.bbrc.2019.06.097. Epub 2019 Jul 2.
917	Elevated circulating macrophage inhibitory cytokine 1 is a biological marker for the diagnosis and prognosis of osteosarcoma.Exp Ther Med. 2018 Dec;16(6):4803-4809. doi: 10.3892/etm.2018.6786. Epub 2018 Sep 21.
918	Pathophysiological Functions of Rnd3/RhoE.Compr Physiol. 2015 Dec 15;6(1):169-86. doi: 10.1002/cphy.c150018.
919	Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.Int J Oncol. 2016 Apr;48(4):1628-38. doi: 10.3892/ijo.2016.3366. Epub 2016 Feb 1.
920	RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.Cancer Lett. 2017 Aug 28;402:153-165. doi: 10.1016/j.canlet.2017.05.024. Epub 2017 Jun 6.
921	Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.Br J Cancer. 2014 May 13;110(10):2489-95. doi: 10.1038/bjc.2014.169. Epub 2014 Apr 10.
922	SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer.PLoS One. 2015 Sep 25;10(9):e0138515. doi: 10.1371/journal.pone.0138515. eCollection 2015.
923	MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.Biochem Biophys Res Commun. 2019 Jan 1;508(1):295-301. doi: 10.1016/j.bbrc.2018.11.144. Epub 2018 Nov 27.
924	Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
925	The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.Oncotarget. 2015 Nov 3;6(34):36731-45. doi: 10.18632/oncotarget.5481.
926	Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression.Oncogene. 2016 Sep 29;35(39):5170-8. doi: 10.1038/onc.2016.49. Epub 2016 Apr 11.
927	Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans.Oncogene. 2016 Jun 23;35(25):3303-13. doi: 10.1038/onc.2015.391. Epub 2015 Oct 12.
928	Tumour-suppressive function of SIRT4 in human colorectal cancer.Br J Cancer. 2015 Jul 28;113(3):492-9. doi: 10.1038/bjc.2015.226. Epub 2015 Jun 18.
929	SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.Int J Oncol. 2016 Nov;49(5):1963-1972. doi: 10.3892/ijo.2016.3697. Epub 2016 Sep 19.
930	Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma.J Cancer. 2017 Oct 17;8(18):3812-3827. doi: 10.7150/jca.20775. eCollection 2017.
931	Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature.J Clin Neurosci. 2018 Feb;48:118-121. doi: 10.1016/j.jocn.2017.11.003. Epub 2017 Nov 26.
932	The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.Tumour Biol. 2016 Oct;37(10):13521-13531. doi: 10.1007/s13277-016-5215-7. Epub 2016 Jul 28.
933	Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.Mol Carcinog. 2016 Jul;55(7):1127-37. doi: 10.1002/mc.22355. Epub 2015 Jul 8.
934	Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.Sci Rep. 2019 Aug 12;9(1):11632. doi: 10.1038/s41598-019-48064-w.
935	Downregulation of Sprouty homolog2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.Mol Med Rep. 2015 Aug;12(2):1810-6. doi: 10.3892/mmr.2015.3567. Epub 2015 Mar 30.
936	Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.Sci Rep. 2016 Dec 14;6:39059. doi: 10.1038/srep39059.
937	Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.Lung Cancer. 2017 Jun;108:150-153. doi: 10.1016/j.lungcan.2017.03.007. Epub 2017 Mar 21.
938	Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.BMC Cancer. 2016 Dec 16;16(1):949. doi: 10.1186/s12885-016-2981-y.
939	GSK3 controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.Oncogene. 2017 Oct 19;36(42):5916. doi: 10.1038/onc.2017.302. Epub 2017 Sep 4.
940	Pulmonary Metastases Exhibit Epigenetic Clonality: Implications for Precision Cancer Therapy.Ann Thorac Surg. 2015 Nov;100(5):1839-48; discussion 1848. doi: 10.1016/j.athoracsur.2015.05.089. Epub 2015 Aug 20.
941	Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis.Asian Pac J Cancer Prev. 2015;16(3):1197-200. doi: 10.7314/apjcp.2015.16.3.1197.
942	Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.Am J Pathol. 2012 Apr;180(4):1663-74. doi: 10.1016/j.ajpath.2011.12.035. Epub 2012 Feb 9.
943	Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells.Biochem Pharmacol. 2018 Sep;155:537-546. doi: 10.1016/j.bcp.2018.07.024. Epub 2018 Jul 20.
944	Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2.Cancer Sci. 2016 Nov;107(11):1622-1631. doi: 10.1111/cas.13063.
945	Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma.Oncotarget. 2016 Feb 9;7(6):6824-34. doi: 10.18632/oncotarget.6829.
946	Tumor Metabolism in the Microenvironment of Nodal Metastasis in Oral Squamous Cell Carcinoma.Otolaryngol Head Neck Surg. 2017 Nov;157(5):798-807. doi: 10.1177/0194599817709224. Epub 2017 Jun 13.
947	The c.*229C?T gene polymorphism in 3'UTR region of the topoisomerase II binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.Tumour Biol. 2016 Apr;37(4):4541-57. doi: 10.1007/s13277-015-4276-3. Epub 2015 Oct 27.
948	Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-B transactivation in LNCaP cells.Tumour Biol. 2017 May;39(5):1010428317698382. doi: 10.1177/1010428317698382.
949	Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma.J Cancer. 2019 May 21;10(10):2220-2228. doi: 10.7150/jca.28261. eCollection 2019.
950	Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells.Biochem Biophys Res Commun. 2015 May 15;460(4):1021-8. doi: 10.1016/j.bbrc.2015.03.144. Epub 2015 Apr 2.
951	All Paths Lead to TRIM25.Trends Cancer. 2017 Oct;3(10):673-675. doi: 10.1016/j.trecan.2017.08.005.
952	Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.Chin J Cancer. 2017 Sep 26;36(1):77. doi: 10.1186/s40880-017-0240-5.
953	Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.J Exp Clin Cancer Res. 2016 Oct 28;35(1):170. doi: 10.1186/s13046-016-0445-5.
954	Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis.Biochem Soc Trans. 2017 Apr 15;45(2):465-475. doi: 10.1042/BST20160022.
955	Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.Oncol Rep. 2016 Jul;36(1):448-54. doi: 10.3892/or.2016.4805. Epub 2016 May 13.
956	In situ hybridization studies of alpha 2-macroglobulin receptor and receptor-associated protein in human prostate carcinoma.Prostate. 1996 May;28(5):311-7. doi: 10.1002/(SICI)1097-0045(199605)28:5<311::AID-PROS7>3.0.CO;2-E.
957	Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases.Clin Exp Metastasis. 2011 Oct;28(7):637-47. doi: 10.1007/s10585-011-9397-5. Epub 2011 Jun 17.
958	Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.PLoS One. 2012;7(7):e40671. doi: 10.1371/journal.pone.0040671. Epub 2012 Jul 10.
959	Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells.Cancer Res. 2002 Apr 15;62(8):2215-9.
960	Identification of ACTG2 functions as a promoter gene in hepatocellular carcinoma cells migration and tumor metastasis.Biochem Biophys Res Commun. 2017 Sep 16;491(2):537-544. doi: 10.1016/j.bbrc.2017.04.007. Epub 2017 Apr 4.
961	ADAM23 methylation and expression analysis in brain tumors.Neurosci Lett. 2005 Jun 3;380(3):260-4. doi: 10.1016/j.neulet.2005.01.050. Epub 2005 Feb 8.
962	Potential markers of tongue tumor progression selected by cDNA microarray.Int J Immunopathol Pharmacol. 2005 Jul-Sep;18(3):513-24. doi: 10.1177/039463200501800311.
963	The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer.Oncogenesis. 2019 Aug 12;8(8):41. doi: 10.1038/s41389-019-0150-2.
964	Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.FEBS J. 2013 Mar;280(5):1249-66. doi: 10.1111/febs.12118. Epub 2013 Feb 13.
965	Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK.Biochem Pharmacol. 2018 Feb;148:174-183. doi: 10.1016/j.bcp.2018.01.012. Epub 2018 Jan 5.
966	Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.Mol Med. 2014 Mar 18;20(1):80-92. doi: 10.2119/molmed.2013.00151.
967	Blood type B antigen modulates cell migration through regulating cdc42 expression and activity in HaCaT cells.J Cell Physiol. 2013 Nov;228(11):2243-51. doi: 10.1002/jcp.24393.
968	Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review].Hum Cell. 2001 Sep;14(3):233-6.
969	Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis.Cancer Res. 2004 Sep 1;64(17):6119-26. doi: 10.1158/0008-5472.CAN-04-1054.
970	Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer.Anticancer Res. 2015 May;35(5):2849-56.
971	ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.J Exp Clin Cancer Res. 2019 Jan 15;38(1):18. doi: 10.1186/s13046-018-1011-0.
972	Preferential expression of NY-BR-1 and GATA-3 in male breast cancer.J Cancer Res Clin Oncol. 2018 Feb;144(2):199-204. doi: 10.1007/s00432-017-2542-z. Epub 2017 Nov 7.
973	Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.Blood. 2002 Nov 1;100(9):3155-63. doi: 10.1182/blood-2002-04-1041.
974	Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract.Endocr Relat Cancer. 2008 Jun;15(2):569-81. doi: 10.1677/ERC-07-0145. Epub 2008 Apr 22.
975	Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.Oncotarget. 2015 Feb 10;6(4):2064-75. doi: 10.18632/oncotarget.2990.
976	IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.Oncotarget. 2014 Aug 30;5(16):6832-45. doi: 10.18632/oncotarget.2257.
977	ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.J Clin Pathol. 2017 Feb;70(2):162-167. doi: 10.1136/jclinpath-2016-203804. Epub 2016 Jul 22.
978	JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.Carcinogenesis. 2014 Feb;35(2):442-51. doi: 10.1093/carcin/bgt311. Epub 2013 Sep 26.
979	Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin 1/FAK axis.Oncotarget. 2015 May 10;6(13):11530-46. doi: 10.18632/oncotarget.3448.
980	Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.Mol Cell. 2005 Dec 22;20(6):881-90. doi: 10.1016/j.molcel.2005.10.026.
981	miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma.J Biomed Sci. 2011 Mar 31;18(1):24. doi: 10.1186/1423-0127-18-24.
982	Overexpression of beta 1,4N-acetylgalactosaminyl- transferase mRNA as a molecular marker for various types of cancers.Oncology. 2002;62(2):149-56. doi: 10.1159/000048261.
983	A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.
984	p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.PLoS One. 2007 Aug 1;2(7):e660. doi: 10.1371/journal.pone.0000660.
985	Decreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2056-63. eCollection 2013.
986	Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.J Clin Invest. 2010 Jan;120(1):223-41. doi: 10.1172/JCI38012. Epub 2009 Dec 14.
987	BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.Mol Med. 2011 Mar-Apr;17(3-4):163-71. doi: 10.2119/molmed.2010.00056. Epub 2010 Dec 8.
988	A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo.Biomacromolecules. 2016 Jul 11;17(7):2337-51. doi: 10.1021/acs.biomac.6b00185. Epub 2016 Jun 28.
989	BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma.Int J Cancer. 2017 Nov 15;141(10):2050-2061. doi: 10.1002/ijc.30906. Epub 2017 Aug 7.
990	Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study.Adv Med Sci. 2019 Sep;64(2):235-240. doi: 10.1016/j.advms.2018.12.007. Epub 2019 Feb 26.
991	BRMS1L suppresses ovarian cancer metastasis via inhibition of the -catenin-wnt pathway.Exp Cell Res. 2018 Oct 1;371(1):214-221. doi: 10.1016/j.yexcr.2018.08.013. Epub 2018 Aug 15.
992	Clinicopathological significance of BTF3 expression in colorectal cancer.Tumour Biol. 2013 Aug;34(4):2141-6. doi: 10.1007/s13277-013-0745-8. Epub 2013 Mar 27.
993	Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.J Natl Cancer Inst. 2004 Aug 4;96(15):1161-70. doi: 10.1093/jnci/djh219.
994	Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.Cancer Res. 2002 Jan 1;62(1):13-7.
995	Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.Cancer Res. 2007 Dec 15;67(24):11751-9. doi: 10.1158/0008-5472.CAN-07-3175.
996	Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases.Anticancer Res. 2004 Nov-Dec;24(6):4003-9.
997	Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.Cancer. 2013 Nov 15;119(22):4003-11. doi: 10.1002/cncr.28300. Epub 2013 Aug 20.
998	L-CAM expression in lymph node and liver metastases of colorectal carcinomas.J Pathol. 1994 Feb;172(2):177-81. doi: 10.1002/path.1711720204.
999	HP1 suppresses metastasis of human cancer cells by decreasing the expression and activation of MMP2.Int J Oncol. 2014 Dec;45(6):2541-8. doi: 10.3892/ijo.2014.2646. Epub 2014 Sep 9.
1000	Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.Clin Cancer Res. 2017 Feb 1;23(3):833-844. doi: 10.1158/1078-0432.CCR-16-0520. Epub 2016 Aug 4.
1001	Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.J BUON. 2018 Jul-Aug;23(4):1185-1194.
1002	CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.Cancer Med. 2017 May;6(5):1062-1071. doi: 10.1002/cam4.1039. Epub 2017 Apr 4.
1003	Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer.Ann Surg Oncol. 2007 Jun;14(6):1909-18. doi: 10.1245/s10434-007-9376-x. Epub 2007 Apr 4.
1004	Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients.Onco Targets Ther. 2019 Jan 29;12:921-932. doi: 10.2147/OTT.S180507. eCollection 2019.
1005	Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer.Br J Cancer. 2019 Jan;120(1):69-78. doi: 10.1038/s41416-018-0198-3. Epub 2018 Oct 31.
1006	The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.Clin Exp Metastasis. 2014 Oct;31(7):817-27. doi: 10.1007/s10585-014-9672-3. Epub 2014 Aug 7.
1007	The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.Int J Cancer. 1994 May 15;57(4):612-9. doi: 10.1002/ijc.2910570428.
1008	CD82, and CD63 in thyroid cancer.Int J Mol Med. 2004 Oct;14(4):517-27.
1009	Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor.Obes Res Clin Pract. 2020 Jan-Feb;14(1):34-38. doi: 10.1016/j.orcp.2019.10.003. Epub 2019 Nov 9.
1010	Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration.Oncol Rep. 2019 Oct;42(4):1507-1516. doi: 10.3892/or.2019.7271. Epub 2019 Aug 8.
1011	Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo.World J Gastroenterol. 2012 Jun 28;18(24):3129-37. doi: 10.3748/wjg.v18.i24.3129.
1012	Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.Tumour Biol. 2016 May;37(5):6589-98. doi: 10.1007/s13277-015-4571-z. Epub 2015 Dec 7.
1013	ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis.J Biol Chem. 2011 Jun 10;286(23):20758-68. doi: 10.1074/jbc.M110.216036. Epub 2011 Apr 14.
1014	C/EBP links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.Oncogene. 2019 May;38(20):3765-3780. doi: 10.1038/s41388-018-0516-5. Epub 2018 Sep 27.
1015	Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.Biochem Biophys Res Commun. 2008 Jul 4;371(3):425-30. doi: 10.1016/j.bbrc.2008.04.083. Epub 2008 Apr 25.
1016	Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.Oncol Rep. 2005 Dec;14(6):1665-74.
1017	p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.Int J Cancer. 2004 Nov 10;112(3):393-8. doi: 10.1002/ijc.20443.
1018	Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.
1019	CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.Cancer Cell. 2017 May 8;31(5):653-668.e7. doi: 10.1016/j.ccell.2017.04.005.
1020	Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.Theranostics. 2018 Aug 7;8(16):4409-4428. doi: 10.7150/thno.26467. eCollection 2018.
1021	CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.Histol Histopathol. 2011 Jan;26(1):71-7. doi: 10.14670/HH-26.71.
1022	Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.Dis Markers. 2019 Oct 22;2019:8964015. doi: 10.1155/2019/8964015. eCollection 2019.
1023	Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases.Br J Cancer. 2010 Feb 16;102(4):774-82. doi: 10.1038/sj.bjc.6605536. Epub 2010 Jan 19.
1024	Distinct presence of the tight junction protein claudin-3 in olfactory bulb and fila olfactoria of the mouse.Histol Histopathol. 2017 Aug;32(8):835-849. doi: 10.14670/HH-11-854. Epub 2016 Dec 12.
1025	Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.J Thromb Haemost. 2018 May;16(5):960-972. doi: 10.1111/jth.13987. Epub 2018 Mar 30.
1026	Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.J Am Coll Surg. 2019 Jul;229(1):79-90. doi: 10.1016/j.jamcollsurg.2019.03.022. Epub 2019 Apr 14.
1027	Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K.Mol Cancer. 2012 Sep 14;11:67. doi: 10.1186/1476-4598-11-67.
1028	Differential expression of PAI-RBP1, C1orf142, and COTL1 in non-small cell lung cancer cell lines with different tumor metastatic potential.J Investig Med. 2012 Apr;60(4):689-94. doi: 10.2310/JIM.0b013e31824963b6.
1029	CPEB4 promotes cell migration and invasion via upregulating Vimentin expression in breast cancer.Biochem Biophys Res Commun. 2017 Jul 22;489(2):135-141. doi: 10.1016/j.bbrc.2017.05.112. Epub 2017 May 20.
1030	Low expression of cyclic AMP response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma.Tumour Biol. 2013 Dec;34(6):3649-57. doi: 10.1007/s13277-013-0946-1. Epub 2013 Aug 9.
1031	The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.Mol Cancer. 2013 Apr 9;12:28. doi: 10.1186/1476-4598-12-28.
1032	Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.Prostate Cancer Prostatic Dis. 2010 Dec;13(4):369-75. doi: 10.1038/pcan.2010.25. Epub 2010 Aug 3.
1033	miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.Sci Rep. 2018 Feb 5;8(1):2375. doi: 10.1038/s41598-018-20258-8.
1034	Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.Int J Cancer. 2002 Aug 10;100(5):549-56. doi: 10.1002/ijc.10512.
1035	Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells.Cancer Cell Int. 2019 Mar 29;19:77. doi: 10.1186/s12935-019-0798-x. eCollection 2019.
1036	CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.Cancer Res. 2012 Jul 15;72(14):3546-56. doi: 10.1158/0008-5472.CAN-11-4032. Epub 2012 Jun 18.
1037	CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.PLoS One. 2012;7(8):e44080. doi: 10.1371/journal.pone.0044080. Epub 2012 Aug 29.
1038	Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.J Clin Invest. 2018 Jan 2;128(1):248-266. doi: 10.1172/JCI92466. Epub 2017 Nov 27.
1039	Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.Cancer Lett. 2011 Mar 1;302(1):54-62. doi: 10.1016/j.canlet.2010.12.013. Epub 2011 Jan 13.
1040	Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90. doi: 10.1073/pnas.0908133107. Epub 2010 Jan 13.
1041	Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-B signaling pathway.Mol Med. 2012 Dec 20;18(1):1402-11. doi: 10.2119/molmed.2012.00243.
1042	DAP1 high expression increases risk of lymph node metastases in squamous cell carcinoma of the oral cavity.Genet Mol Res. 2015 Sep 8;14(3):10515-23. doi: 10.4238/2015.September.8.13.
1043	Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.Breast Cancer Res Treat. 2007 Oct;105(2):157-67. doi: 10.1007/s10549-006-9449-8. Epub 2007 Jan 13.
1044	Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.Oncogene. 2015 Oct;34(43):5447-59. doi: 10.1038/onc.2014.473. Epub 2015 Feb 16.
1045	DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.Exp Cell Res. 2019 Jan 15;374(2):304-314. doi: 10.1016/j.yexcr.2018.12.001. Epub 2018 Dec 4.
1046	The prognostic effect of DDX3 upregulation in distant breast cancer metastases.Clin Exp Metastasis. 2017 Jan;34(1):85-92. doi: 10.1007/s10585-016-9832-8. Epub 2016 Dec 20.
1047	Deleterious synergistic effects of distress and surgery on cancer metastasis: Abolishment through an integrated perioperative immune-stimulating stress-inflammatory-reducing intervention.Brain Behav Immun. 2019 Aug;80:170-178. doi: 10.1016/j.bbi.2019.03.005. Epub 2019 Mar 6.
1048	The genomic relationship between primary breast carcinomas and their nodal metastases.Cancer Invest. 2011 May;29(4):300-7. doi: 10.3109/07357907.2011.568564.
1049	Cell adhesion molecules in metastatic neuroblastoma models.Clin Exp Metastasis. 2014 Apr;31(4):483-96. doi: 10.1007/s10585-014-9643-8. Epub 2014 Feb 19.
1050	Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.Nat Biotechnol. 2015 Jun;33(6):656-60. doi: 10.1038/nbt.3239. Epub 2015 May 25.
1051	Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells.Oncogene. 2005 Oct 13;24(45):6842-7. doi: 10.1038/sj.onc.1208834.
1052	DLC-1 expression levels in breast cancer assessed by qRT- PCR are negatively associated with malignancy.Asian Pac J Cancer Prev. 2012;13(4):1231-3. doi: 10.7314/apjcp.2012.13.4.1231.
1053	Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.BMC Cancer. 2010 Nov 25;10:649. doi: 10.1186/1471-2407-10-649.
1054	Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8.Cancer Res. 2005 Oct 1;65(19):8784-91. doi: 10.1158/0008-5472.CAN-04-4422.
1055	Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.Virus Res. 2011 Apr;157(1):76-81. doi: 10.1016/j.virusres.2011.02.009. Epub 2011 Feb 21.
1056	BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.Leukemia. 2017 Mar;31(3):678-687. doi: 10.1038/leu.2016.260. Epub 2016 Sep 28.
1057	Withaferin A inhibits matrix metalloproteinase-9 activity by suppressing the Akt signaling pathway.Oncol Rep. 2013 Aug;30(2):933-8. doi: 10.3892/or.2013.2487. Epub 2013 May 23.
1058	Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA.Adv Exp Med Biol. 2017;983:207-216. doi: 10.1007/978-981-10-4310-9_15.
1059	DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53.J Exp Clin Cancer Res. 2019 Feb 12;38(1):72. doi: 10.1186/s13046-019-1068-4.
1060	The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.Cancer Res. 2006 Dec 15;66(24):11983-90. doi: 10.1158/0008-5472.CAN-06-0943.
1061	Desmocollin? affects the adhesive strength and cytoskeletal arrangement in esophageal squamous cell carcinoma cells.Mol Med Rep. 2014 Nov;10(5):2358-64. doi: 10.3892/mmr.2014.2485. Epub 2014 Aug 12.
1062	Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer.Hum Pathol. 2009 Sep;40(9):1320-9. doi: 10.1016/j.humpath.2009.02.002. Epub 2009 Apr 22.
1063	Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer.J Diabetes Complications. 2017 Apr;31(4):687-692. doi: 10.1016/j.jdiacomp.2017.01.012. Epub 2017 Jan 26.
1064	EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.BMC Cancer. 2011 Aug 26;11:380. doi: 10.1186/1471-2407-11-380.
1065	Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression.Ann Oncol. 2014 Oct;25(10):2080-2086. doi: 10.1093/annonc/mdu249. Epub 2014 Jul 10.
1066	Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.Ophthalmology. 2019 Jul;126(7):1045-1052. doi: 10.1016/j.ophtha.2018.12.047. Epub 2018 Dec 31.
1067	Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.Int J Cancer. 1990 Mar 15;45(3):457-61. doi: 10.1002/ijc.2910450314.
1068	Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.Am J Pathol. 2001 Dec;159(6):2089-94. doi: 10.1016/S0002-9440(10)63060-X.
1069	Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes.Mol Pharm. 2020 Jan 6;17(1):229-238. doi: 10.1021/acs.molpharmaceut.9b00943. Epub 2019 Dec 10.
1070	eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.Nature. 2014 Sep 4;513(7516):105-9. doi: 10.1038/nature13572. Epub 2014 Jul 27.
1071	DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.J Exp Clin Cancer Res. 2015 Jan 22;34(1):3. doi: 10.1186/s13046-014-0117-2.
1072	Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases.Int J Biol Markers. 2019 Sep;34(3):269-275. doi: 10.1177/1724600819849438. Epub 2019 Jun 18.
1073	Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.Prostate. 1999 Nov 1;41(3):190-5. doi: 10.1002/(sici)1097-0045(19991101)41:3<190::aid-pros6>3.0.co;2-2.
1074	Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis.Microvasc Res. 2010 Jul;80(1):133-41. doi: 10.1016/j.mvr.2010.02.006. Epub 2010 Feb 11.
1075	ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer.Cancer Manag Res. 2018 Nov 22;10:6157-6166. doi: 10.2147/CMAR.S181265. eCollection 2018.
1076	siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.Mol Cell Biochem. 2012 May;364(1-2):363-71. doi: 10.1007/s11010-012-1238-6.
1077	Primary cutaneous and subcutaneous Ewing sarcoma.Pediatr Blood Cancer. 2015 Sep;62(9):1555-61. doi: 10.1002/pbc.25535. Epub 2015 Apr 20.
1078	Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.Dev Cell. 2013 Dec 9;27(5):560-73. doi: 10.1016/j.devcel.2013.10.020.
1079	The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.BMC Cancer. 2008 Sep 30;8:276. doi: 10.1186/1471-2407-8-276.
1080	LFG-500 inhibits the invasion of cancer cells via down-regulation of PI3K/AKT/NF-B signaling pathway.PLoS One. 2014 Mar 11;9(3):e91332. doi: 10.1371/journal.pone.0091332. eCollection 2014.
1081	Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.Cell Death Dis. 2017 Jun 8;8(6):e2870. doi: 10.1038/cddis.2017.273.
1082	Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.Genomics. 2014 Oct;104(4):234-41. doi: 10.1016/j.ygeno.2014.07.012. Epub 2014 Jul 25.
1083	Human breast-cancer metastasis formation in a nude-mouse model: studies of hyaluronidase, hyaluronan and hyaluronan-binding sites in metastatic cells.Int J Cancer. 1999 Jul 2;82(1):77-83. doi: 10.1002/(sici)1097-0215(19990702)82:1<77::aid-ijc14>3.0.co;2-q.
1084	Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.PLoS One. 2013 Dec 27;8(12):e84218. doi: 10.1371/journal.pone.0084218. eCollection 2013.
1085	Fibroblast growth factor 17 is over-expressed in human prostate cancer.J Pathol. 2004 Dec;204(5):578-86. doi: 10.1002/path.1668.
1086	Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma.Cancer Lett. 2007 Jul 8;252(1):36-42. doi: 10.1016/j.canlet.2006.12.003. Epub 2007 Jan 9.
1087	Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.Int J Colorectal Dis. 2008 Nov;23(11):1041-7. doi: 10.1007/s00384-008-0520-2. Epub 2008 Jul 30.
1088	Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.Breast Cancer Res. 2014 Dec 30;16(6):3413. doi: 10.1186/s13058-014-0503-x.
1089	Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.Hepatology. 2009 Aug;50(2):490-9. doi: 10.1002/hep.23008.
1090	FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers.Cell Res. 2011 Feb;21(2):316-26. doi: 10.1038/cr.2010.126. Epub 2010 Sep 7.
1091	Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.Int J Oncol. 2011 Apr;38(4):993-1000. doi: 10.3892/ijo.2011.921. Epub 2011 Jan 24.
1092	Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Beta-catenin/FOXG1 complex.J Exp Clin Cancer Res. 2019 Nov 27;38(1):475. doi: 10.1186/s13046-019-1433-3.
1093	Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the -catenin/TCF4 pathway through SPRY2.J Exp Clin Cancer Res. 2019 Jan 28;38(1):38. doi: 10.1186/s13046-019-1046-x.
1094	ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.Oncotarget. 2017 Jul 18;8(29):47365-47378. doi: 10.18632/oncotarget.17648.
1095	Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.Cell Death Dis. 2019 Feb 27;10(3):204. doi: 10.1038/s41419-018-1248-8.
1096	Reduced expression of -L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients.Oncotarget. 2018 Feb 7;9(20):15228-15238. doi: 10.18632/oncotarget.24445. eCollection 2018 Mar 16.
1097	MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8.Oncotarget. 2016 Jun 28;7(26):40644-40656. doi: 10.18632/oncotarget.9811.
1098	miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.Clin Cancer Res. 2017 Sep 1;23(17):5255-5266. doi: 10.1158/1078-0432.CCR-17-0023. Epub 2017 May 22.
1099	The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.
1100	Heterotrimeric G-protein alpha-12 (G12) subunit promotes oral cancer metastasis.Oncotarget. 2014 Oct 30;5(20):9626-40. doi: 10.18632/oncotarget.2437.
1101	A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.Breast Cancer Res Treat. 2008 Oct;111(3):449-52. doi: 10.1007/s10549-007-9808-0. Epub 2007 Nov 4.
1102	Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.Hum Pathol. 2009 Jun;40(6):795-806. doi: 10.1016/j.humpath.2008.10.019. Epub 2009 Jan 20.
1103	Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis.J Cell Mol Med. 2012 Dec;16(12):3037-51. doi: 10.1111/j.1582-4934.2012.01633.x.
1104	Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.PLoS One. 2019 Jun 14;14(6):e0218067. doi: 10.1371/journal.pone.0218067. eCollection 2019.
1105	Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.J Natl Cancer Inst. 2007 Sep 5;99(17):1313-27. doi: 10.1093/jnci/djm107. Epub 2007 Aug 28.
1106	A novel variant of human Grb7 is associated with invasive esophageal carcinoma.J Clin Invest. 1998 Aug 15;102(4):821-7. doi: 10.1172/JCI2921.
1107	Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.Cancer Res. 2009 Jan 1;69(1):151-60. doi: 10.1158/0008-5472.CAN-08-0442.
1108	Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before (131)I therapy. A study of 416 patients.Hell J Nucl Med. 2018 May-Aug;21(2):121-124.
1109	Up-regulation of GTPBP4 in colorectal carcinoma is responsible for tumor metastasis.Biochem Biophys Res Commun. 2016 Nov 4;480(1):48-54. doi: 10.1016/j.bbrc.2016.10.010. Epub 2016 Oct 5.
1110	Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.Int J Mol Sci. 2012 Oct 10;13(10):12925-38. doi: 10.3390/ijms131012925.
1111	Evolution of the androgen receptor pathway during progression of prostate cancer.Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082.
1112	Detection of differentially expressed HES-6 gene in metastatic colon carcinoma by combination of suppression subtractive hybridization and cDNA library array.Cancer Lett. 2003 Aug 20;198(2):229-39. doi: 10.1016/s0304-3835(03)00313-6.
1113	The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo.BMC Cancer. 2019 Dec 3;19(1):1181. doi: 10.1186/s12885-019-6396-4.
1114	WITHDRAWN: Upregulation of HINT2 Inhibits Non-Small Cell Lung Cancer Cell Invasion Via COX-2/PGE?Mediated Activation of -catenin Signaling.Oncol Res. 2017 Aug 11. doi: 10.3727/096504017X15021536183508. Online ahead of print.
1115	Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.Am J Respir Crit Care Med. 2016 Apr 15;193(8):869-80. doi: 10.1164/rccm.201412-2226OC.
1116	T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Clin Cancer Res. 2018 Nov 15;24(22):5562-5573. doi: 10.1158/1078-0432.CCR-18-0573. Epub 2018 May 31.
1117	Extracellular Matrix Receptor Expression in Subtypes of Lung Adenocarcinoma Potentiates Outgrowth of Micrometastases.Cancer Res. 2017 Apr 15;77(8):1905-1917. doi: 10.1158/0008-5472.CAN-16-1978. Epub 2017 Feb 14.
1118	Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis.J Biol Chem. 2013 May 24;288(21):15046-56. doi: 10.1074/jbc.M113.466136. Epub 2013 Apr 5.
1119	Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.Sci Rep. 2018 Sep 7;8(1):13483. doi: 10.1038/s41598-018-31030-3.
1120	Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.J Biol Chem. 2010 Sep 3;285(36):28010-9. doi: 10.1074/jbc.M110.116384. Epub 2010 Jun 24.
1121	Antagonism between HTRA3 and TGF1 Contributes to Metastasis in Non-Small Cell Lung Cancer.Cancer Res. 2019 Jun 1;79(11):2853-2864. doi: 10.1158/0008-5472.CAN-18-2507. Epub 2019 Apr 2.
1122	HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2622-7. doi: 10.1073/pnas.0914492107. Epub 2010 Jan 22.
1123	Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.Int J Cancer. 2010 Apr 1;126(7):1749-60. doi: 10.1002/ijc.24890.
1124	VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice.Oncogene. 2019 May;38(21):4169-4181. doi: 10.1038/s41388-019-0715-8. Epub 2019 Jan 30.
1125	High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.Eur J Cancer. 2010 Feb;46(3):659-68. doi: 10.1016/j.ejca.2009.11.018. Epub 2009 Dec 22.
1126	-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness.J Clin Endocrinol Metab. 2014 May;99(5):E786-95. doi: 10.1210/jc.2013-2874. Epub 2014 Jan 31.
1127	Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.PLoS One. 2011;6(9):e25301. doi: 10.1371/journal.pone.0025301. Epub 2011 Sep 22.
1128	Engagement of IIb3 (GPIIb/IIIa) with 3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis.J Biol Chem. 2012 Jan 13;287(3):2168-78. doi: 10.1074/jbc.M111.269811. Epub 2011 Nov 18.
1129	Altered integrin expression patterns shown by microarray in human cutaneous melanoma.Melanoma Res. 2017 Jun;27(3):180-188. doi: 10.1097/CMR.0000000000000322.
1130	Integrin 4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.Cancer Res. 2020 Feb 15;80(4):771-783. doi: 10.1158/0008-5472.CAN-19-1145. Epub 2019 Dec 16.
1131	ITIH5 induces a shift in TGF- superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.Mol Carcinog. 2018 Feb;57(2):167-181. doi: 10.1002/mc.22742. Epub 2017 Oct 30.
1132	JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.Oncogene. 2014 Feb 27;33(9):1148-57. doi: 10.1038/onc.2013.46. Epub 2013 Feb 25.
1133	Downregulation of AP-1 repressor JDP2 is associated with tumor metastasis and poor prognosis in patients with pancreatic carcinoma.Int J Biol Markers. 2010 Jul-Sep;25(3):136-40. doi: 10.1177/172460081002500303.
1134	Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.Genes Chromosomes Cancer. 2006 Jun;45(6):612-27. doi: 10.1002/gcc.20325.
1135	KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.J Clin Invest. 2013 Feb;123(2):727-39. doi: 10.1172/JCI64535. Epub 2013 Jan 16.
1136	Histone Demethylase JMJD2D Interacts With -Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.Gastroenterology. 2019 Mar;156(4):1112-1126. doi: 10.1053/j.gastro.2018.11.036. Epub 2018 Nov 23.
1137	Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer.Ann Thorac Surg. 2002 Mar;73(3):905-10. doi: 10.1016/s0003-4975(01)03413-0.
1138	KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.J Ovarian Res. 2014 May 12;7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014.
1139	Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.FASEB J. 2012 Dec;26(12):4937-50. doi: 10.1096/fj.12-209502. Epub 2012 Aug 28.
1140	KLF9-dependent ROS regulate melanoma progression in stage-specific manner.Oncogene. 2019 May;38(19):3585-3597. doi: 10.1038/s41388-019-0689-6. Epub 2019 Jan 21.
1141	Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.Oncotarget. 2016 Dec 20;7(51):84645-84657. doi: 10.18632/oncotarget.13175.
1142	Micrometastases in sentinel nodes of gastric cancer.Br J Cancer. 2003 Aug 18;89(4):676-80. doi: 10.1038/sj.bjc.6601183.
1143	YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16.Oncotarget. 2018 May 1;9(33):22915-22928. doi: 10.18632/oncotarget.25145. eCollection 2018 May 1.
1144	Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer.Cancer Med. 2018 Jul;7(7):3351-3362. doi: 10.1002/cam4.1576. Epub 2018 May 23.
1145	Rapid detection of metastasis of gastric cancer using reverse transcription loop-mediated isothermal amplification.Int J Cancer. 2007 Mar 1;120(5):1063-9. doi: 10.1002/ijc.22397.
1146	(18)F-Branched-Chain Amino Acids: Structure-Activity Relationships and PET Imaging Potential.J Nucl Med. 2019 Jul;60(7):1003-1009. doi: 10.2967/jnumed.118.220483. Epub 2019 Jan 25.
1147	Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.Oncogene. 2006 May 11;25(20):2953-60. doi: 10.1038/sj.onc.1209262.
1148	Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.J Immunol. 2015 Aug 15;195(4):1858-67. doi: 10.4049/jimmunol.1500365. Epub 2015 Jul 1.
1149	Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.Carcinogenesis. 2014 May;35(5):1154-61. doi: 10.1093/carcin/bgu040. Epub 2014 Feb 7.
1150	Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.J Biol Chem. 2013 Jan 18;288(3):1469-79. doi: 10.1074/jbc.M112.438341. Epub 2012 Nov 27.
1151	Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma.Oncogene. 2012 May 24;31(21):2640-52. doi: 10.1038/onc.2011.440. Epub 2011 Sep 26.
1152	A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas.Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17202-7. doi: 10.1073/pnas.0604481103. Epub 2006 Nov 1.
1153	Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.Mol Cancer. 2019 Jan 31;18(1):18. doi: 10.1186/s12943-019-0948-8.
1154	Validation of RNA arbitrarily primed PCR probes hybridized to glass cDNA microarrays: application to the analysis of limited samples.Clin Chem. 2005 Jan;51(1):93-101. doi: 10.1373/clinchem.2004.036236.
1155	ORAOV1 is a probable target within the 11q13.3 amplicon in lymph node metastases from gastric adenocarcinoma.Int J Mol Med. 2012 Jan;29(1):81-7. doi: 10.3892/ijmm.2011.811. Epub 2011 Oct 11.
1156	Tumor-suppressive functions of leucine zipper transcription factor-like 1.Cancer Res. 2010 Apr 1;70(7):2942-50. doi: 10.1158/0008-5472.CAN-09-3826. Epub 2010 Mar 16.
1157	Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.Cancer. 2009 Apr 15;115(8):1638-50. doi: 10.1002/cncr.24180.
1158	MAL2 expression predicts distant metastasis and short survival in pancreatic cancer.Surgery. 2013 Sep;154(3):573-82. doi: 10.1016/j.surg.2013.03.010. Epub 2013 Jul 19.
1159	Differentiation of classic medulloblastoma into metastatic large cell medulloblastoma with focal rhabdoid differentiation in the absence of posterior fossa recurrence.Acta Neuropathol. 2005 May;109(5):543-51. doi: 10.1007/s00401-005-0986-8. Epub 2005 Mar 10.
1160	The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.Breast Cancer Res Treat. 2012 Sep;135(2):381-90. doi: 10.1007/s10549-012-2155-9. Epub 2012 Jul 8.
1161	Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s.Am J Pathol. 2019 May;189(5):1065-1076. doi: 10.1016/j.ajpath.2019.01.010. Epub 2019 Feb 5.
1162	MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.Mol Cancer. 2014 Nov 6;13:245. doi: 10.1186/1476-4598-13-245.
1163	MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.Tumour Biol. 2015 Jun;36(6):4261-9. doi: 10.1007/s13277-015-3063-5. Epub 2015 Jan 16.
1164	Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.Eur J Cancer. 2014 Apr;50(6):1125-36. doi: 10.1016/j.ejca.2014.01.030. Epub 2014 Feb 21.
1165	Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130.Oncogene. 2007 Mar 15;26(12):1739-47. doi: 10.1038/sj.onc.1209963. Epub 2006 Sep 11.
1166	Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.J Exp Clin Cancer Res. 2019 Sep 6;38(1):393. doi: 10.1186/s13046-019-1408-4.
1167	Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation.Biochem J. 2013 Jan 15;449(2):437-48. doi: 10.1042/BJ20120343.
1168	Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization.Oncogene. 1990 Sep;5(9):1391-5.
1169	Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer.Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):147-56. doi: 10.1097/01.pai.0000137364.36091.b0.
1170	Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.Clin Cancer Res. 2008 Nov 1;14(21):6979-87. doi: 10.1158/1078-0432.CCR-08-0090.
1171	AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck.Pathol Oncol Res. 2020 Apr;26(2):1287-1292. doi: 10.1007/s12253-019-00696-z. Epub 2019 Jul 4.
1172	MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer.BMC Cancer. 2011 May 26;11:200. doi: 10.1186/1471-2407-11-200.
1173	Expression of stromal cell markers in distinct compartments of human skin cancers.J Cutan Pathol. 2006 Feb;33(2):145-55. doi: 10.1111/j.0303-6987.2006.00446.x.
1174	Identification of URIM, a novel gene up-regulated in metastasis.Anticancer Res. 1999 Jan-Feb;19(1A):525-30.
1175	Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression.Cancer Res. 2004 Feb 1;64(3):864-70. doi: 10.1158/0008-5472.can-03-2807.
1176	Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis.Melanoma Res. 2010 Oct;20(5):392-400.
1177	Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1.J Pathol. 2013 Jun;230(2):184-93. doi: 10.1002/path.4169.
1178	Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.BMC Cancer. 2010 Aug 15;10:428. doi: 10.1186/1471-2407-10-428.
1179	Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.Ann Surg Oncol. 2012 Nov;19(12):3719-26. doi: 10.1245/s10434-012-2454-8. Epub 2012 Jul 3.
1180	B-myb is a gene implicated in cell cycle and proliferation of breast cancer.Int J Clin Exp Pathol. 2014 Aug 15;7(9):5819-27. eCollection 2014.
1181	Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.Genes Chromosomes Cancer. 1991 Nov;3(6):443-54. doi: 10.1002/gcc.2870030606.
1182	MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.PLoS One. 2011 Apr 18;6(4):e18409. doi: 10.1371/journal.pone.0018409.
1183	Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.PLoS One. 2014 Sep 26;9(9):e108609. doi: 10.1371/journal.pone.0108609. eCollection 2014.
1184	Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.Cancer Gene Ther. 2005 Apr;12(4):350-8. doi: 10.1038/sj.cgt.7700794.
1185	NANOG modulates stemness in human colorectal cancer.Oncogene. 2013 Sep 12;32(37):4397-405. doi: 10.1038/onc.2012.461. Epub 2012 Oct 22.
1186	Regulation of metastasis; mitochondrial DNA mutations have appeared on stage.J Bioenerg Biomembr. 2012 Dec;44(6):639-44. doi: 10.1007/s10863-012-9468-6.
1187	N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.J Exp Clin Cancer Res. 2019 Dec 12;38(1):490. doi: 10.1186/s13046-019-1476-5.
1188	Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.Hepatol Int. 2016 Mar;10(2):370-6. doi: 10.1007/s12072-015-9686-1. Epub 2015 Dec 8.
1189	Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2.Hum Reprod. 2012 Nov;27(11):3179-86. doi: 10.1093/humrep/des304. Epub 2012 Aug 27.
1190	Decreased expression of NEDD4L contributes to NSCLC progression and metastasis.Biochem Biophys Res Commun. 2019 May 28;513(2):398-404. doi: 10.1016/j.bbrc.2019.04.001. Epub 2019 Apr 6.
1191	Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer.Int J Cancer. 1998 Dec 9;78(6):766-74. doi: 10.1002/(sici)1097-0215(19981209)78:6<766::aid-ijc15>3.0.co;2-l.
1192	Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.Cancer Res. 1997 Aug 15;57(16):3526-31.
1193	NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.Oncogene. 2010 Apr 15;29(15):2292-301. doi: 10.1038/onc.2009.499. Epub 2010 Jan 25.
1194	Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.J Pathol. 2019 Feb;247(2):199-213. doi: 10.1002/path.5183. Epub 2018 Dec 28.
1195	Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.Clin Cancer Res. 2007 Dec 1;13(23):6978-83. doi: 10.1158/1078-0432.CCR-07-1417.
1196	Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2.Clin Epigenetics. 2019 Feb 14;11(1):29. doi: 10.1186/s13148-019-0624-2.
1197	Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread.Clin Proteomics. 2019 Jan 22;16:3. doi: 10.1186/s12014-019-9223-7. eCollection 2019.
1198	Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.Cancer Cell. 2013 Jan 14;23(1):63-76. doi: 10.1016/j.ccr.2012.11.019.
1199	Highly bright and stable NIR-BRET with blue-shifted coelenterazine derivatives for deep-tissue imaging of molecular events in vivo.Theranostics. 2019 Apr 13;9(9):2646-2661. doi: 10.7150/thno.32219. eCollection 2019.
1200	Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer.Diagn Mol Pathol. 1997 Aug;6(4):209-21. doi: 10.1097/00019606-199708000-00005.
1201	Differential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture.BMC Cancer. 2009 Jun 5;9:169. doi: 10.1186/1471-2407-9-169.
1202	NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-/TGF-RI/SMADs signaling.Biochem Biophys Res Commun. 2019 Nov 12;519(3):489-496. doi: 10.1016/j.bbrc.2019.08.020. Epub 2019 Sep 14.
1203	NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.Oncol Rep. 2017 Jan;37(1):449-457. doi: 10.3892/or.2016.5239. Epub 2016 Nov 9.
1204	NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.Cancer Sci. 2017 Jun;108(6):1169-1176. doi: 10.1111/cas.13243. Epub 2017 Jun 14.
1205	Different expression of occludin and ZO-1 in primary and metastatic liver tumors.Pathol Oncol Res. 2008 Sep;14(3):299-306. doi: 10.1007/s12253-008-9031-2. Epub 2008 Apr 2.
1206	OLIG2 as a specific marker of oligodendroglial tumour cells.Lancet. 2001 Jul 28;358(9278):298-300. doi: 10.1016/S0140-6736(01)05499-X.
1207	HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model.J Cell Physiol. 2019 Apr;234(4):3675-3684. doi: 10.1002/jcp.27140. Epub 2018 Sep 7.
1208	Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin.Int J Cancer. 2007 Jul 1;121(1):184-92. doi: 10.1002/ijc.22644.
1209	Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.Eur J Endocrinol. 2013 Jan 17;168(2):253-61. doi: 10.1530/EJE-12-0814. Print 2013 Feb.
1210	Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.Parasitol Int. 2012 Mar;61(1):136-9. doi: 10.1016/j.parint.2011.07.003. Epub 2011 Jul 8.
1211	Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.Onco Targets Ther. 2017 Mar 8;10:1475-1485. doi: 10.2147/OTT.S92389. eCollection 2017.
1212	Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.Int J Pharm. 2018 May 30;543(1-2):130-138. doi: 10.1016/j.ijpharm.2018.03.045. Epub 2018 Mar 27.
1213	Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer.Lung Cancer. 2012 Sep;77(3):585-92. doi: 10.1016/j.lungcan.2012.05.105. Epub 2012 Jun 29.
1214	Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype.J Biol Chem. 2012 Aug 17;287(34):29184-93. doi: 10.1074/jbc.M112.377176. Epub 2012 Jun 29.
1215	Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5.Cell Physiol Biochem. 2015;35(2):740-54. doi: 10.1159/000369734. Epub 2015 Jan 30.
1216	Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):637-643. doi: 10.1097/PAI.0000000000000707.
1217	MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.Oncotarget. 2016 Jul 5;7(27):42461-42473. doi: 10.18632/oncotarget.9886.
1218	3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end.RNA Biol. 2011 Jul-Aug;8(4):595-9. doi: 10.4161/rna.8.4.16018. Epub 2011 Jul 1.
1219	Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.Urol Oncol. 2011 May-Jun;29(3):244-51. doi: 10.1016/j.urolonc.2009.02.004. Epub 2009 Apr 22.
1220	PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma.Hepatology. 2020 May;71(5):1643-1659. doi: 10.1002/hep.30930. Epub 2020 Jan 21.
1221	PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.Oncol Rep. 2019 Jan;41(1):43-56. doi: 10.3892/or.2018.6825. Epub 2018 Oct 25.
1222	Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.Oncogene. 2014 Jul 10;33(28):3707-16. doi: 10.1038/onc.2013.332. Epub 2013 Aug 26.
1223	Loss of heterozygosity of gene THW is frequently found in melanoma metastases.Anticancer Res. 2001 Mar-Apr;21(2A):1071-80.
1224	PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.Cell Physiol Biochem. 2018;50(6):2108-2123. doi: 10.1159/000495055. Epub 2018 Nov 9.
1225	Loss of profilin2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.Int J Oncol. 2018 Sep;53(3):1118-1128. doi: 10.3892/ijo.2018.4475. Epub 2018 Jul 9.
1226	PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.Cell Physiol Biochem. 2018;51(5):2434-2444. doi: 10.1159/000495900. Epub 2018 Dec 11.
1227	The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer.Transl Oncol. 2018 Apr;11(2):436-443. doi: 10.1016/j.tranon.2018.01.015. Epub 2018 Feb 21.
1228	PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.Cancer Res. 2011 May 15;71(10):3709-19. doi: 10.1158/0008-5472.CAN-10-2342. Epub 2011 May 10.
1229	The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.J Natl Cancer Inst. 2011 Nov 16;103(22):1696-712. doi: 10.1093/jnci/djr360. Epub 2011 Oct 24.
1230	Overexpression of PIWI proteins in human stage III epithelial ovarian cancer with lymph node metastasis.Cancer Biomark. 2013;13(5):315-21. doi: 10.3233/CBM-130360.
1231	Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.PLoS One. 2014 Mar 6;9(3):e90528. doi: 10.1371/journal.pone.0090528. eCollection 2014.
1232	ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.J Clin Invest. 2012 Apr;122(4):1296-305. doi: 10.1172/JCI60568. Epub 2012 Mar 1.
1233	Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.Asia Pac J Clin Oncol. 2011 Dec;7(4):339-45. doi: 10.1111/j.1743-7563.2011.01437.x.
1234	Visualization of the metastatic process by green fluorescent protein expression.Anticancer Res. 1997 Jul-Aug;17(4A):2377-84.
1235	Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.J Neurooncol. 2000 Jun;48(2):103-11. doi: 10.1023/a:1006446426611.
1236	SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.Gynecol Oncol. 2019 Jun;153(3):651-660. doi: 10.1016/j.ygyno.2019.03.099. Epub 2019 Mar 21.
1237	Pyrophosphatase 1 expression is associated with future recurrence and overall survival in Chinese patients with intrahepatic cholangiocarcinoma.Oncol Lett. 2018 May;15(5):8095-8101. doi: 10.3892/ol.2018.8278. Epub 2018 Mar 15.
1238	Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway.Biol Chem. 2007 May;388(5):489-95. doi: 10.1515/BC.2007.062.
1239	Low spinophilin expression enhances aggressive biological behavior of breast cancer.Oncotarget. 2015 May 10;6(13):11191-202. doi: 10.18632/oncotarget.3586.
1240	Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms.Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2737-47. doi: 10.1158/1055-9965.EPI-14-0683. Epub 2014 Sep 9.
1241	Anticancer activity of the PR domain of tumor suppressor RIZ1.Int J Med Sci. 2011 Feb 21;8(2):161-7. doi: 10.7150/ijms.8.161.
1242	PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.Cell Rep. 2014 Sep 25;8(6):1957-1973. doi: 10.1016/j.celrep.2014.08.041. Epub 2014 Sep 18.
1243	New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.PLoS One. 2009;4(3):e4995. doi: 10.1371/journal.pone.0004995. Epub 2009 Mar 25.
1244	Loss of receptor protein tyrosine phosphatase / (RPTP/) promotes prostate cancer metastasis.J Biol Chem. 2012 Nov 23;287(48):40339-49. doi: 10.1074/jbc.M112.405852. Epub 2012 Oct 11.
1245	Bit1 in anoikis resistance and tumor metastasis.Cancer Lett. 2013 Jun 10;333(2):147-51. doi: 10.1016/j.canlet.2013.01.043. Epub 2013 Jan 31.
1246	Pituitary tumor-transforming gene 1 is expressed in primary ductal breast carcinoma, lymph node infiltration, and distant metastases.Dis Markers. 2013;35(4):267-72. doi: 10.1155/2013/912304.
1247	Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition.J Cancer. 2018 Jun 23;9(15):2650-2658. doi: 10.7150/jca.25188. eCollection 2018.
1248	The bispecific anti-CD3anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer.Invest New Drugs. 2019 Oct;37(5):810-817. doi: 10.1007/s10637-018-0683-9. Epub 2018 Oct 29.
1249	Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma.J Biol Chem. 1995 Oct 27;270(43):25715-21. doi: 10.1074/jbc.270.43.25715.
1250	Hypoxia-induced Rab11-family interacting protein4expression promotes migration and invasion of colon cancer and correlates with poor prognosis.Mol Med Rep. 2018 Mar;17(3):3797-3806. doi: 10.3892/mmr.2017.8283. Epub 2017 Dec 15.
1251	Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway.Tumour Biol. 2015 Aug;36(8):5815-24. doi: 10.1007/s13277-015-3251-3. Epub 2015 Feb 24.
1252	Inactivation of Rab23 inhibits the invasion and motility of pancreatic duct adenocarcinoma.Genet Mol Res. 2015 Mar 30;14(1):2707-15. doi: 10.4238/2015.March.30.31.
1253	Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.Tumour Biol. 2015 Nov;36(11):8661-70. doi: 10.1007/s13277-015-3626-5. Epub 2015 Jun 6.
1254	RAB38 is a potential prognostic factor for tumor recurrence in non-small cell lung cancer.Oncol Lett. 2019 Sep;18(3):2598-2604. doi: 10.3892/ol.2019.10547. Epub 2019 Jun 28.
1255	RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.J Exp Clin Cancer Res. 2013 Aug 13;32(1):52. doi: 10.1186/1756-9966-32-52.
1256	Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.Int J Cancer. 1989 Sep 15;44(3):554-9. doi: 10.1002/ijc.2910440330.
1257	Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.J Invest Dermatol. 2012 Dec;132(12):2780-90. doi: 10.1038/jid.2012.233. Epub 2012 Jul 26.
1258	Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14911-8. doi: 10.1073/pnas.96.26.14911.
1259	RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-B pathway.Cancer Biol Ther. 2019;20(4):435-443. doi: 10.1080/15384047.2018.1529117. Epub 2018 Oct 25.
1260	Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.J Neurooncol. 2018 Nov;140(2):237-248. doi: 10.1007/s11060-018-2959-5. Epub 2018 Aug 9.
1261	Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.Sci Rep. 2017 Jul 5;7(1):4687. doi: 10.1038/s41598-017-04234-2.
1262	RCAN1-4 is a thyroid cancer growth and metastasis suppressor.JCI Insight. 2017 Mar 9;2(5):e90651. doi: 10.1172/jci.insight.90651.
1263	Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma.Am J Cancer Res. 2017 Mar 1;7(3):688-699. eCollection 2017.
1264	FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.Mol Oncol. 2019 Apr;13(4):792-810. doi: 10.1002/1878-0261.12429. Epub 2019 Jan 24.
1265	Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.Cancer Lett. 2013 Oct 1;339(1):33-41. doi: 10.1016/j.canlet.2013.07.025. Epub 2013 Jul 30.
1266	RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
1267	Over-expression of regulator of G protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells.J Surg Oncol. 2013 Sep;108(3):192-6. doi: 10.1002/jso.23367. Epub 2013 Jul 19.
1268	Reduced expression of epidermal growth factor receptor related protein in gastric cancer.Gut. 2005 Feb;54(2):201-6. doi: 10.1136/gut.2003.027078.
1269	Arkadia regulates tumor metastasis by modulation of the TGF- pathway.Cancer Res. 2013 Mar 15;73(6):1800-10. doi: 10.1158/0008-5472.CAN-12-1916. Epub 2013 Mar 6.
1270	RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms.Pancreas. 2011 May;40(4):627-33. doi: 10.1097/MPA.0b013e3182152bda.
1271	S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.Acta Biochim Pol. 2012;59(4):593-8. Epub 2012 Nov 16.
1272	Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302.
1273	S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.DNA Cell Biol. 2018 May;37(5):491-500. doi: 10.1089/dna.2017.3953. Epub 2018 Feb 27.
1274	A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol. 2019 Dec;32(12):1834-1846. doi: 10.1038/s41379-019-0302-0. Epub 2019 Jun 25.
1275	RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.Am J Clin Pathol. 2004 May;121(5):637-43. doi: 10.1309/MMAC-TXT5-5L8Q-TKC1.
1276	Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.Clin Exp Metastasis. 2014 Dec;31(8):935-44. doi: 10.1007/s10585-014-9681-2. Epub 2014 Sep 21.
1277	SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-RI.Mol Carcinog. 2017 Oct;56(10):2332-2341. doi: 10.1002/mc.22687. Epub 2017 Jun 30.
1278	SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.Cell Death Dis. 2019 Sep 26;10(10):720. doi: 10.1038/s41419-019-1947-9.
1279	sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line.Cancer Biother Radiopharm. 2013 Sep;28(7):565-71. doi: 10.1089/cbr.2012.1453. Epub 2013 Jun 26.
1280	Mitochondrial Reprogramming Regulates Breast Cancer Progression.Clin Cancer Res. 2016 Jul 1;22(13):3348-60. doi: 10.1158/1078-0432.CCR-15-2456. Epub 2016 Feb 17.
1281	SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3509-14. doi: 10.1073/pnas.0712269105. Epub 2008 Feb 26.
1282	Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.Gynecol Oncol. 2010 Mar;116(3):539-43. doi: 10.1016/j.ygyno.2009.09.037. Epub 2009 Nov 10.
1283	Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.Biomed Pharmacother. 2019 Jun;114:108864. doi: 10.1016/j.biopha.2019.108864. Epub 2019 Apr 10.
1284	Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):190-195. doi: 10.1007/s00259-016-3485-3. Epub 2016 Aug 16.
1285	SMAGP, a new small trans-membrane glycoprotein altered in cancer.Oncogene. 2004 Apr 22;23(19):3395-403. doi: 10.1038/sj.onc.1207469.
1286	Aberrant BAF57 signaling facilitates prometastatic phenotypes.Clin Cancer Res. 2013 May 15;19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14.
1287	G9a and histone deacetylases are crucial for Snail2-mediated E-cadherin repression and metastasis in hepatocellular carcinoma.Cancer Sci. 2019 Nov;110(11):3442-3452. doi: 10.1111/cas.14173. Epub 2019 Sep 19.
1288	Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.Cancer Res. 1996 Apr 15;56(8):1823-7.
1289	A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer.Hum Pathol. 2019 Mar;85:221-227. doi: 10.1016/j.humpath.2018.11.005. Epub 2018 Nov 20.
1290	LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.Mol Med Rep. 2018 Jun;17(6):8282-8288. doi: 10.3892/mmr.2018.8892. Epub 2018 Apr 18.
1291	The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.Hum Pathol. 2013 Oct;44(10):2188-98. doi: 10.1016/j.humpath.2013.04.013. Epub 2013 Jul 8.
1292	Expression of PH-20 in normal and neoplastic breast tissue.J Surg Res. 2002 Apr;103(2):203-7. doi: 10.1006/jsre.2002.6351.
1293	SPARCL1 suppresses metastasis in prostate cancer.Mol Oncol. 2013 Dec;7(6):1019-30. doi: 10.1016/j.molonc.2013.07.008. Epub 2013 Jul 20.
1294	ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.Carcinogenesis. 2007 Nov;28(11):2274-81. doi: 10.1093/carcin/bgm140. Epub 2007 Jun 29.
1295	Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.J Cell Mol Med. 2020 Jan;24(1):98-113. doi: 10.1111/jcmm.14618. Epub 2019 Nov 5.
1296	Small proline rich protein 2a in benign and malignant liver disease.Hepatology. 2014 Mar;59(3):1130-43. doi: 10.1002/hep.26889. Epub 2014 Jan 27.
1297	SPSB3 targets SNAIL for degradation in GSK-3 phosphorylation-dependent manner and regulates metastasis.Oncogene. 2018 Feb 8;37(6):768-776. doi: 10.1038/onc.2017.370. Epub 2017 Oct 23.
1298	SPZ1 is critical for chemoresistance and aggressiveness in drug-resistant breast cancer cells.Biochem Pharmacol. 2018 Oct;156:43-51. doi: 10.1016/j.bcp.2018.07.046. Epub 2018 Aug 1.
1299	SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer.Lung Cancer. 2016 Sep;99:57-65. doi: 10.1016/j.lungcan.2016.05.018. Epub 2016 May 26.
1300	Splicing factor SRSF6 promotes hyperplasia of sensitized skin.Nat Struct Mol Biol. 2014 Feb;21(2):189-97. doi: 10.1038/nsmb.2756. Epub 2014 Jan 19.
1301	Clinical impact of molecular and cytogenetic findings in synovial sarcoma.Genes Chromosomes Cancer. 2001 Aug;31(4):362-72. doi: 10.1002/gcc.1155.
1302	Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.Cancer Res. 2005 Mar 15;65(6):2207-15. doi: 10.1158/0008-5472.CAN-04-1882.
1303	STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-.Melanoma Res. 2018 Jun;28(3):204-210. doi: 10.1097/CMR.0000000000000435.
1304	STIM1 silencing inhibits the migration and invasion of A549 cells.Mol Med Rep. 2017 Sep;16(3):3283-3289. doi: 10.3892/mmr.2017.7010. Epub 2017 Jul 15.
1305	Association between LKB1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.BMJ Open. 2019 Aug 5;9(8):e027185. doi: 10.1136/bmjopen-2018-027185.
1306	miR-199b-5p-Stonin 2 axis regulates metastases and epithelial-to-mesenchymal transition of papillary thyroid carcinoma.IUBMB Life. 2019 Jan;71(1):28-40. doi: 10.1002/iub.1889. Epub 2018 Oct 16.
1307	SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.Oncotarget. 2017 Sep 19;8(52):89692-89706. doi: 10.18632/oncotarget.21058. eCollection 2017 Oct 27.
1308	TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex.Oncotarget. 2017 Nov 18;8(63):106565-106576. doi: 10.18632/oncotarget.22497. eCollection 2017 Dec 5.
1309	MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.Int J Cancer. 2004 Mar 20;109(2):265-73. doi: 10.1002/ijc.11681.
1310	Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma.Hum Mol Genet. 2012 Apr 1;21(7):1557-65. doi: 10.1093/hmg/ddr593. Epub 2011 Dec 15.
1311	Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics.Oncol Lett. 2018 Jan;15(1):1037-1045. doi: 10.3892/ol.2017.7402. Epub 2017 Nov 14.
1312	C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer.Int J Cancer. 2004 Aug 10;111(1):72-5. doi: 10.1002/ijc.20235.
1313	Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.Clin Cancer Res. 2009 Oct 1;15(19):5993-6001. doi: 10.1158/1078-0432.CCR-09-0557. Epub 2009 Sep 15.
1314	Aberrant expression of trefoil factor 3 is associated with colorectal carcinoma metastasis.J Cancer Res Ther. 2013 Jul-Sep;9(3):376-80. doi: 10.4103/0973-1482.119308.
1315	A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function.Mol Cell Biol. 2012 May;32(9):1654-70. doi: 10.1128/MCB.06033-11. Epub 2012 Feb 27.
1316	Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis.Cell Death Dis. 2019 Oct 17;10(11):793. doi: 10.1038/s41419-019-2016-0.
1317	Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells.J Cell Sci. 2012 Dec 15;125(Pt 24):5960-73. doi: 10.1242/jcs.100586. Epub 2012 Oct 17.
1318	The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.Endocr Relat Cancer. 2010 Oct 5;17(4):897-908. doi: 10.1677/ERC-10-0020. Print 2010 Dec.
1319	TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.Cancer Cell Int. 2019 Mar 29;19:75. doi: 10.1186/s12935-019-0791-4. eCollection 2019.
1320	Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis.J Cell Mol Med. 2014 Aug;18(8):1655-66. doi: 10.1111/jcmm.12352. Epub 2014 Jun 28.
1321	Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.Epigenetics. 2017 Jul 3;12(7):575-583. doi: 10.1080/15592294.2017.1341027. Epub 2017 Jul 5.
1322	Expression and purification of a rapidly degraded protein, TMEM8B-a, in mammalian cell line.Protein Expr Purif. 2018 Nov;151:38-45. doi: 10.1016/j.pep.2018.06.002. Epub 2018 Jun 8.
1323	Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.BMC Cancer. 2008 Jul 1;8:187. doi: 10.1186/1471-2407-8-187.
1324	Expression of decoy receptor 3 in liver tissue microarrays.Natl Med J India. 2008 Nov-Dec;21(6):275-8.
1325	ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17969-74. doi: 10.1073/pnas.1309362110. Epub 2013 Oct 14.
1326	StarD13 3'-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity.Eur J Cell Biol. 2018 Jan;97(1):23-31. doi: 10.1016/j.ejcb.2017.11.002. Epub 2017 Nov 11.
1327	TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma.Cell Physiol Biochem. 2018;50(5):2004-2016. doi: 10.1159/000494892. Epub 2018 Nov 7.
1328	TRAF4 overexpression is a common characteristic of human carcinomas.Oncogene. 2007 Jan 4;26(1):142-7. doi: 10.1038/sj.onc.1209762. Epub 2006 Jun 26.
1329	TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.Cell Death Dis. 2016 Dec 15;7(12):e2522. doi: 10.1038/cddis.2016.400.
1330	Knockdown of TRB3 induces apoptosis in human lung adenocarcinoma cells through regulation of Notch 1 expression.Mol Med Rep. 2013 Jul;8(1):47-52. doi: 10.3892/mmr.2013.1453. Epub 2013 Apr 30.
1331	TRIM2 is a novel promoter of human colorectal cancer.Scand J Gastroenterol. 2019 Feb;54(2):210-218. doi: 10.1080/00365521.2019.1575463. Epub 2019 Mar 27.
1332	TRIM65 triggers -catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.J Cell Sci. 2017 Sep 15;130(18):3108-3115. doi: 10.1242/jcs.206623. Epub 2017 Jul 28.
1333	NF-kappa B genes have a major role in inflammatory breast cancer.BMC Cancer. 2008 Feb 4;8:41. doi: 10.1186/1471-2407-8-41.
1334	Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.J Pathol. 2019 Aug;248(4):421-437. doi: 10.1002/path.5281. Epub 2019 Jun 18.
1335	Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).J Biol Chem. 2012 Aug 17;287(34):28790-801. doi: 10.1074/jbc.M112.367987. Epub 2012 Jul 2.
1336	Changes in Vasodilator-Stimulated Phosphoprotein Phosphorylation, Profilin-1, and Cofilin-1 in Accreta and Protection by DHA.Reprod Sci. 2019 Jun;26(6):757-765. doi: 10.1177/1933719118792095. Epub 2018 Aug 9.
1337	Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.Gastroenterology. 2019 Jan;156(1):203-217.e20. doi: 10.1053/j.gastro.2018.09.053. Epub 2018 Oct 6.
1338	BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.Oncotarget. 2015 Aug 21;6(24):20252-65. doi: 10.18632/oncotarget.3857.
1339	Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.Cell Physiol Biochem. 2018;45(5):1759-1771. doi: 10.1159/000487784. Epub 2018 Feb 23.
1340	Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma.Int J Cancer. 2008 Aug 15;123(4):826-30. doi: 10.1002/ijc.23577.
1341	Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers.Biosci Rep. 2019 May 7;39(5):BSR20181743. doi: 10.1042/BSR20181743. Print 2019 May 31.
1342	Nucleoside Diphosphate Kinase Escalates A-to-C Mutations in MutT-Deficient Strains of Escherichia coli.J Bacteriol. 2019 Dec 6;202(1):e00567-19. doi: 10.1128/JB.00567-19. Print 2019 Dec 6.
1343	DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.J Cell Mol Med. 2020 Jan;24(1):1141-1145. doi: 10.1111/jcmm.14734. Epub 2019 Nov 20.
1344	Significance of ELF3 mRNA expression for detection of lymph node metastases of colorectal cancer.Anticancer Res. 2012 Sep;32(9):3753-8.
1345	EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):309-318. doi: 10.21873/cgp.20136.
1346	GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.Oncogene. 2018 Mar;37(10):1340-1353. doi: 10.1038/s41388-017-0038-6. Epub 2017 Dec 19.
1347	HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma.Int J Biol Sci. 2019 May 7;15(6):1139-1147. doi: 10.7150/ijbs.30904. eCollection 2019.
1348	Intrabiliary metastases in colorectal cancer: a systematic review.J Hepatobiliary Pancreat Sci. 2019 Jul;26(7):270-280. doi: 10.1002/jhbp.635. Epub 2019 Jun 10.
1349	Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
1350	Unconventional myosin VIIA promotes melanoma progression.J Cell Sci. 2018 Feb 22;131(4):jcs209924. doi: 10.1242/jcs.209924.
1351	Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis.EMBO Rep. 2015 Oct;16(10):1394-408. doi: 10.15252/embr.201540107. Epub 2015 Aug 31.
1352	Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.BMC Cancer. 2019 Jun 17;19(1):599. doi: 10.1186/s12885-019-5808-9.
1353	Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.Cell Death Dis. 2019 Jun 17;10(7):477. doi: 10.1038/s41419-019-1703-1.
1354	Twist on a classic: vitamin D and hypercalcaemia of malignancy.BMJ Case Rep. 2017 Nov 23;2017:bcr2017220819. doi: 10.1136/bcr-2017-220819.
1355	Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.Oncogene. 2020 Feb;39(9):1914-1930. doi: 10.1038/s41388-019-1112-z. Epub 2019 Nov 21.
1356	Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma?.Oncotarget. 2018 Apr 3;9(25):17656-17663. doi: 10.18632/oncotarget.24825. eCollection 2018 Apr 3.
1357	Novel role of Snail 1 in promoting tumor neoangiogenesis.Biosci Rep. 2019 May 10;39(5):BSR20182161. doi: 10.1042/BSR20182161. Print 2019 May 31.
1358	BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.Cancer Lett. 2016 Feb 1;371(1):125-33. doi: 10.1016/j.canlet.2015.11.031. Epub 2015 Dec 3.